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Abstract	  
	  Human	   embryonic	   stem	   (ES)	   cells	   are	   derived	   from	   the	   inner	   cell	   mass	   of	  blastocyst	   stage	   embryos.	   	   Once	   explanted	   and	   cultured	   in	   vitro	   under	  appropriate	   conditions,	   human	   ES	   cells	   retain	   pluripotency	   (i.e.	   capacity	   to	  differentiate	   into	   all	   somatic	   cell	   types)	   and	   acquire	   the	   ability	   to	   self-­‐renew	  indefinitely.	   	  These	  two	  properties	  of	  human	  ES	  cells	  make	  them	  an	  invaluable	  resource	   for	   developmental	   biology,	   cell	   replacement	   therapies,	   drug	  development	  and	  toxicology	  screening.	  	  	  	  In	   order	   to	   exploit	   these	   unique	   cells	   and	   to	   better	   understand	   human	  development,	   it	   is	   imperative	   to	   understand	   the	   mechanisms	   behind	   the	  specification	   of	   somatic	   cell	   types.	   Much	   work	   has	   been	   conducted	   on	  monolayer	   formats	   to	   delineate	   signalling	   and	   gene	   expression	   networks	  responsible	  for	  lineage	  specific	  differentiation,	  however	  less	  focus	  has	  been	  on	  the	   use	   of	   embryoid	   bodies	   as	   a	   more	   representative	   model	   of	   in	   vivo	  differentiation.	   In	   this	   study	   we	   develop	   a	   differentiation	   assay	   to	   better	  recapitulate	  embryonic	  development,	  which	  we	  also	  show	  as	  a	  useful	  model	  for	  predictive	   toxicology.	   Within	   the	   assay,	   however,	   we	   found	   persistently	  heterogeneous	   differentiation.	   To	   better	   understand	   how	   hESCs	  make	   lineage	  decisions,	   we	   went	   back	   to	   interrogate	   heterogeneity	   within	   the	   stem	   cell	  compartment,	  and	  show	  that	  discreet,	  but	  functional	  heterogeneity	  biases	  cells	  to	   particular	   fates.	   Finally,	  we	   shed	   light	   onto	   a	   potential	  mechanism	   through	  which	   heterogeneity	   arises,	   which	   could	   offer	   a	   platform	   for	   future	   work	   to	  homogenise	  stem	  cells	  thus	  resulting	  in	  uniform,	  controlled	  differentiation.	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1 General	  Introduction	  
	  
	  1.1 Stem	  cells	  and	  pluripotency	  	  	  	  The	  human	  body	  consists	  of	  hugely	  diverse	  and	  specialised	  cell	  types	  that	  have	  individual	   roles	   depending	   upon	   their	   location.	   The	   intricate	   actions	   and	  interactions	   of	   and	   between	   different	   cell	   types	   allows	   for	   the	   proper	  development	  and	  functioning	  of	  the	  human	  body.	  These	  markedly	  different	  cell	  types	  however,	  all	  arise	  from	  a	  single	  cell	  known	  as	  the	  zygote,	  which	  contains	  a	  single	  genome.	  	  Once	  the	  zygote	  has	  been	  established	  via	  sperm	  and	  egg	  fusing	  in	   sexual	   reproduction,	   it	   undergoes	   cleavage	   events	   to	   form	   the	  morula.	   The	  totipotent	   morula	   continues	   to	   divide	   and	   undergoes	   compaction	   before	  reaching	  the	  blastocyst	  stage,	  which	  marks	  the	  first	  point	  of	  lineage	  segregation.	  Here	  outer	   cells	   of	   the	  morula	  differentiate	   towards	   the	   trophoblastic	   lineage,	  whilst	  the	  inner	  cells	  will	  form	  the	  inner	  cell	  mass	  (ICM).	  It	  is	  the	  ICM	  that	  will	  go	  on	  to	  form	  all	  somatic	  and	  germ	  cell	  lineages,	  and	  are	  also	  the	  cells	  that	  can	  be	  isolated	  in	  vitro	  to	  generate	  human	  embryonic	  stem	  cell	  (hESC)	  lines.	  	  	  hESCs	  have	  unique	  characteristics,	  specifically,	  they	  can	  self-­‐renew	  indefinitely	  whilst	   still	   retaining	   the	   ability	   to	   differentiate	   into	   all	   cell	   types	   of	   the	   adult.	  	  For	  this	  reason,	  hESCs	  hold	  great	  potential	  in	  applications	  such	  as	  regenerative	  medicine,	  disease	  modelling	  and	  toxicology.	  Nevertheless,	  substantial	  progress	  towards	   these	   applications	   has	   only	   occurred	   relatively	   recently	   due	   to	   the	  ethical	   and	   practical	   issues	   of	   research	  with	   human	   embryos.	   The	   benefits	   of	  hESCs	   are	   particularly	   apparent	   within	   the	   area	   of	   toxicology	   and	   drug	  development.	   Classified	   as	   a	   ‘near-­‐term’	   use	   of	   ES	   cell	   technology	   by	   the	  consortium	   ‘Stem	   Cells	   for	   Safer	   Medicine’	   (SC4SM)	   in	   the	   recent	   Pattison	  Report,	  it	  is	  believed	  that,	  in	  principle,	  hESCs	  could	  be	  used	  to	  faithfully	  predict	  drug	   toxicity	   (Rubin	  2008).	  With	   an	  understanding	  of	   the	   signalling	  pathways	  that	   are	   active	   or	   inhibited	   in	   cell	   specification,	   protocols	   now	   exist	   for	   the	  differentiation	   of	   hESC	   to	   toxicologically	   relevant	   cell	   types,	   including	  cardiomyoctes	  and	  hepatocytes.	  These	  cell	   types	  are	  particularly	   important	  as	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cardiotoxicity	   and	   hepatoxicity	   are	   often	   the	   cause	   of	   drug	   failure,	   and	   are	  difficult	   to	  source	  (Denning	  &	  Anderson	  2008;	  Greenhough	  et	  al.	  2010).	  There	  continues	  to	  be,	  however,	  a	  lack	  of	  high-­‐throughput	  in	  vitro	  assays	  to	  predict	  the	  toxic	  potential	  of	  new	  drugs.	  	  The	  use	  of	  hESCs	   in	   therapeutic	  and	  toxicological	  applications,	  however,	  relies	  on	   our	   ability	   to	   efficiently	   and	   reproducibly	   differentiate	   cells	   to	   desired	   cell	  types.	  Before	  permission	  was	  granted	  in	  1998	  for	  the	  use	  of	  human	  embryos	  for	  cell	   line	   derivation,	   some	   of	   the	   knowledge	   that	   was	   gained	   with	   respect	   to	  pluripotency,	   differentiation	   and	   the	   mechanisms	   behind	   early	   development	  were	  obtained	  from	  embryonal	  carcinoma	  (EC)	  cells,	  the	  malignant	  counterpart	  to	   embryonic	   stem	   cells,	   and	   animal	   models.	   The	   characterisation	   and	  techniques	  used	  to	  derive	  mouse	  EC,	  ESC	  and	  human	  EC	  cells	  in	  vitro,	  then	  laid	  the	   foundations	   for	   the	   successful	   derivation	   of	   hESCs.	   Since	   their	   derivation	  there	  have	  been	  a	  large	  number	  of	  reports	  detailing	  the	  directed	  differentiation	  of	   hESCs,	   but	   it	   is	   becoming	   increasingly	   apparent	   that	   the	   intricacy	   of	   fate	  decisions	   extends	   beyond	   our	   current	   knowledge.	   A	   reoccurring	   feature	   that	  continues	   to	   plague	   directed	   differentiation	   is	   the	   lack	   of	   efficiency	   and	   the	  heterogeneity	   of	   differentiated	   cell	   types	   that	   result.	   This	   points	   to	   more	  fundamental	  mechanisms	   through	  which	   cells	   respond	   to	   environmental	   cues	  and	  acquire	  appropriate	  fates.	  Accumulating	  evidence	  demonstrates	  that	  hESCs	  show	   a	   high	   degree	   of	   heterogeneity	   in	   stem	   cell	   gene	   expression	   and	   in	  signalling	   pathways,	   and	   this	   heterogeneity	   appears	   to	   have	   functional	  consequences	   for	   their	   behaviour	   (Blauwkamp	   et	   al.	   2012;	   Tonge	   et	   al.	   2011;	  Fischer	  et	  al.	  2010).	  Although	  it	  has	  been	  reported	  that	  hESCs	  can	  also	  express	  low	   levels	   of	   lineage	   associated	   genes,	   there	   are	   very	   few	   reports	   on	   the	  functional	   consequences	   of	   this	   heterogeneity.	   Furthermore,	   there	   are	   no	  reports	  on	  the	  functional	  characterisation	  at	  the	  single	  cell	  level.	  	  Within	   this	   study,	   we	   developed	   a	   differentiation	   assay	   that	   we	   show	   can	   be	  used	  as	  an	  effective	  tool	  for	  predictive	  toxicology.	  Within	  the	  assay,	  as	  has	  been	  previously	  reported,	  we	  did	  see	  underlying	  heterogeneity	  in	  the	  differentiation	  of	   hESCs.	   We	   therefore	   went	   back	   to	   investigate	   further	   the	   mechanisms	   of	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differentiation,	   by	   determining	   whether	   the	   heterogeneity	   that	   has	   been	  observed	   in	   stem	   cells	   was	   having	   functional	   consequences	   on	   lineage	  specification.	   Using	   a	   reporter	   line	   for	   the	   endoderm	   specific	   gene	  GATA6	  we	  identify,	   characterise	   and	   provide	   a	  mechanistic	   insight	   into	   a	   sub-­‐fraction	   of	  cells	  in	  culture	  that	  exhibit	  endoderm	  differentiation	  bias.	  Importantly,	  we	  show	  this	   functional	  bias	  at	  a	  single	  cell	   level.	  We	  conclude	   that	  hESC	  heterogeneity	  may	   be	   responsible,	   at	   least	   in	   part,	   for	   the	   non-­‐uniform	   behaviour	   of	   hESCs	  during	  differentiation.	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1.2 Research	  leading	  to	  the	  derivation	  of	  hESCs	  	  	   1.2.1 Mouse	  embryonal	  carcinoma	  cells	  	  	  	  Teratomas,	  a	  benign	  tumour,	  and	  teratocarcinomas,	  the	  malignant	  counterpart,	  have	  long	  fascinated	  scientists,	  as	  early	  as	  the	  1800’s,	  as	  these	  tumours	  exhibit	  features	   of	   embryonic	   development	   and	   consist	   of	   highly	   differentiated	   cell	  types	   from	   each	   of	   the	   three	   primary	   germ	   layers.	   Early	   progress	   within	   the	  field	   of	   development	   came	   from	   research	   in	   1954	   by	   Stevens	   et	   al	   who	  discovered	   a	   high	   incidence	   of	   testicular	   teratocarcinomas	   in	   the	   mouse	   129	  strain	   (Stevens	  &	   Little	   1954).	   These	   teratocarcinomas	   contained	   elements	   of	  the	  three	  primary	  germ	  layers,	  were	  malignant,	  and	  also	  contained	  clonogenic,	  pluripotent	  embryonal	  carcinoma	  cells	  (EC),	  later	  described	  as	  cancer	  stem	  cells	  (Kleinsmith	   &	   Pierce	   1964).	   The	   first	   instance	   of	   the	   stable	   maintenance	   of	  cancer	  stem	  cells	  or	  multipotent	  EC	  cell	  lines	  in	  vitro	  was	  then	  reported	  (Finch	  &	  Ephrussi	  1967).	  The	  subline	  402	  AIII	  from	  a	  teratocarcinoma	  from	  the	  testis	  of	  a	  strain	   129	   mouse,	   originally	   passaged	   in	   vivo,	  were	   seeded	   onto	   a	   layer	   of	  irradiated	   mouse	   embryonic	   fibroblasts	   (MEFs)	   in	   DMEM	   and	   15%	   fetal	   calf	  serum.	   It	   was	   found	   that	   MEFs	   appeared	   important	   in	   the	   retention	   of	  pluripotency	  and	  were	  presumed	  to	  provide	  a	  critical	  nutrient	  or	  trophic	  factor	  aiding	   the	   pluripotent	   state	   of	   these	   EC	   cells.	   This	   break	   through	   allowed	   the	  derivation	  of	  further	  EC	  cell	  lines,	  which	  were	  shown	  to	  have	  the	  ability	  to	  self-­‐renew	  and	  the	  capacity	  for	  multi-­‐lineage	  differentiation,	  and	  were	  thought	  to	  be	  analogous	  to	  cells	  of	  the	  inner	  cell	  mass	  (ICM)	  of	  the	  blastocyst.	  Indeed,	  these	  EC	  cells	  were	  shown	   to	  be	   functionally	  equivalent	   to	  cells	  of	   the	   ICM	  through	   the	  formation	   of	   chimeric	   mice	   following	   blastocyst	   injection	   (Brinster	   1974).	   In	  
vitro,	  their	  diverse	  differentiation	  capacity	  became	  apparent	  through	  embryoid	  body	   (EB)	   differentiation,	   which	   led	   to	   the	   generation	   of	   a	   wide	   variety	   of	  somatic	   cell	   types,	   further	   validating	   the	  notion	   that	  EC	   cells	  were	   indeed	   the	  malignant	   counterparts	   to	   cells	   of	   the	   ICM	   (G.	   R.	   Martin	   &	   Evans	   1975).	  Furthermore,	  the	  EC	  line,	  F9,	  could	  be	  induced	  to	  differentiate	  through	  the	  use	  of	  retinoic	  acid	  leading	  to	  endodermal	  specification,	  showing	  that	  EC	  cells	  could	  
	   16	  
respond	   to	   exogenous	   signals	   that	   would	   bias	   their	   differentiated	   phenotype	  (Strickland	   &	   Mahdavi	   1978).	   Subsequent	   characterisation	   of	   F9	   EC	   cells	  identified	  the	  expression	  of	  a	  unique	  surface	  marker,	  the	  F9	  antigen,	  which	  was	  also	   found	   to	   be	   expressed	   on	   cleavage	   stage	   embryos	   but	   not	   differentiated	  teratoma	   cell	   types	   (Artzt	   et	   al.	   1973).	   The	   advent	   of	   monoclonal	   antibodies	  then	  allowed	  the	  identification	  of	  another	  surface	  antigen,	  MC480,	  better	  known	  as	   SSEA-­‐1,	  which	   had	   similar	   expression	   patterns	   to	   the	   F9	   antigen	   (Solter	   &	  Knowles	  1978),	   and	  proved	   instrumental	   in	   the	   isolation	  of	  mouse	  embryonic	  stem	  cells	   (ESCs).	  The	  extraordinary	  resemblance	  of	  mouse	  EC	  cells	   to	  cells	  of	  the	  mouse	   ICM	   then	   drove	   interest	   in	   isolating	   and	   characterising	   the	   human	  counterpart.	  	  
1.2.2 Human	  embryonal	  carcinoma	  cells	  	  	  	  Similarly	   to	   the	   129	   mouse	   strain,	   teratomas	   are	   also	   a	   feature	   of	   human	  disease,	  which	  are	  most	  commonly	  manifested	  as	  benign	  ovarian	  tumours	  and	  dermoid	  cysts,	   although	   in	   rare	  cases	   they	  can	  be	  present	  as	   tumours	   in	  new-­‐borns.	  Using	  an	  accumulation	  of	  techniques	  performed	  to	  derive	  mouse	  EC	  cells,	  human	  EC	  cells	  were	  isolated	  and	  successfully	  propagated	  in	  vitro	  (Andrews	  et	  al.	   1980;	   Hogan	   et	   al.	   1977;	   Andrews	   1988).	   Subsequent	   characterisation	   of	  human	   EC	   lines,	   however,	   highlighted	   important	   differences	   between	   human	  and	   mouse.	   Developmental	   differences	   and	   differences	   in	   surface	   antigen	  expression	   indicated	   that	   human	   and	   mouse	   EC	   cells	   either	   corresponded	   to	  different	   embryonic	   cells,	   or	   that	   equivalent	   cells	   differed	   between	   species	  
(Table	   1)	   (Andrews	   et	   al.	   1980).	   Nevertheless,	   although	   differences	   were	  apparent,	  pluripotency	  associated	  transcription	  factors	  OCT4,	  SOX2	  and	  NANOG	  were	   later	   found	   to	   be	   expressed	   in	   both	   EC	   and	   ES	   lines	   of	   both	   species	  (Schöler	   et	   al.	   1989;	  Gubbay	   et	   al.	   1990;	  Mitsui	   et	   al.	   2003;	   I.	   Chambers	   et	   al.	  2003). 	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Table.	  1:	  Comparison	  of	  mouse	  and	  human	  EC	  cell	  surface	  antigen	  
expression	  profiles	  	  	  
	  	  	  Subsequent	  work	  on	  human	  EC	   lines,	  notably	  NT2/D1,	   then	  provided	   insights	  into	  mechanistic	  events	  of	  development	  in	  vitro.	  For	  example,	  the	  discovery	  that	  retinoic	   acid,	   a	  morphogen	   expressed	   during	   development,	   induced	  HOX	   gene	  expression	   in	   a	   concentration	   dependent	   manner	   giving	   rise	   to	   cell	   types	  indicative	   of	   the	   hind-­‐brain	   region	   at	   low	   concentrations	   (10-­‐8M),	   and	   more	  spinal	  cord	  and	  limb	  bud	  cell	   types	  at	  higher	  concentrations	  (10-­‐6M)	  (Simeone	  et	  al.	  1990).	  Furthermore,	  the	  use	  of	  NT2/D1	  was	  the	  first	  instance	  of	  the	  use	  of	  pluripotent	   cells	   in	   regenerative	  medicine	  whereby	  NT2/D1	  derived	  neurones	  were	   transplanted	   into	   stroke	   patients	   (Kondziolka	   et	   al.	   2000).	   Although	  useful,	   EC	   cells	   did	   have	   problems	   when	   studying	   development.	   Cells	   often	  showed	  a	  restricted	  differentiation	  potential,	  and	  in	  some	  cases,	  nullipotency.	  A	  general	  worry	  was	  that	  these	  cells	  may	  not	  truly	  behave	  in	  the	  same	  way	  as	  cells	  of	   the	   ICM	   and	   thus	   made	   it	   difficult	   to	   interpret	   the	   exact	   mechanisms	  responsible	   for	   self-­‐renewal	   and	   differentiation.	   For	   these	   reasons,	   work	  was	  focussed	  on	  deriving	  cells	  directly	  from	  the	  ICM.	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1.2.3 Mouse	  embryonic	  stem	  cells	  	  
	  
	  The	   derivation	   of	   embryonic	   stem	   cells	   previous	   to	   1981	   had	   proven	   to	   be	  mostly	   unsuccessful,	   although	   cells	   resembling	   those	   of	   the	   ICM	   had	   been	  isolated	  transiently.	  The	  cause	  for	  the	  degradation	  of	  these	  embryo-­‐derived	  cells	  was	  postulated	  by	  Kaufmann	  et	  al	  to	  be	  due	  to	  the	  exact	  embryo	  stage	  at	  which	  cells	  were	  derived,	  the	  number	  of	  cells	  explanted	  and	  tissue	  culture	  conditions	  (Evans	  &	  Kaufman	  1981).	  Successful	  derivation	  was	  achieved	  by	  explanting	  day	  2.5	  mouse	  blastocysts	  into	  petri	  dishes,	  where	  they	  saw	  the	  generation	  of	  giant	  trophoblast	  cells	  and	  large	  egg	  cylinder-­‐like	  structures	  deriving	  from	  cells	  of	  the	  ICM.	  These	  ICM	  cells	  were	  picked	  onto	  inactivated	  mouse	  embryonic	  fibroblast	  cells	   and	   gave	   rise	   to	   morphologically	   similar	   cells	   to	   established	   EC	   lines.	  Importantly,	  these	  proliferating	  ICM	  cells	  had	  normal	  40XX	  or	  40XY	  karyotypes	  (Evans	  &	  Kaufman	  1981).	  	  Similar	  experiments	  were	  conducted	  by	  Gail	  Martin,	  who	  used	   teratocarcinoma	  conditioned	  media	   to	  maintain	   these	   ICM	  cells	  and	  who	  coined	  the	  term	  ‘embryonic	  stem	  cells’	  due	  to	  their	  direct	  derivation	  from	  the	   mouse	   blastocyst	   (G.	   R.	   Martin	   1981).	   The	   derivation	   of	   embryonic	   stem	  cells	  led	  to	  an	  explosion	  in	  research	  within	  the	  field	  of	  mammalian	  development,	  as	   these	   ICM-­‐derived	  cells	  provided	  an	   in	  vitro	   tool	   to	   interrogate	   the	  genetics	  and	  signalling	  behind	  developmental	  processes.	  	  The	   advances	   in	   molecular	   genetics	   during	   the	   1980s	   allowed	   genetic	  manipulation	   through	   insertional	  mutagenesis	   via	   retroviral	   vectors	   (Evans	   et	  al.	   1985)	   and	   the	   ability	   to	   target	   specific	   genes	   by	   using	   homologous	  recombination	   (Doetschman	   et	   al.	   1987;	   Thomas	   &	   Capecchi	   1987).	   The	  interrogation	   of	   genes	   involved	   in	   pluripotency	   subsequently	   identified	   core	  stem	   cell	   associated	   transcription	   factors,	   OCT4	   (Schöler	   et	   al.	   1989),	   SOX2	  (Gubbay	  et	  al.	  1990)	  and	  NANOG	  (I.	  Chambers	  et	  al.	  2003),	  to	  be	  important	  for	  the	  propagation	  of	  pluripotent	  ES	  cells.	  	  Mechanistic	   insight	   into	   pluripotency	   then	   identified	   LIF	   (leukemic	   inhibitory	  factor),	   a	   member	   of	   the	   interleukin	   6	   (IL6)	   family,	   as	   a	   key	   factor	   in	   the	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maintenance	   of	   pluripotency	   in	   mESCs	   in	   vitro	   (A.	   G.	   Smith	   et	   al.	   1988).	   In	  mESCs,	  LIF	  binds	  to	  a	  heterodimeric	  cell	  surface	  receptor	  consisting	  of	  the	  LIF	  receptor	  (LIFRβ)	  and	  the	  glycoprotein,	  gp130,	  resulting	  in	  the	  activation	  of	  JAKs	  (receptor	  associated	  janus	  kinases).	  This	  in	  turn	  phosphorylates	  STAT3	  (signal	  transducers	   and	   activators	   of	   transcription	   3),	   which	   translocates	   into	   the	  nucleus,	   resulting	   in	   target	   gene	   transcription.	   An	   important	   target	   includes	  GABP	   (GA-­‐binding	  protein)	  which	  directly	   activates	   the	   expression	  of	  OCT3/4	  thus	   reinforcing	   the	   pluripotent	   state	   (Kinoshita	   et	   al.	   2007).	   Although	   the	  mainstay	   of	   experimental	   embryology,	   the	   mouse	   does	   show	   substantial	  differences	   in	   early	   developmental	   structures,	   including	   the	   placenta,	  extraembryonic	   membranes	   and	   egg	   cylinder.	   The	   techniques	   that	   had	   been	  learnt	  from	  the	  study	  of	  mouse	  and	  human	  EC	  and	  mouse	  ES	  cells	  then	  allowed	  the	  derivation	  of	  hESCs,	  which	  offered	  a	  better	  platform	  in	  which	   to	  study	  the	  development	  and	  function	  of	  these	  tissues	  within	  the	  human	  context.	  	  1.3 Human	  embryonic	  stem	  cells	  	  	  	  	  In	  1998,	  Thomson	  et	  al	  successfully	  derived	  human	  embryonic	  stem	  cell	  (hESC)	  lines	  using	  MEF	  feeder	  cells.	  When	  characterised,	  hESCs	  showed	  the	  same	  long-­‐term	   self-­‐renewal	   and	   differentiation	   capacities	   as	   mESCs,	   but	   similarly	   to	  primate	   ESCs	   and	   human	   EC	   cells,	   showed	  morphological	   differences.	   Human	  cells	   grew	  as	   flatter	   colonies	  with	  well-­‐defined	  borders,	  whereas	  mESCs	  were	  more	  tightly	  packed	  with	  irregular	  borders	  (Thomson	  et	  al.	  1998).	  These	  hESC	  lines,	  (H1,	  H7,	  H9,	  H13,	  &	  H14)	  expressed	  the	  same	  markers	  as	  human	  EC	  cells	  as	  well	  as	  non-­‐human	  primate	  ES	  lines,	  including	  SSEA-­‐3,	  TRA-­‐1-­‐81,	  TRA-­‐1-­‐60,	  SSEA4	  and	  ALP	  but	  similarly	  to	  human	  EC	  cells,	  lacked	  the	  expression	  of	  SSEA-­‐1	  found	  on	  mESCs	  (Thomson	  et	  al.	  1998).	  Subsequent	  research	  then	  focussed	  on	  understanding	  the	  exact	  signalling	  and	  gene	  expression	  networks	  that	  governed	  self-­‐renewal	  and	  differentiation	  of	  hESCs.	  This	  led	  to	  the	  finding	  that	  hESCs	  do	  not	  rely	  on	   the	  same	  signalling	  pathways	   for	  self-­‐renewal	  as	  mESCs.	  hESCs	  do	  not	   respond	   to	  LIF	   and	   thus	  LIF	  does	  not	   confer	   self-­‐renewal	   (Thomson	  et	   al.	  1998).	   Additionally,	   BMP	   signalling	   which	   confers	   self-­‐renewal	   in	   mESCs	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actually	   is	   a	   potent	   inducer	   of	   differentiation	   in	   hESCs	   (Xu	   et	   al.	   2002).	  Mechanistic	  differences	  between	  cells	  of	  the	  two	  species,	  likely	  due	  to	  differing	  embryological	  stages,	  brought	  into	  focus	  the	  relevance	  of	  using	  hESCs	  to	  study	  human	   development.	   As	   the	   field	   progressed,	   a	   deeper	   understanding	   of	   the	  signalling	  pathways	  involved	  in	  lineage	  specification	  brought	  the	  reality	  of	  using	  these	  cells	  for	  therapeutic	  and	  toxicological	  applications	  a	  step	  closer.	   In	  2005,	  the	  Pattison	  report	  described	  ES	  technology	  in	  toxicology	  as	  a	  ‘near-­‐term’	  use,	  but	   despite	   progress,	   there	   is	   still	   a	   significant	   and	   urgent	   need	   for	   high-­‐throughput,	  reliable	  assays	  for	  predictive	  toxicology.	  	  1.4 Human	  embryonic	  stem	  cells	  in	  toxicology	  	  	  	  Drug	  discovery	  is	  an	  expensive	  and	  often	  lengthy	  process	  which	  is	  hampered	  by	  ~90%	   attrition	   rates	   of	   new	   drug	   candidates	   (Hay	   et	   al.	   2014).	   Current	  programmes	   in	   the	   identification	   of	   new	  drug	   candidates	   employ	   both	   in	  vivo	  and	   in	   vitro	  methods,	   using	   primary	   and	   transformed	   human	   cell	   lines	   and	  animal	   models	   prior	   to	   progression	   into	   man.	   Although	   valuable,	   current	  estimates	  say	  that	  the	  methods	  employed	  fail	  to	  detect	  adverse	  effects	  in	  up	  to	  30%	   of	   new	   drugs	   trialled	   (H.	   Olson	   et	   al.	   2000).	   Examples	   of	   the	   dangers	   of	  failed	   drug	   safety	   predictions	   include	   the	   non-­‐steroidal	   anti-­‐inflammatory	  (NSAID)	   drug	   Benoxaprofen	   which	   showed	   no	   adverse	   effects	   in	   health	   to	  rhesus	  monkeys,	  but	  caused	  severe	  renal	  and	  hepato-­‐toxicity	  in	  humans	  (Brass	  1993).	  An	  additional	  NSAID,	  Phenylbutazone,	  a	  drug	  routinely	  used	  in	  horses	  for	  pain	  relief	  also	  showed	  fatal	  liver	  and	  bone	  marrow	  disease	  in	  human	  patients	  (Benjamin	  et	  al.	  1981).	  Cerivastatin,	  a	  cholesterol-­‐lowering	  drug	  was	  shown	  to	  cause	  rhabdomyolosis	  in	  humans,	  which	  was	  not	  picked	  up	  in	  pre-­‐clinical	  tests	  with	   rats,	  mice,	  minipigs,	   dogs	   or	  monkeys,	   unless	   administered	   at	   very	   high	  doses	  and	  was	  consequently	  deemed	  to	  be	  well	  tolerated	  in	  all	  species	  (Keutz	  &	  Schlüter	  1998).	  	  	  Reproductive	   toxicology	   is	   also	   an	   important	   aspect	   of	   pre-­‐clinical	   testing	   to	  assess	   the	   potential	   toxic	   or	   teratogenic	   effects	   of	   drug	   candidates	   on	   the	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developing	   foetus.	   Currently,	   studies	   are	   carried	   out	   which	   involve	   in	   vivo	  animal	   studies	   using	   a	   rodent	   (usually	   rat),	   and	   non-­‐rodent	   species	   (usually	  rabbit)	  with	   preterm	   evaluation	   (ICH	   (M3),	   OPPTS	   870.3700,	   OECD	   guideline	  414).	   Compounds	   are	   administered	   during	   early	   organogenesis	   between	  implantation	  and	  the	  closure	  of	  the	  hard	  palate.	  Assessments	  are	  then	  made	  at	  the	  end	  of	  gestation	  for	  developmental	  external,	  visceral	  and	  skeletal	  endpoints	  on	   the	   foetus	   (Daston	   2007).	   Although	   incredibly	   valuable,	   the	   use	   of	   model	  organisms	   does	   mean	   that	   observations	   are	   extrapolated	   to	   the	   case	   of	   the	  human	   embryo,	   which	   can	   show	   poor	   correlations	   in	   up	   to	   60%	   of	   cases	  (Gottmann	   et	   al.	   2001),	   the	   most	   infamous	   case	   being	   that	   of	   the	   drug	  Thalidomide.	  A	  drug	  administered	   to	  alleviate	  morning	   sickness,	  Thalidomide,	  despite	  not	  showing	  adverse	  effects	  on	  several	  rodent	  species,	  was	  responsible	  for	   extensive	   teratogenic	   effects	   on	   the	   human	   embryo	   during	   prenatal	  development	  (Brent	  1964).	  Eventually,	  and	  rather	  too	  late,	  one	  strain	  of	  rabbit	  (New	   Zealand	   white)	   was	   found	   to	   be	   sensitive	   to	   the	   drug,	   and	   only	   upon	  extremely	  high	  doses	  were	  effects	  apparent	  in	  other	  species	  (Bailey	  et	  al.	  2005).	  	  	  As	  well	  as	  the	  problem	  of	  species	  differences	  for	  toxicological	  testing,	  the	  speed	  of	  data	  collection,	  the	  cost	  of	  such	  procedures	  and	  importantly	  the	  vast	  numbers	  of	  animals	  used	  in	  pre-­‐clinical	  toxicity	  make	  drug	  development	  vastly	  expensive	  and	  time	  consuming	  (Schumann	  2010).	  To	  circumvent	  these	  problems,	   in	  vitro	  studies	   on	   human	   cells	   are	   performed	   on	   promising	   drug	   candidates.	   In	   vitro	  studies	   have	   several	   benefits,	   for	   example	   they	   use	   human	   cell	   lines	   and	   they	  allow	  for	  a	  high-­‐throughput	  approach	  that	  can	  be	  employed	  to	  screen	  thousands	  of	  compounds	  for	  adverse	  effects	  on	  cell	  behaviour.	  If	  employed	  early	  on	  within	  the	  drug	  development	  process,	  potential	  teratogenic	  or	  toxic	  compounds	  can	  be	  filtered	   out,	   reducing	   the	   amount	   of	   money	   spent	   on	   the	   development	   of	   a	  dangerous	  drug.	  Most	  in	  vitro	  studies	  to	  date	  have	  been	  performed	  on	  primary	  or	   transformed	  cell	   lines,	  which	  have	   significant	  drawbacks.	  Primary	   lines	  are	  difficult	   to	   source	   as	   they	  have	   to	  be	   taken	   from	   the	   tissue	  of	   origin	   and	   they	  have	  a	  restricted	  capacity	  for	  proliferation	  (Hayflick	  1965).	  The	  development	  of	  transformed	  lines	  circumvented	  the	  problem	  of	  senescence,	  however	  these	  lines	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often	   differed	   significantly	   from	   the	   cell	   or	   tissue	   of	   origin,	   resulting	   in	  potentially	  unreliable	  data.	  	  	  To	   increase	   the	   speed	   and	  quantity	   of	   data,	  murine	  ESCs	  were	   employed	   as	   a	  model	   for	   developmental	   toxicology.	   Their	   ability	   to	   proliferate	   as	   an	  undifferentiated	  cell,	  as	  well	  as	  their	  ability	  to	  differentiate	  in	  culture	  led	  to	  the	  development	  of	  the	  EST	  (embryonic	  stem	  cell	  test).	  This	  method	  is	  based	  on	  the	  analysis	   of	   three	   toxicological	   endpoints	   after	   10	   days	   of	   exposure	   to	   the	  compound	   of	   interest.	   The	   first	   is	   the	   beating	   morphology	   of	   mESC	   derived	  cardiomyocytes,	   secondly	   the	   cytotoxicity	   of	   differentiating	  mESCs	   and	   finally	  the	   cytotoxicity	   of	   fully	   differentiated	   mouse	   fibroblasts,	   3T3,	   using	   the	   MTT	  assay	  (Spielmann	  1997).	  Successfully	  validated	  by	  the	  European	  centre	  for	  the	  validation	   of	   alternative	   methods	   (ECVAM)	   as	   an	   assay	   for	   investigating	  reproductive	   toxicology,	   the	   EST	   is	   still	   in	   use	   today	   (Genschow	   et	   al.	   2004).	  Nevertheless,	  the	  development	  of	  humanised	  in	  vitro	  models	  is	  still	  a	  necessity.	  hESCs	  have	  generated	  excitement	  within	  the	  area	  of	   toxicology,	  but	  a	   lack	  of	  a	  complete	   understanding	   of	   the	   signalling	   pathways	   and	   gene	   regulatory	  networks	  (GRNs)	  in	  cell	  specification	  has	  hindered	  their	  use.	  	  
1.5 Signalling	  pathways	  in	  the	  self-­‐renewal	  and	  differentiation	  of	  human	  embryonic	  stem	  cells	  	  	  	  The	  maintenance	  of	  pluripotency	  and	  the	  differentiation	  of	  hESCs	   involves	   the	  activation	   or	   repression	   of	   signalling	   cascades	   resulting	   in	   the	   expression	   of	  transcription	  factors	  enforcing	  a	  particular	  lineage.	  The	  importance	  of	  signalling	  in	   hESCs	   was	   demonstrated	   by	   a	   study,	   which	   concluded	   that	   up	   to	   17%	   of	  genes	   enriched	   in	   hESCs	  were	   involved	   in	   signal	   transduction	   and	   regulation.	  Pathways	   found	   to	   be	   important	   included	   the	   FGF,	   WNT,	   LIF	   and	   TGFβ	  pathways,	  with	  the	  expression	  of	  both	  agonists	  and	  antagonists	  directing	  cells	  to	  specific	   fates	   throughout	   development	   (Brandenberger	   et	   al.	   2004).	   The	   FGF,	  WNT,	  LIF	  and	  TGFβ	  pathways	  all	  play	  important	  roles	  in	  pluripotency	  and	  early	  specification	  of	  hESCs	  to	  each	  of	  the	  three	  primary	  germ	  layers.	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1.5.1 TGFβ	  signalling	  in	  pluripotency	  	  	  	  The	  TGFβ	   signalling	  pathway	   is	  a	  highly	  conserved	  pathway	   involved	   in	  many	  cellular	  functions,	  including	  cell	  growth,	  differentiation	  and	  apoptosis	  as	  well	  as	  hPSC	   maintenance,	   and	   functions	   during	   both	   embryogenesis	   and	   within	   the	  adult	   organism.	   The	   TGFβ	   superfamily	   of	   ligands	   consists	   of	   2	   sub-­‐groups.	  Firstly,	   TGFβs	   including	   Activin	   A,	   Nodal	   and	   TGFβ,	   which	   signal	   through	  SMAD2/3	  proteins,	   via	  ALK4,	  ALK5	   and	  ALK7	   receptors	   (TGFBR1	  &	  ACVR1C)	  (Schier	   2003)(James	   et	   al.	   2005);	   and	   secondly	   BMPs	   and	   GDFs	   through	   the	  SMAD1/5/8	   proteins	   via	   type	   I	   receptors	   ALK1,	   ALK2,	   ALK3	   and	   ALK6	  (ACVERL1,	   ACVER1,	   BMPR1A	   and	   BMPR1B	   respectively)	   (Kretzschmar	   et	   al.	  1997;	  Kingsley.	  1994;	  James	  et	  al.	  2005).	  Mechanistically,	  the	  TGFβ	  ligand	  binds	  to	  a	  type	  II	  receptor	  (TGF-­‐βRII)	  on	  the	  cell	  surface,	  which	  then	  recruits	  the	  TGFβ	  type	  I	  receptor	  (TGF-­‐βRI).	  The	  presence	  of	  the	  type	  II	  receptor	  is	  imperative	  as	  TGF-­‐βRI	   is	   unable	   to	  bind	   the	  TGFβ	   ligand	   in	   its	   absence	   (Heldin	   et	   al.	   1997).	  The	   activation	   of	   TGF-­‐βRI	   then	   induces	   the	   rapid	   phosphorylation	   of	   SMAD2,	  and	  the	  closely	  related	  protein	  SMAD3,	  at	  the	  C-­‐terminal	  serine	  residue,	  causing	  their	  translocation	  to	  the	  nucleus	  (Macías-­‐Silva	  et	  al.	  1996).	  The	  phosphorylated	  SMAD2/3	  proteins	  synergise	  through	  functional	  and	  physical	  interactions	  with	  the	   co-­‐factor	   SMAD,	   SMAD4.	   This	   subsequently	   leads	   to	   the	   activation	   of	  downstream	  targets	  within	  the	  nucleus	  (Nakao	  et	  al.	  1997).	  	  In	   hESCs,	   TGFβs	   of	   the	   SMAD2/3	   branch	   have	   roles	   in	   maintaining	   the	  undifferentiated,	  pluripotent	  state	  through	  the	  sustained	  expression	  of	  stem	  cell	  transcription	   factors,	   for	   example	  NANOG,	  which	   is	   directly	   activated	  by	  TGFβ	  signalling	   (Xu	   et	   al.	   2008)	   (Vallier	   et	   al.	   2009).	   Studies	   have	   shown	   that	  activation	   of	   the	   TGFβ/Activin/Nodal	   pathway	   through	   SMAD2/3	   with	   the	  recombinant	  protein	  Activin	  A	  is	  supportive	  of	  the	  undifferentiated	  state	  (James	  et	   al.	   2005).	   The	   importance	   of	   TGFβ	   signalling	   for	   the	   pluripotent	   state	   is	  further	   demonstrated	   through	   its	   inhibition	  with	   chemical	   inhibitors,	   such	   as	  SB431542,	   and	   the	   consequential	   down-­‐regulation	   of	   NANOG	   and	   loss	   of	  pluripotency	  (Xu	  et	  al.	  2008).	  There	  are	  conflicting	  reports	  describing	  the	  ability	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of	   Activin	   A	   stimulated	   TGFβ	   signalling	   alone	   to	   maintain	   pluripotency,	   or	  whether	  the	  presence	  of	  FGF	  is	  required	  (Beattie	  et	  al.	  2005;	  Vallier	  et	  al.	  2005).	  These	  conflicting	  reports	  are	  likely	  culture	  context	  dependent,	  as	  matrices	  and	  media	  are	  not	  consistent	  between	  reports.	  	  
1.5.2 TGFβ	  signalling	  in	  differentiation	  	  	  	  Studied	  extensively	  in	  xenopus,	  TGFβ	  signalling	  has	  been	  found	  to	  be	  central	  to	  mesoderm	  formation	  and	  patterning.	  The	  first	  instance	  of	  the	  cloning	  of	  a	  TGFβ	  receptor	  was	  the	  Activin	  type	  II	  receptor.	  The	  cloning	  of	  a	  truncated	  dominant	  negative	  form	  of	  this	  receptor	  led	  to	  defects	  at	  the	  gastrula	  stage	  in	  the	  xenopus	  embryo	   and	   reduced	   the	   levels	   of	   mesoderm	   whilst	   enhancing	   the	   levels	   of	  ectoderm	   tissue	   specification	   (Hemmati-­‐Brivanlou	   &	   Melton	   1992).	   The	  mutations	   of	   this	   receptor	   also	   led	   to	   the	   blocking	   of	   BMP	   signalling,	  demonstrating	   that	   the	  same	  receptor	   is	  able	   to	  bind	   to	  more	   than	  one	   ligand	  (Kessler	  &	  Melton	  1994).	   SMAD2/3	   through	  TGFβ	   signalling	   is	   also	   important	  for	  anterior-­‐posterior	  patterning	  of	  the	  epiblast	  leading	  to	  the	  correct	  formation	  of	  the	  primitive	  streak	  during	  gastrulation,	  in	  the	  mouse	  embryo	  (Conlon	  et	  al.	  1994).	  Double	  mutant	  mice	   for	  both	  SMAD2/3	  proteins	   exhibit	   severe	  defects	  with	  a	  complete	   failure	   to	   induce	  mesoderm	  or	  enter	  gastrulation	  (Dunn	  et	  al.	  2004).	  Additionally,	  there	  was	  a	  loss	  of	  pluripotent	  epiblast	  in	  null	  mice	  by	  E7.5	  however	   extra-­‐embryonic	   ectoderm	   was	   retained,	   implying	   that	   SMAD2/3	   is	  necessary	  for	  the	  proper	  formation	  and	  retention	  of	  the	  ICM/epiblast	  (James	  et	  al.	  2005).	  	  
	  In	   hESCs,	  D'Amour	   et	   al	   showed	   that	   in	   low	   serum	   conditions,	   high	   levels	   of	  recombinant	   Activin	   A	  was	   sufficient	   to	   induce	   up	   to	   80%	   of	   SOX17+	   cells	   in	  culture,	   reasoned	   to	   be	   definitive	   endoderm-­‐like	   cells	   (D’Amour	   et	   al.	   2005).	  The	   over-­‐expression	   of	   Lefty	   and	   Cerberus,	   antagonists	   of	   TGFβ	   signalling,	   or	  the	  use	  of	  the	  pharmacological	   inhibitor	  SB431542,	  which	  blocks	  ALK4/5/7	  in	  TGFβ	   signalling,	   leads	   to	   the	   promotion	   of	   neuronal	   specification	   to	   the	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detriment	   of	   mesendoderm	   (Smith	   et	   al.	   2008).	   The	   TGFβ	   pathway	   in	  mesendodermal	   specification	   therefore	  appears	  key,	   and	   it’s	   function	   remains	  well	  conserved	  throughout	  species.	  	  	  Subsequently,	   a	   paradox	   is	   established	   as	   the	   same	   signalling	   pathway	   is	  involved	   in	   two	   very	   opposite	   cellular	   phenotypes.	   This	   complexity	   can	   be	  addressed	  when	  combining	  a	  second	  signalling	  pathway,	  PI3K/Akt.	  The	  levels	  of	  PI3K/Akt	  influence	  cell	  fate,	  such	  that	  at	  high	  activation	  levels,	  TGFβ	  signalling	  cooperates	   to	   enforce	   the	   pro-­‐self-­‐renewal	   phenotype,	   whereas	   at	   low	  activation	   levels,	   WNT	   effectors	   are	   activated	   leading	   to	   differentiation,	   and	  mesendodermal	  specification	  (Singh	  et	  al.	  2012).	  	  	  
1.5.3 BMP	  signalling	  in	  differentiation	  	  	  	  The	   second	   sub-­‐group	   of	   the	   TGFβ	   family	   are	   the	   BMPs	   and	   GDFs.	   The	  mechanism	   of	   action	   for	   the	   BMP	   pathway	   is	   similar	   to	   that	   of	   the	   TGFβ,	   but	  BMP	  ligands	  are	  able	  to	  bind	  both	  type	  I	  and	  type	  II	  receptors,	  albeit	  only	  with	  low	  affinity.	  When	  both	  receptor	  types	  are	  present	  high	  affinity	  binding	  occurs	  to	   induce	   signal	   transduction	   (F.	   Liu	   et	   al.	   1995).	   	   The	   binding	   of	   BMP	   to	   its	  receptors	  leads	  to	  the	  phosphorylation	  of	  SMAD1/5/8	  proteins	  that,	  similarly	  to	  SMAD2/3,	   associate	   and	   form	   a	   complex	   with	   SMAD4.	   The	   phosphorylated	  complex	   then	   translocates	   to	   the	  nucleus	   to	   activate	  downstream	   targets.	   The	  activation	   of	   the	   BMP	   pathway	   through	   SMAD1/5	   proteins	   with	   the	  supplementation	   of	   recombinant	  BMP4	   in	   both	   serum	  and	   serum-­‐free	   culture	  medium	  appears	  to	  differentiate	  hESCs	  towards	  the	  trophoblast	   lineage	  (Xu	  et	  al.	   2002).	   Conversely,	   the	   BMP	   ligand	   inhibitor	   Noggin	   or	   pharmacological	  inhibitors	  such	  as	  Dorsomorphin	  can	  be	  used	  in	  conjunction	  with	  FGF	  to	  inhibit	  differentiation,	   and	   maintain	   pluripotency.	   Interestingly,	   the	   role	   of	   BMPs	  within	   the	   mouse	   context	   actually	   confers	   self-­‐renewal	   in	   vitro,	   highlighting	  important	   species	   differences	   during	   early	   development,	   possibly	   due	   to	  different	  developmental	  timings	  of	  ES	  cell	  derivation	  (Ying	  et	  al.	  2003).	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  In	  combination	  with	  the	  TGFβ/Activin/Nodal	  pathway,	  BMP4	  is	  shown	  to	  be	  a	  driver	  of	  differentiation	  towards	  the	  mesendoderm	  lineage.	  BMP4	  functions	  to	  surpass	   the	  self-­‐renewal	  effects	  of	   the	  TGFβ/Activin/Nodal	  pathway	  by	  down-­‐regulating	   pluripotency	   genes,	   in	   particular	   SOX2,	   which	   has	   SMAD1	   binding	  sites,	  consequently	  pushing	  cells	   to	  a	  mesendodermal	   fate	  (Teo	  et	  al.	  2012).	   It	  has	  also	  been	  shown	   that	  BMP4	  signalling	  activates	  genes	  associated	  with	   the	  WNT	  signalling	  pathway,	   including	  WNT3,	  which	  upregulates	  genes	  associated	  with	   mesendodermal	   and	   primitive	   streak	   lineages	   (Kurek	   et	   al.	   2015).	   The	  alternate	   lineages	   of	   trophectoderm	   and	   mesendoderm	   are	   thought	   to	   arise	  from	  the	   levels	  of	  WNT	  signalling	  activation	  within	  cells,	  which	  would	  explain	  how	  BMP4	  can	  be	  implicated	  in	  two	  opposing	  lineages	  (Kurek	  et	  al.	  2015).	  	  	  
1.5.4 FGF	  signalling	  in	  pluripotency	  	  	  	  FGFs	   are	   a	   family	   of	   growth	   factors	   that	   are	   involved	   in	   angiogenesis,	  wound	  healing	  and	  early	  embryogenesis.	  The	  most	  commonly	  used	  FGF	  in	  hESC	  culture,	  basic	  FGF	  (FGF2),	  allows	  the	  maintenance	  of	  pluripotency	  and	  confers	  indefinite	  self-­‐renewal	  when	   in	  combination	  with	  agonists	  of	   the	  TGFβ	  pathway	  (Vallier,	  Alexander	  et	   al.	   2005).	   FGF	   signalling	   in	  hESCs	   functions	   through	   two	  distinct	  pathways.	  Firstly	   is	   the	  MEK/ERK	  pathway.	  Considerable	  confusion	  surrounds	  the	  role	  of	  ERK	  signaling	  in	  hESCs	  as	  shown	  by	  a	  number	  of	  conflicting	  reports.	  	  Reports	  exist	  which	  advocate	  ERK	  in	  the	  maintenance	  of	  pluripotency	  	  (Li	  et	  al.	  2007;	   Armstrong	   et	   al.	   2006),	   and	   others	   suggest	   it	   has	   roles	   in	   promoting	  differentiation	   (Na	   et	   al.	   2010).	   Secondly	   is	   the	   PI3K	   pathway,	   which	   has	  important	   roles	   in	   pluripotency	   by	   functioning	   in	   conjunction	   with	   the	  TGFβ/Activin/Nodal	  pathway.	   Inhibition	  of	  PI3K	  using	   specific	   inhibitors	   such	  as	   LY294002	   results	   in	   loss	   of	   stem	   cell	   transcription	   factor	   expression	   and	  consequently	  differentiation.	  Supportive	  of	  the	  observation	  that	  ERK	  signalling	  results	   in	   hESC	   differentiation,	   the	   interplay	   of	   PI3K	   and	   ERK	   signalling	   is	  believed	   to	   control	   WNT	   signalling	   and	   consequently	   self-­‐renewal	   versus	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differentiation.	  The	   inhibition	  of	  PI3K	  signalling	   leads	   to	   the	  activation	  of	  ERK	  and	  consequently	  the	  inactivation	  of	  GSK3β,	   the	  accumulation	  of	  β-­‐catenin	  and	  mesendodermal	  gene	  expression.	  The	  inhibition	  of	  PI3K	  and	  ERK	  reverses	  this	  effect,	  maintaining	  pluripotency	   (Singh	  et	  al.	  2012).	  The	   interplay	  of	  PI3K	  and	  ERK	   signalling	   therefore	   appears	   to	   control	   the	   pluripotent	   and	  differentiated	  states,	   whereby	   PI3K	   functions	   upstream	   of	   ERK	   and	   functions	   as	   a	   master	  regulator	  (Chen	  et	  al.	  2012;	  Eiselleova	  et	  al.	  2009).	  FGF2	  signalling	  also	  has	  been	  shown	  to	  increase	  the	  survival	  of	  hESCs	  upon	  dissociation	  and	  in	  the	  presence	  of	   oxidative	   stress.	   The	   exact	   mechanism	   through	   which	   this	   occurs	   has	   not	  been	  elucidated	  (Eiselleova	  et	  al.	  2009).	  	   1.5.5 FGF	  signalling	  in	  differentiation	  	  	  	  As	  well	  as	   its	  role	   in	  pluripotency,	  FGF	  signalling	  also	  plays	   important	  roles	   in	  early	  gastrulation.	  In	  xenopus,	  the	  expression	  of	  a	  dominant	  negative	  mutant	  of	  the	  FGF	  receptor	  leads	  to	  normal	  cleavage	  stage	  embryos,	  but	  the	  development	  of	  gross	  morphological	  abnormalities	  during	  gastrulation.	  Additionally,	  xenopus	  failed	   to	   fully	   form	   tails	   later	   in	  development	   (Amaya	   et	   al.	   1991).	  Within	   the	  human	  context,	  it	  has	  been	  found	  that	  FGF2	  is	  required	  for	  definitive	  endoderm	  specification	   and	   the	   dose	   of	   FGF	   affects	   the	   eventual	   lineage	   that	   cells	   will	  acquire.	   High	   concentrations	   of	   FGF2	   appear	   to	   prevent	   hepatocyte	  differentiation,	   whereas	   moderate	   levels	   induce	   a	   pancreatic	   fate	   in	   hESCs.	  (Morrison	  et	  al.	  2008,	  Ameri	  et	  al.	  2010)	  FGF	  signalling	  through	  the	  MEK/ERK	  pathway	  has	  also	  been	  implicated	  in	  directing	  BMP4	  induced	  differentiation	  to	  the	  mesendodermal	  lineage	  through	  the	  maintenance	  of	  NANOG	  expression	  (Yu	  et	   al.	   2011).	   Genetic	   knock-­‐out	   of	   the	   Fgfr-­‐1	   gene	   in	  mice	   results	   in	   aberrant	  patterning	   of	   mesoderm	   during	   gastrulation,	   such	   that	   somites	   are	   never	  generated	   (Yamaguchi	   et	   al.	   1994).	   Within	   the	   human	   context,	   blocking	   FGF	  signalling	   in	   the	   presence	   of	   BMP4	   with	   the	   inhibitor	   SU5402	   during	   early	  specification	  of	  hESCs	  results	  in	  the	  loss	  of	  mesendoderm	  specification	  in	  favour	  of	  the	  trophectoderm	  and	  primitive	  endoderm	  lineages	  (D’Amour	  et	  al.).	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1.5.6 WNT	  signalling	  in	  differentiation	  	  	  	  WNT	   signalling	   functions	   through	   3	   distinct	   pathways,	   however	   the	   most	  intensively	   researched	   in	   hESCs	   is	   the	   β-­‐catenin	   (canonical)	   pathway.	   	   In	   the	  absence	   of	   WNT	   signalling	   activation,	   β-­‐catenin	   is	   phosphorylated	   by	   GSK3β	  causing	  ubiquitination	  and	  degradation.	  However,	  when	  WNTs	  (glycoproteins)	  bind	  to	  the	  trans-­‐membrane-­‐spanning	  receptor	  frizzled,	  GBP/Frat-­‐1	  is	  recruited	  to	   displace	   GSK3β	   from	   axin	   which	   results	   in	   the	   elimination	   of	   its	   ability	   to	  phosphorylate	   β-­‐catenin	   (Huelsken	   and	   Behrens	   2002).	   Stabilised	   β-­‐catenin	  enters	   the	   nucleus	   and	   associates	   with	   TCF-­‐LEF,	   which	   leads	   to	   the	  transcription	   of	   target	   genes.	   As	   well	   as	   target	   gene	   transcription	   TCF	   also	  associates	   with	   SMAD4,	   possibly	   linking	   the	   BMP/TGFβ	   signalling	   pathways	  with	   WNT	   signalling	   (Huelsken	   and	   Behrens	   2002).	   Despite	   a	   wealth	   of	  biochemical	  information	  on	  WNT	  signalling,	  its	  exact	  role	  in	  hESCs	  still	  remains	  elusive.	   The	   stabilisation	   of	   mESCs	   in	   serum	   free	   conditions	   (2i)	   requires	  inhibition	  of	  MEK1/2	  and	  GSK3β	   (activation	  of	  WNT	  signalling),	   but	   the	   same	  conditions	   applied	   to	   hESCs	   causes	   rapid	   differentiation	   (Ying	   et	   al.	   2008).	  Singly,	   the	   activation	   of	  WNT	   signalling	   in	   hESCs	   is	   generally	   found	   to	   cause	  differentiation	   (Davidson	   et	   al.	   2012),	   which	   would	   correlate	   with	   the	  observation	   that	   active	  WNT	   signalling	   in	   hESCs	   results	   in	   higher	   expression	  levels	   of	   mesendodermal	   markers	   and	   consequently	   a	   bias	   towards	  mesendoderm	  differentiation	   (Blauwkamp	  et	  al.	  2012).	  The	  synergistic	  nature	  of	  the	  WNT	  and	  BMP	  pathways	  has	  also	  implied	  a	  role	  for	  WNT	  signalling	  as	  an	  inducer	  for	  differentiation.	  In	  addition,	  the	  use	  of	  IWP-­‐2,	  a	  WNT	  inhibitor,	  allows	  the	  long-­‐term	  self-­‐renewal	  of	  hESCs	  which	  actually	  appear	  more	  uniform	  (Kurek	  et	   al.	   2015).	   In	   contrast,	   some	   reports	   have	   described	   the	   addition	   of	   GSK3β	  inhibitors	  resulting	  in	  self-­‐renewal,	  and	  propagation	  of	  pluripotent	  cells	  (Sato	  et	  al.	   2003).	   These	   contradictory	   observations	   are	   most	   likely	   culture	   condition	  and	  context	  dependent,	  highlighted	  by	  the	  necessity	  to	  inhibit	  GSK3β	  to	  activate	  WNT	  signalling	  for	  the	  derivation	  of	  naïve	  hESCs	  (Chan	  et	  al.	  2013;	  Gafni	  et	  al.	  2013;	   Takashima	   et	   al.	   2014).	   Therefore,	   WNT	   signalling	   appears	   to	   have	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different	   role	   in	   lineage	   decisions	   of	   hESCs	   depending	   upon	   the	   activation	   or	  repression	  status	  of	  further	  signalling	  pathways.	  	   1.5.7 Signalling	  inhibition	  for	  neural	  specification	  	  	  	  The	   generation	   of	   ectoderm	   also	   involves	   the	   aforementioned	   signalling	  pathways	   but	   neural	   specification	   requires	   their	   inhibition.	   Initial	   studies	   in	  
xenopus	   demonstrated	   that	   inhibition	   of	   the	   BMP	   pathway	   with	   recombinant	  proteins	  such	  as	  Noggin	  were	  imperative	  for	  neural	  induction	  (Smith	  &	  Harland	  1992,	   Sasai	   et	   al.	   1994).	   Neural	   induction	   through	   BMP	   inhibition	   was	   later	  confirmed	  in	  mammalian	  cells	  and	  was	  found	  to	  induce	  neural	  differentiation	  in	  hESCs	   (Lee	   et	   al.	   2007).	   The	   discovery	   of	   chemical	   inhibitors,	   including	  Dorsomorphin	   then	  provided	   a	   cost	   effective	  way	   to	  potently	   inhibit	   the	  BMP	  pathway	   and	   further	   improve	   neural	   specification	   in	   hESCs	   (Morizane	   et	   al.	  2011).	  Nevertheless,	  the	  inhibition	  of	  BMP	  signalling	  alone	  did	  not	  prove	  to	  be	  that	   efficient	   for	   neural	   specification.	   Efficient	   neural	   differentiation	   also	  required	   the	   inhibition	   of	   the	   TGFβ/Activin/Nodal	   pathway,	   which	   was	  achieved	   through	   the	   use	   of	   the	   chemical	   inhibitor	   SB431542	   (Smith	   et	   al.	  2008).	   Using	   a	   combination	   of	   Noggin	   and	   SB431542	   Chambers	   et	   al	  demonstrated	   more	   efficient	   generation	   of	   PAX6(+)	   neural	   cells	   than	   either	  inhibitor	   singly.	   The	  mechanism	   through	  which	  neural	   specification	  occurs	  by	  blocking	   both	   pathways	   is	   thought	   to	   be	   three-­‐fold.	   Firstly,	   the	  TGFβ/Nodal/Activin	   pathway	   directly	   activates	   NANOG	   expression,	   which	  enforces	   pluripotency	   but	   also	   functions	   to	   block	   neuroectoderm	   and	   neural	  crest	   formation	   during	   early	   differentiation.	   Inhibition	   would	   therefore	  destabilise	  the	  NANOG	  mediated	  pluripotency	  network,	  and	  the	  block	  on	  neural	  cell	  types	  (Xu	  et	  al.	  2008;	  Wang	  et	  al.	  2012).	  Secondly,	  blocking	  BMP	  signalling	  would	  prevent	  BMP	  induced	  trophoblast	  differentiation	  (Xu	  et	  al.	  2002).	  Finally	  is	   the	  suppression	  of	  endoderm	  and	  mesoderm	   fates	   through	   the	   inhibition	  of	  both	  TGFβ/Nodal/Activin	  and	  BMP	  signalling	  which	  have	  been	  shown	  to	  act	  in	  combination	  for	  mesendoderm	  specification	  (D'Amour	  et	  al.	  2005;	  Chambers	  et	  al.	  2009).	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  With	   the	   knowledge	   gained	   with	   respect	   to	   signalling	   pathways	   that	   induce	  particular	   lineages,	   differentiation	   protocols	   generally	   involve	   the	   addition	   of	  recombinant	  proteins	  to	  activate,	  or	  chemical	   inhibitors	  to	  block	  combinations	  of	   these	   pathways	   to	   derive	   cell	   types	   of	   interest.	   It	   is	   becoming	   increasingly	  apparent,	  however,	  that	  the	  uniform	  conditions	  that	  are	  applied	  to	  a	  population	  of	   cells	   to	   induce	   differentiation	   do	   not	   elicit	   uniform	   responses	   in	   individual	  hESCs.	  This	  implies,	  and	  as	  mounting	  evidence	  demonstrates,	  that	  hESCs	  cannot	  represent	   one	   single	   entity.	   hESCs	   appear	   to	   exist	   as	   a	   heterogeneous	  population	   of	   cells	   in	   culture	   and	   accumulating	   evidence	   now	   shows	   that	   this	  heterogeneity	   impinges	   on	   how	   a	   particular	   cell	   responds	   to	   extrinsic	   cues.	  Differences	   in	   signalling,	  gene	  expression	  and	  metabolism	  raise	   the	  possibility	  that	  a	  population	  of	  hESCs	  represent	  subtly	  different	  pluripotent	  cell	  types.	  	  1.6 Cell	  states,	  sub-­‐states	  and	  heterogeneity	  	  	  Broadly	   speaking,	   hESCs	   have	   four	   options	   that	   will	   dictate	   their	   fates.	   Self-­‐renewal,	  differentiation	  and	   lineage	  specification,	  death	  and	   finally	  quiescence	  (Enver	  et	  al.	  2009).	  Furthermore,	  these	  four	  options	  are	  further	  complicated,	  for	  example	   in	   the	   context	   of	   differentiation	   and	   lineage	   specification,	   as	   hESCs	  have	   at	   least	   three	   choices	   in	   germ	   layer	   specification.	   Each	  of	   these	  different	  fates	  can	  be	  generally	  regarded	  as	  cell	  states	  and	  it	  is	  generally	  accepted	  that	  the	  transition	   to	   any	   of	   these	   states	   mentioned	   above	   is	   largely	   governed	   by	  transcription	  factors.	  This	  can	  be	  demonstrated	  during	  development	  when	  cells	  transition	  from	  a	  pluripotent	  state	  to	  a	  restricted	  state,	  passing	  through	  stable	  gene	   expression	   networks	   (Enver	   et	   al.	   2009).	   Some	   of	   the	   earliest	   work	   in	  cellular	   behaviour	   and	   the	   depiction	   of	   cell	   states	   was	   introduced	   by	   the	  
‘canalization	   of	   development’	   which	   involves	   cells	   rolling	   down	   bifurcating	  channels	   on	   a	   hillside	   to	   a	   final,	   fixed	   destination	   (Waddington	   1957).	   This	  model	   was	   further	   developed	   from	   the	   idea	   that	   cells,	   rather	   than	   rolling	  smoothly	  down	  the	  hillside,	  enter	  stable	  or	  meta-­‐stable	  states	  along	  the	  path	  of	  differentiation	   to	   encompass	   transitory	   intermediate	   cell	   types	   which	   appear	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during	  development,	  for	  example	  progenitor	  cells	  (Andrews	  2002).	  	  Within	  the	  landscape	  context,	   these	  states	  are	  depicted	  as	   impressions	  along	   the	   route	  of	  differentiation	   and	   are	   mathematically	   known	   as	   attractors	   (Fig.	   1.1).	  Attractors	  represent	  mathematically	  stable	  solutions	  to	  which	  a	  dynamic	  system	  gravitates	  to	  over	  time.	  In	  the	  context	  of	  a	  biological	  system,	  an	  attractor	  would	  represent	   the	  most	   stable	   gene	   regulatory	   network	   for	   a	   particular	   cell.	   Thus	  different	   cell	   states,	   governed	   by	   stable	   gene	   regulatory	   networks	   appear	  throughout	   development	   and	   represent	   equilibrium	   points	   through	   which	   a	  dynamical	  system	  progresses	  (Enver	  et	  al.	  2009).	  There	  is	  growing	  evidence	  to	  suggest	   that	   more	   discreet	   states	   exist,	   known	   as	   substates,	   which	   sub-­‐fractionate	   overarching	   cell	   states.	   In	   the	   context	   of	   the	   pluripotent	   state	   for	  example,	  substates	  represent	  situations	   in	  which	  cells	  are	  all	  capable	  of	  multi-­‐lineage	  differentiation	  but	  the	  probabilities	  of	  a	  cell	  choosing	  a	  particular	  fate	  is	  altered,	  such	  that	  a	  cell	  is	  more	  or	  less	  likely	  to	  follow	  one	  particular	  route	  over	  another	   (Enver	   et	   al.	   2009).	   Conceptually	   therefore,	   within	   a	   cell	   state,	   a	   cell	  could	  sit	  and	  remain	  at	   the	  bottom	  of	  an	  attractor,	  which	  would	  represent	   the	  most	   stable	   ‘fixed	   point’	   of	   that	   state.	   This	   would	   correspond	   to	   the	   stable	  expression	  of	  a	  network	  of	  genes	  applicable	  to	  that	  attractor.	  On	  the	  other	  hand,	  a	   cell	   could	   circulate	   around	   the	   attractor	   through	   oscillatory	   states,	   possibly	  due	   to	   the	   stochastic	   input	   of	   signals,	   consequently	   generating	   heterogeneity	  within	   the	  expression	   levels	  of	   genes	  within	   that	  network	   (Enver	  et	   al.	  2005).	  Between	   individual	   cells	   this	   could	   represent	   differences	   in	   growth	   factor	  responsiveness	   and	   protein	   expression	   differences,	   resulting	   in	   discreet	   yet	  functional	  changes.	  This	  concept	  is	  apparent	  within	  adult	  stem	  cell	  systems	  such	  as	   the	  hematopoietic	   system,	  whereby	  single	  cells	  have	  been	   found	   to	  express	  genes	   of	   both	   the	   erythroid	   (β-­‐globin)	   and	   myeloid	   (MPO)	   lineages	   prior	   to	  exclusive	   commitment	   to	   either	   the	   erythroid	   or	   granulocytic	   lineages	  respectively	  (Hu	  et	  al.	  1997).	  	  Within	   the	   pluripotent	   context,	   the	   most	   well	   known	   example	   of	   substates	  within	   the	   pluripotent	   state	   is	   that	   of	   naïve	   and	   primed	   ESCs.	   Thought	   to	   be	  analogous	   to	   cells	   of	   the	   late	   ICM,	   mouse	   naïve	   cells	   show	   increased	   cloning	  efficiencies	  and	  superior	  chimeric	  contributions	  than	  primed	  cells,	  thought	  to	  be	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analogous	  to	  cells	  of	  the	  late	  epiblast	  (Tesar	  et	  al.	  2007;	  Ying	  et	  al.	  2008).	  Both	  subsets	   of	   cells	   are	   pluripotent	   and	   self-­‐renew	   and	   thus	   can	   be	   regarded	   as	  substates	   of	   the	   overarching	   pluripotent	   state.	  Naïve-­‐like	   cells	   have	   also	   been	  reported	   in	   hESCs,	   and	   exhibit	   similarities	   to	   their	   mouse	   counterparts	  (Takashima	  et	  al.	  2014a;	  Gafni	  et	  al.	  2013;	  Ware	  et	  al.	  2014;	  Chan	  et	  al.	  2013).	  Whilst	   the	   naïve	   and	   primed	   substates	   can	   be	   regarded	   as	   quite	   separate	  entities,	  due	  to	  the	  apparent	  need	  to	  physically	  reprogramme	  mEpi	  stem	  cells	  to	  a	  naïve	  state	  (Guo	  et	  al.	  2009),	  accumulating	  evidence	  suggests	  the	  existence	  of	  more	  subtle	   forms	  of	  substates	  and	  heterogeneity	  that	  exist	  specifically	  within	  
‘primed’	   hESCs	   that	   can	   alter	   the	   functional	   properties	   of	   a	   cell	   (Fig.	   1.2).	  Initially	   based	   on	   the	   heterogeneous	   expression	   patterns	   of	   hESC	   surface	  markers	   due	   to	   the	   convenience	   of	   cell	   staining,	   SSEA-­‐3,	   TRA-­‐1-­‐60,	   CD9	   and	  GCTM2	   have	   been	   used	   to	   segregate	   functionally	   discreet	   subsets	   of	   cells	   in	  culture	  (Tonge	  et	  al.	  2011;	  Enver	  et	  al.	  2005;	  Laslett	  et	  al.	  2007).	  These	  studies	  provided	  evidence	  that,	  within	  the	  stem	  cell	  compartment,	  there	  are	  continuous	  gradients	  of	  the	  expression	  of	  pluripotency	  genes.	  Additionally,	  the	  appearance	  of	   lineage	   gene	   expression	   alongside	   markers	   of	   pluripotency	   has	   been	  observed	   in	   hESCs	   (Laslett	   et	   al.	   2007).	   Thus,	  within	   an	   attractor	  model	   cells	  with	   variable	   expression	   of	   pluripotency	   genes	   would	   represent	   cells	   in	  different	  oscillatory	  states,	  whereby	  the	  lower	  expression	  of	  pluripotency	  genes	  would	   correspond	   to	   cells	   residing	   in	   substates	   closer	   to	   the	   commitment	  barrier.	   This	  was	   proven	   functionally	   through	   clonogenic	   assays	   (Tonge	   et	   al.	  2011).	  	  	  Within	   the	   in	   vivo	   context	   it	   is	   also	   feasible	   that	   the	   plastic	   nature	   of	   ESCs	   is	  apparent	  within	  the	  mouse	  blastocyst.	  NANOG	  is	  a	  gene	  which	  was	  identified	  as	  having	   a	   central	   role	   in	   the	   pluripotent	   phenotype	   of	   ESCs	   (I.	   Chambers	   et	   al.	  2003)	  but	  was	  later	  shown	  to	  be	  expressed	  heterogeneously	  within	  cells	  of	  the	  ICM	   of	   E3.5	   mouse	   embryos	   (Chazaud	   et	   al.	   2006).	   Further	   investigation	   of	  
NANOG	  in	  vitro	  then	  demonstrated	  that	  it	  was	  not	  essential	  for	  pluripotency	  (I.	  Chambers	   et	   al.	   2007),	   although	   NANOG	   negative	   cells	   did	   show	   a	   higher	  propensity	   to	   differentiate.	   It	   would	   therefore	   remain	   possible	   that	   some	   of	  these	  NANOG(-­‐)	  cells	  within	  the	  ICM	  may	  still	  be	  pluripotent	  (Enver	  et	  al.	  2009).	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  We	   therefore	   hypothesise	   that	   these	   oscillatory	   states	   within	   the	   stem	   cell	  compartment	   may	   be	   responsible,	   at	   least	   in	   part,	   for	   the	   non-­‐uniform	  differentiation	   of	   hESCs	   in	   vitro.	   The	   identification	   and	   characterisation	   of	  functionally	  discreet	  substates	  would	  provide	  a	  better	  understanding	  of	  cell	  fate	  decisions	   of	   stem	   cells,	   and	   may	   allow	   for	   more	   efficient,	   homogeneous	  differentiation	  in	  culture.	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Fig.	  1.1:	  The	  Landscape	  Model	  of	  Cell	  Differentiation	  	  	  	  	  	  	  	  	  	  	  Enver	  et	  al	  describe	  a	  model	   that	  describes	   the	  movement	  of	   cells	   throughout	  differentiation	  in	  a	  3D	  plane.	  Depressions	  in	  the	  landscape	  represent	  observable	  states	   that	   cells	   transition	   through	   during	   differentiation.	   Mathematically,	  depressions	   represent	   attractors	   that	   are	   stable	   solutions	   to	   a	   set	   of	  mathematical	  equations	  that	  describe	  a	  dynamic	  system,	  such	  that	  the	  basin	  of	  an	   attractor	   represents	   the	  most	   stable	   point	   (purple	   line).	   The	   depth	   of	   the	  attractors	   correlates	   to	   their	   stability.	   Cells	   transition	   between	   attractors,	   not	  necessarily	  following	  the	  same	  pathways	  (red	  &	  green	  lines)	  to	  reach	  their	  final	  destination.	  Cells	  can	  equally	  move	  in	  reverse	  (dotted	  green	  line)	  for	  example	  in	  the	  case	  of	   trans-­‐differentiation	  or	   re-­‐programming.	  Furthermore,	  within	  each	  depression,	   cells	   can	   oscillate	   around	   the	   walls	   of	   the	   attractor,	   representing	  discreet	  substates	  (Enver	  et	  al.	  2009).	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Fig.	  1.2:	  Sub-­‐States	  Within	  The	  Pluripotent	  State	  
	  Conceptually,	   the	   valley	   represents	   the	   pluripotent	   state.	   Balls	   represent	   cells	  and	   if	   they	   reside	   within	   the	   valley	   are	   pluripotent.	   Balls	   can	   roll	   out	   of	   the	  valley	   and	   commit	   to	   differentiation,	   or	   they	   can	   reside	   at	   the	   basin	   of	   the	  attractor	   representing	   the	   most	   stable	   GRN	   of	   that	   state.	   Equally,	   through	  stochastic	  inputs	  of	  energy	  (signalling),	  balls	  can	  roll	  around	  the	  valley	  into	  sub-­‐states.	  These	  sub-­‐states	  may	  represent	  heightened	  sensitivity	  to	  signalling	  cues	  and/or	   gene	   expression	   changes.	   They	   therefore	   may	   represent	   functionally	  discreet	  sub-­‐states	  altering	  the	  behaviour	  of	  cells.	  Furthermore,	  these	  substates	  may	  show	  specific	  biases	  to	  any	  of	  the	  possible	  lineages	  available	  to	  that	  cell.	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2 Methods	  
	  2.1 Mouse	  embryonic	  fibroblast	  (MEF)	  preparation	  
	  
	  Human	  ES	  cells	  were	  grown	  on	  mitomycin	  inactivated	  feeder	  cells	  from	  the	  CF1	  mouse	   strain	   made	   in-­‐house.	   MEFs	   were	   defrosted	   as	   P0	   and	   cultured	   in	  DMEM/10%	  FCS.	  Cells	  were	  passaged	  and	  bulked	  to	  P4	  before	  treatment	  with	  mitomycin	   C.	   Mitomycin	   C	   was	   diluted	   in	   DMEM/FCS	   (Sigma;	   M-­‐4287)	   at	  1µg/mL	  and	  added	  to	  MEFs	  for	  2h.	   Cells	  were	  then	  washed	  in	  PBS,	  trypsinised,	  neutralised	  and	  counted.	  On	  average	  2	  x	  106	  cells	  were	  resuspended	  in	  0.5mL	  of	  freeze	  media	  (80%	  DMEM,	  10%FCS	  &	  10%	  DMSO)	  and	  stored	  at	  -­‐80OC.	  	  2.2 Human	  embryonic	  stem	  cell	  culture	  
	  
	  Human	  embryonic	  stem	  cells	  (hESCs)	  were	  cultured	   in	  both	   feeder	  and	   feeder	  free	  formats,	  as	  specified	  by	  individual	  experimental	  procedures	  outlined	  below.	  In	  each	  case,	  hESCs	  were	  incubated	  at	  37OC	  in	  a	  5%	  CO2	  humidified	  incubator.	  	   2.2.1 MEF	  culture	  	  	  3	  mL	  of	  0.1%	  Gelatin/PBS	  was	  added	  to	  T25	  flasks	  and	  incubated	  for	  30mins	  at	  room	   temperature.	   The	   gelatin	   was	   aspirated	   and	   MEFs	   were	   seeded	   at	   a	  density	   of	   10,000	   cells/cm2	   in	   DMEM/FCS.	   MEFs	   were	   incubated	   at	   10%	  CO2/37OC	   overnight	   before	   use.	   Fresh	   MEFs	   were	   used	   for	   hESC	   culture	  wherever	   possible.	   On	   the	   day	   of	   passage,	   media	   from	   the	   MEF	   flasks	   was	  replaced	  with	  2mL	  of	  hESC	  media	  and	  kept	   in	  a	  5%	  CO2/37OC	   incubator	   for	  a	  minimum	  of	  30	  minutes	  to	  equilibrate.	  Media	  was	  aspirated	  from	  the	  hESCs	  and	  1	  mL/T25	  of	  1mg/mL	  collagenase	  IV	  added.	  Cells	  were	  incubated	  for	  7	  minutes	  at	  37OC	  with	  continual	  monitoring	  for	  lifting	  of	  colony	  edges	  using	  a	  microscope.	  After	  7	  min.,	  the	  collagenase	  was	  removed	  and	  replaced	  by	  3mL	  of	  fresh	  media.	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Cells	   were	   either	   gently	   scraped	   using	   a	   5mL	   stripette	   or	   beaded	   from	   the	  surface	  of	  the	  flask	  and	  split	  at	  a	  ratio	  of	  1:3-­‐1:4.	  	  
	  
Table	  1.1:	  Components	  of	  hESC	  culture	  media	  on	  MEF	  feeder	  cells	  
	  	  hESC	  medium	  is	  referred	  throughout	  this	  study	  as	  KO/SR,	  meaning	  the	  medium	  is	  made	  using	  knockout	  DMEM	  and	  20%	  Knockout	  serum	  replacement.	  
	   2.2.2 MEF	  free	  cultures	  
	  
	  hESCs	  were	  cultured	  on	  a	  combination	  of	  either	  Geltrex	  (LifeTech	  A1313302)	  &	  E8	   (LifeTech	   A1517001)	   or	   Vitronectin	   (LifeTech	   A14701SA)	   &	   E8	   (LifeTech	  A1517001).	  In	  both	  cases,	  the	  matrices	  were	  thawed	  on	  ice,	  and	  diluted	  1:100	  in	  either	  KO	  DMEM	  (Geltrex)	  or	  PBS	  (w/o	  Ca+,	  Mg++	  (Vitronectin)).	  Culture	  vessels	  were	  coated	  with	  100µL/cm2	  of	  the	  diluted	  matrix	  for	  1h	  at	  room	  temperature.	  These	  vessels	  could	  then	  be	  stored	  for	  up	  to	  1	  week	  at	  4OC.	   Cells	  were	  passaged	  by	   washing	   twice	   with	   PBS	   and	   then	   adding	   100µL/cm2	   of	   ReleSr	   (StemCell	  Technologies).	  ReleSr	  was	  removed	  immediately	  so	  that	  only	  a	  thin	  film	  covered	  the	  cells.	  Cells	  were	  incubated	  at	  room	  temperature	  for	  4	  mins,	  and	  fresh	  E8	  was	  added	   to	   neutralise.	   Cells	   were	   removed	   from	   the	   culture	   plastic	   by	   firmly	  rinsing	  with	  E8	  using	  a	  P1000.	  Cells	  were	  not	  pipetted	  more	  than	  3	  times	  as	  this	  produced	   very	   small	   clumps	   of	   cells	   that	   were	   susceptible	   to	   death.	   Colonies	  were	  passaged	  at	  a	  ratio	  of	  1:3-­‐1:6.	  Enzymatic	  passaging	  was	  not	  used	  in	  feeder	  free	  conditions	  as	  it	  greatly	  affected	  cell	  attachment.	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   2.2.3 hESC	  culture	  with	  inhibitors	  	  	  	  hESCs	   put	   under	   culture	   conditions	   with	   various	   inhibitors	   were	   grown	   on	  feeder	   layers	   in	   mTesr	   plus	   the	   appropriate	   inhibitors.	   MEF	   plates	   were	  prepared	  as	  described	  in	  2.2.1,	  however	  the	  density	  of	  MEF	  cells	  was	  increased	  to	  40,000/cm2.	  hESCs	  were	  passaged	  by	  adding	  100uL/cm2	  of	  collagenase	  and	  incubating	   cells	   for	   5	  mins	   at	   37oC	   at	   5%	   CO2.	   Collagenase	  was	   removed	   and	  100uL/cm2	   fresh	   media	   added	   before	   scraping	   using	   a	   5mL	   p1000	   tip.	   Cells	  were	   pipetted	   2-­‐3	   times	   and	   split	   1:10	   every	   3-­‐4	   days	   onto	   fresh	   MEFs.	  Alternatively,	   cells	  were	  dissociated	  using	   trypLE	  described	   in	  2.5.	   Cells	  were	  resuspended	  in	  fresh	  media	  and	  split	  1:10	  every	  3-­‐4	  days	  onto	  fresh	  MEFs.	  	  2.3 hESC	  freezing	  
	  
	  hESCs	  were	  digested	  using	  collagenase	   IV	   for	  7	  minutes	  at	  37OC,	  5%	  CO2.	  The	  collagenase	  was	   removed	   and	   fresh	   hESC	  media	   or	   E8	   added.	   The	   cells	   were	  either	  scraped	  or	  beaded	  off	  the	  vessel	  surface	  and	  centrifuged	  for	  3	  minutes	  at	  1000rpm.	  The	  supernatant	  was	  aspirated	  and	  cells	  were	  resuspended	  gently	  in	  freeze	   media	   (60%	   hESC,	   30%	   KOSR	   and	   10%	   DMSO)	   and	   subsequently	  aliquotted	   into	   1.5mL	   cryovials.	   Cryovials	   were	   placed	   into	   a	   Mr	   Frosty	  Isopropanol	   freezing	  container	  and	  placed	   into	   -­‐80OC	   for	  24	  hours.	  Vials	  were	  then	  transferred	  to	  liquid	  nitrogen	  after	  24h	  for	  long-­‐term	  storage.	  	  	  2.4 hESC	  thawing	  
	  
	  MEF	  culture	  vessels	  were	  prepared	  the	  night	  before	  thawing	  of	  hESCs	  (See	  2.1).	  Fresh	  hESC	  media	  was	  added	  to	  these	  vessels	  and	  incubated	  at	  37OC	  at	  5%	  CO2	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to	  equilibrate.	  Cells	  were	  removed	  from	  liquid	  nitrogen	  and	  transported	  on	  ice,	  before	  being	  placed	  into	  a	  37OC	  pre-­‐warmed	  water-­‐bath	  until	  the	  cell	  pellet	  was	  mostly	   defrosted.	   The	   cells	   were	   transferred	   to	   a	   15mL	   falcon	   tube	   and	  centrifuged	  at	  1000rpm	  for	  3	  minutes.	  The	  supernatant	  was	  aspirated	  and	  cells	  were	  re-­‐suspended	  in	  fresh	  hESC	  media	  before	  seeding	  into	  the	  pre-­‐equilibrated	  MEF	  flask.	  For	  improved	  viability,	  cells	  were	  seeded	  in	  10µM	  Y-­‐27632	  (Abcam	  -­‐	  ab120129).	  	  2.5 Single	  cell	  dissociation	  
	  
	  For	  experiments	  that	  required	  single	  cells,	  hESCs	  were	  dissociated	  using	  TrypLE	  (LifeTech;	   12563-­‐029).	  Media	  was	   aspirated	   from	   the	   cells	   and	  100µL/cm2	  of	  1X	  TrypLE	  added	  to	  the	  vessel.	  Cells	  were	  incubated	  for	  2	  minutes	  at	  37OC,	  5%	  CO2,	  removed	  and	  cells	  were	  dislodged	  by	  gently	  hitting	  the	  flask,	  then	  returned	  for	  a	  further	  minute	  to	  37OC,	  5%	  CO2.	   A	  2:1	  ratio	  of	  hESC	  media	  to	  TrypLE	  was	  added	  to	  neutralise,	  and	  cells	  were	  transferred	  to	  a	  15mL	  falcon	  tube.	  This	  was	  then	   centrifuged	   at	   1000	   rpm	   for	   3	  mins,	   the	   supernatant	   aspirated	   and	   cells	  were	  re-­‐suspended	  in	  hESC	  media	  for	  further	  downstream	  application.	  	  2.6 Cell	  counting	  
	  
	  hESCs	  were	  counted	  by	  dissociating	  to	  single	  cells	  (see	  2.5)	  and	  resuspended	  in	  an	   appropriate	   dilution	   volume	   of	   hESC	  media.	   10	  µL	   of	   cell	   suspension	  was	  added	   to	   an	   improved	   neubauer	   haemocytometer	   and	   the	   four	    corner	   grids	  were	  counted.	  The	  cell	  count	  was	  determined	  by	  using	  the	  following	  formula	  	  	  
Concentration	  [cell/mL]	  =	  No	  of	  cells	  counted	  ÷	  No	  of	  grids	  counted	  *	  10,000	  
Total	  cell	  number	  =	  Concentration	  *	  Total	  volume	  (mL)	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2.7 Screening	  on	  hESCs	  	  	  In	  all	  screens,	  hESCs	  were	  dissociated	  to	  single	  cells	  and	  re-­‐seeded	  on	  feeder	  free	  conditions.	  hESCs	  were	  dissociated	  as	  described	  in	  2.5	  and	  counted	  as	  described	  in	  2.6.	  For	  inhibitor	  screens,	  10,000	  cells	  /	  cm2	  were	  plated	  onto	  vitronectin	  in	  E8	  in	  the	  presence	  of	  10	  μM	  Y-­‐27632	  and	  incubated	  at	  37oC	  at	  5%	  CO2	  overnight.	  The	  media	  was	  then	  changed	  to	  fresh	  E8	  without	  Y-­‐27632	  but	  with	  the	  addition	  of	  	  inhibitors	  being	  screened.	  Media	  was	  changed	  on	  a	  daily	  basis	  for	  the	  duration	  of	  the	  assay.	  	  2.8 Embryoid	  body	  differentiation	  
	   2.8.1 Plate	  set-­‐up	  
	  
	  Cells	   were	   either	   differentiated	   in	   neutral	   conditions	   that	   did	   not	   contain	  recombinant	  proteins	  or	  chemical	   inhibitors	   to	  direct	  differentiation,	  or	  under	  conditions	  permissive	  for	  endoderm,	  mesoderm	  and	  ectoderm	  conditions.	  For	  neutral	  conditions,	  50	  µL	  of	  APEL	  media	  (Table.	  1.2)	   (Ng	  et	  al.	  2008)	  was	  pipetted	   into	   the	   inner	   60	   wells	   of	   a	   non-­‐adherent	   U-­‐shaped	   96-­‐well	   plate	  (Sigma	   Aldrich).	   The	   outer	   36	   wells	   were	   filled	   with	   100µL	   of	   sterile	   PBS	   to	  humidify	  the	  plate	  and	  prevent	  evaporation.	  Plates	  were	  stored	  at	  37o	  C	  at	  5%	  CO2	  until	  ready	  to	  use.	  For	  directed	  differentiation,	  plates	  were	  filled	  with	  50µL	  of	  APEL	  media	  containing	  the	  appropriate	  combination	  of	  human	  recombinant	  proteins	  and/or	  inhibitors	  at	  X2	  concentration	  (Table.	  1.3).	  
	   2.8.2 Harvesting	  and	  seeding	  of	  cells	  
	  
	  24h	  prior	  to	  EB	  formation,	  T25	  flasks	  were	  coated	  with	  MEF	  conditioned	  media	  overnight.	  The	  next	  day	  80-­‐90%	  confluent	  hESCs	  were	  dissociated	  as	  described	  in	  2.5	  and	  resuspended	  in	  fresh	  hESC	  media	  without	  Y-­‐27632	  and	  seeded	  onto	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the	  MEF	  coated	  flasks.	  Cells	  were	  incubated	  at	  37oC	  for	  30	  mins,	  and	  the	  media	  was	  then	  changed	  containing	  10	  µM	  Y-­‐27632.	  Cells	  were	  incubated	  at	  37oC	  for	  a	  further	  hour	  before	  re-­‐trypsinisation	  and	  neutralisation	  with	  APEL	  media,	  and	  then	  centrifuged.	  Cells	  were	  re-­‐suspended	  in	  fresh	  APEL	  media,	  counted	  and	  cell	  dilution	   made	   such	   that	   there	   were	   3000	   cells	   per	   50µL.	   50	   µL	   of	   cell	  suspension	   was	   then	   seeded	   into	   the	   inner	   60	   wells	   of	   a	   pre-­‐prepared	   non-­‐adherent	   U-­‐shaped	   96-­‐well	   plate	   (Sigma	   Aldrich).	   Plates	   were	   centrifuged	   at	  1000rpm	   for	  3	  mins	   to	   collect	   cells	   at	   the	  bottom	  of	   the	  wells.	  EBs	  were	   then	  incubated	  at	  37oC	  at	  5%	  CO2	  for	  the	  specified	  assay	  duration.	  	  
Table	  1.2:	  Components	  of	  APEL	  medium	  
	  




Table	  1.3:	  Growth	  factors	  and	  chemical	  inhibitors	  used	  to	  differentiate	  
hESCs	  in	  embryoid	  bodies	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2.9 hESC	  FACS	  antibody	  staining	  	  	   2.9.1 FACS	  analysis	  	  	  Media	   was	   aspirated	   and	   cells	   were	   dissociated	   using	   trypLE	   as	   described	  above.	   Cells	   were	   neutralised	  with	   FACS	   buffer	   (10%	   FCS/PBS),	   counted	   and	  centrifuged	  at	  1000	  rpm	  for	  3	  minutes.	  Supernatant	  was	  aspirated	  and	  cells	  re-­‐suspended	   in	   FACS	   buffer	   at	   a	   cell	   density	   of	   1	   x	   107	   per	   mL.	   200µL	   of	   the	  sample	   was	   transferred	   to	   a	   5mL	   FACS	   tube	   and	   the	   appropriate	   antibodies	  added,	  as	  per	  Table	  3.	  Cells	  and	  primary	  antibody	  were	  incubated	  at	  4OC	  for	  30	  minutes	  with	  occasional	   flicking	  to	  re-­‐suspend	  the	  cells.	  After	  30	  minutes	  cells	  were	  washed	  once	   in	  FACS	  buffer,	   centrifuged	  at	  1000	  rpm	  for	  3	  minutes	  and	  re-­‐suspended	   in	  200µL	  of	   FACS	  buffer.	   The	   secondary	   antibody	  was	   added	   as	  per	   table	   3	   for	   a	   further	   30	   minutes	   at	   4OC	   with	   occasional	   flicking.	   After	  secondary	  staining,	  cells	  were	  twice	  washed	  in	  FACS	  buffer,	  centrifuged	  at	  1000	  rpm	  for	  3	  minutes	  and	  resuspended	  in	  500µL	  for	  FACS	  analysis.	  	   2.9.2 FACS	  for	  cell	  sorting	  
	  
	  Cells	  for	  sorting	  were	  prepared	  in	  the	  same	  way	  as	  described	  above,	  however	  all	  washes	   and	   staining	   procedures	   were	   performed	   in	   hESC	   media.	   Single	   cells	  were	   sorted	   into	   FACS	   tubes	   containing	   1mL	   of	   hESC	  media.	   Resulting	   sorted	  cells	  were	  seeded	  in	  the	  presence	  of	  50µg/mL	  of	  gentamycin	  (LifeTechnologies)	  to	  prevent	  contamination.	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Table	  1.3.	  Antibodies	  used	  for	  the	  detection	  of	  surface	  antigens	  and	  
transcription	  factor	  expression	  in	  hESCs	  
	  
	  
	   The	  above	  table	  details	  surface	  antigens*	  used	  to	  identify	  and	  purify	  hESCs.	  P3X	   and	   TRA-­‐1-­‐85	   were	   used	   as	   negative	   and	   positive	   controls	  respectively.	   Additionally	   shown	   are	   stem	   cell	   associated**	   and	   lineage	  associated***	  transcription	  factors.	  
	  
	  
	  	  The	  table	  above	  details	  the	  secondary	  antibodies	  used	  in	  conjunction	  with	  the	  primary	  antibodies	  listed	  in	  Table.	  1.	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2.10 Functional	  assays	  
	   2.10.1 Single	  cell	  deposition	  
	  
	  24h	  before	  sorting	  of	  single	  cells,	  96-­‐well	  culture	  treated	  plates	  were	  prepared	  by	   seeding	   MEF	   cells	   at	   a	   density	   of	   10,000	   cells/cm2	   into	   each	   well,	   as	  described	  (see	  2.2.1).	  MEF	  cells	  were	  seeded	  in	  hESC	  media	  with	  the	  addition	  of	  12µM	  Y-­‐27632	  so	  as	  to	  condition	  the	  media.	  MEF	  cells	  were	  cultured	  at	  37oC	  at	  10%	  CO2	  overnight	  before	  use.	  To	  generate	  clonal	  sublines	  of	  hESCs,	  cells	  from	  cultures	   at	    80-­‐90%	   confluency	  were	   dissociated	   to	   single	   cells	   using	   TrypLE	  
(see	   2.5).	   Cells	   were	   resuspended	   in	   fresh	   hESC	  media	   and	   pipetting	   with	   a	  P1000	   ensured	   clumps	   of	   cells	   were	   properly	   dissociated.	   Cells	   were	   then	  stained	  with	  the	  appropriate	  markers	  as	  previously	  described	  (see	  2.8.2).	  Using	  the	   pre-­‐prepared	   MEF	   plate,	   single	   cells	   were	   sorted	   using	   a	   ‘BD	   FACS	   Jazz’	  directly	  into	  the	  wells	  of	  the	  96-­‐well	  plate	  containing	  the	  conditioned	  media	  and	  Y-­‐27632.	   The	  plate	  was	  then	  briefly	  centrifuged	  at	  1000rpm	  for	  1	  min	  to	  ensure	  cells	  pierced	  the	  meniscus,	  and	  incubated	  at	  37oC	  at	  5%	  CO2	  for	  2	  days.	  After	  2	  days,	   the	   hESC	  media	  was	   replaced	  with	   fresh	  media	   to	   remove	   the	   Y-­‐27632,	  and	  colonies	  were	  left	  to	  develop	  over	  the	  next	  8-­‐12	  days.	  Wells	  that	  contained	  large	  hESC	  like	  colonies	  were	  then	  passaged	  using	  the	  standard	  MEF	  passaging	  or	  MEF	  free	  passaging	  (see	  2.2.1	  &	  2.2.2).	  	   2.10.2 Clonogenic	  assays	  
	  
	  Clonogenic	  assays	  were	  performed	  after	  FACS	  cell	  sorting	  on	  both	  MEF	  and	  MEF	  free	  conditions.	  Cells	  of	  80-­‐90%	  confluency	  were	  dissociated	  with	  trypLE	  (see	  
2.5).	  These	  cells	  were	  then	  stained	  with	  the	  appropriate	  antibodies	  (see	  2.8.2).	  After	   staining,	   cells	   were	   bulk	   sorted	   using	   a	   ‘BD	   FACS	   Jazz’	   into	   tubes	  containing	  1mL	  of	  hESC	  media.	  After	  sorting,	  cells	  were	  centrifuged	  at	  1000rpm	  for	  3	  mins	  and	  counted	  (see	  2.6).	  For	  clonongenic	  assays	  cell	  suspensions	  were	  made	  at	  a	  density	  of	  500	  cells/cm2	  in	  the	  required	  volume	  of	  hESC/E8	  media	  for	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MEF	  or	  feeder	  free	  conditions	  respectively,	  with	  the	  addition	  of	  10µM	  Y-­‐27632	  and	   50µg/mL	   gentamycin.	   Cells	   were	   left	   to	   attach	   for	   24hrs	   and	  media	   was	  replaced	   to	   remove	   dead	   cells	   and	   the	   Y-­‐27632	   inhibitor.	   No	   further	   media	  changes	  were	   necessary.	   After	   four	   days,	  media	  was	   removed	   from	   each	  well	  and	  resulting	  colonies	  were	  washed	  once	  with	  PBS	  (w/o	  Ca+,	  Mg++),	  before	  the	  addition	   of	   4%	   PFA.	   Cells	   were	   incubated	   for	   15	   mins	   at	   room	   temperature	  before	  PFA	  removal,	  and	  were	  washed	  once	   in	  PBS	  (w/o	  Ca+,	  Mg++)	  to	  remove	  residual	   PFA.	   Plates	   could	   then	   be	   stored	   at	   4oC	   indefinitely,	   or	   stained	   for	  appropriate	  markers	  	  2.11 Immunostaining	  
	  
	  For	  surface	  marker	  staining	  in	  situ,	  cells	  were	  washed	  with	  twice	  with	  PBS	  and	  fixed	   with	   4%	   PFA	   for	   15	   minutes	   at	   room	   temperature.	   Cells	   were	  subsequently	  washed	   in	  PBS,	  and	  at	   this	  stage	  could	  be	  stored	  at	  4OC	   for	   later	  staining.	   Cells	   were	   blocked	   in	   blocking	   solution	   consisting	   of	   PBS,	   10%FCS,	  0.3M	  Glycine	   and	  1%	  BSA	   for	  1h	   at	   room	   temperature.	  The	  primary	   antibody	  was	   resuspended	   in	   PBS,	   10%	   FCS	   and	   1%	   BSA	   at	   the	   appropriate	  concentration,	  and	  incubated	  for	  1h	  at	  4OC.	  Cells	  were	  washed	  twice	  in	  PBS	  and	  the	  secondary	  was	  applied,	  again	  resuspended	   in	  PBS,	  10%FCS	  &1%	  BSA.	  The	  secondary	  was	   incubated	   for	   1h	   at	   4OC,	   and	   cells	   were	  washed	   twice	   in	   PBS.	  Plates	  could	  then	  be	  stored	  in	  PBS	  at	  4OC.	  For	  intracellular	  staining,	  cells	  were	  fixed	  as	  above,	  but	  initial	  blocking	  included	  PBS,	  10%	  serum	  (species	  specific	  to	  the	  animal	  in	  which	  the	  secondary	  antibody	  was	  raised),	  0.3M	  Glycine,	  1%	  BSA	  and	  0.1%	  Tween	  for	  2h	  at	  room	  temperature.	  The	  primary	   and	   secondary	   antibodies	  were	   resuspended	   in	  PBS,	   10%	   serum	  (species	   specific),	   1%	  BSA	   and	   0.1%	  Tween.	   Primary	   antibody	  was	   incubated	  over	  night	  at	  4OC,	  and	  secondary	  for	  2h	  at	  4OC.	  Between	  antibodies,	  cells	  were	  washed	  twice	  in	  PBS.	  Surface	  staining	  was	  performed	  before	  permeabilisation	  if	  combined	  with	  intracellular	  staining.	  In	  all	  cases,	  staining	  was	  performed	  under	  sterile	  conditions	  to	  allow	  for	  long-­‐term	  storage.	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2.12 RNA	  extraction	  
	   2.12.1 Extraction	  from	  monolayer	  cultures	  
	  
	  Cells	   were	   washed	   once	   with	   sterile	   PBS	   (w/o	   Ca+,	   Mg++)	   and	   100µL/cm2	   of	  Trizol	   reagent	   (LifeTechnologies)	   was	   added	   onto	   the	   surface	   of	   the	   culture	  vessel	  and	  evenly	  distributed	  by	  rocking.	  After	  2	  minutes,	   lysis	  was	  monitored	  under	   the	   microscope	   and	   the	   suspension	   was	   subsequently	   transferred	   into	  a	    1.5mL	  eppendorf	   tube	   for	  extraction.	  Samples	  could	  also	  be	  stored	  at	   -­‐20OC	  for	  extraction	  at	  a	  later	  date.	  	   2.12.2 Extraction	  from	  EB	  culture	  
	  
	  EBs	  were	  transferred	  into	  a	  15mL	  falcon	  tube	  and	  washed	  once	  with	  PBS.	  EBs	  were	  not	  centrifuged	  initially,	  but	  left	  for	  2	  mins	  to	  collect	  at	  the	  bottom	  of	  the	  tube	   through	   gravitational	   pull.	  Media	  was	   then	   aspirate	   and	   this	   allowed	   the	  removal	  of	  dead	  cells	  and	  debris.	  EBs	  were	  then	  washed	  in	  PBS,	  centrifuged	  at	  1000rpm	   for	   1	   minute	   and	   resuspended	   in	   1mL	   of	   Trizol	   and	   transferred	   to	  1.5mL	  eppendorf	  tubes.	  EBs	  were	  kept	  in	  trizol	  for	  10-­‐12	  minutes	  with	  regular	  vortexing	  to	  break	  up	  the	  structures,	  before	  being	  placed	  at	  -­‐20OC	  overnight	  to	  ensure	  complete	  cell	  lysis.	  Samples	  were	  then	  thawed	  for	  extraction	  or	  kept	  at	  -­‐20OC	  for	  storage.	  	   2.12.3 Harvest	  from	  cells	  in	  suspension	  
	  
	  Cells	   in	  suspension	  were	  pelleted	  by	  centrifugation	  at	  1000rpm	  for	  3	  minutes,	  and	  the	  supernatant	  aspirated.	  The	  cell	  pellet	  was	  re-­‐suspended	  and	  washed	  in	  sterile	  PBS	  and	  re-­‐centrifuged.	  The	  cell	  pellet	  was	  then	  re-­‐suspended	  in	  1mL	  of	  trizol	   and	   transferred	   to	   a	   1.5mL	   eppendorf	   tube	   for	   extraction	   or	   storage	   as	  above.	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2.13 Total	  RNA	  isolation	  	  	  	  Samples	  in	  trizol	  were	  thawed	  (if	  stored)	  at	  room	  temperature	  and	  vortexed	  to	  homogenise.	   200µL	  of	   Chloroform	  per	  mL	  of	  Trizol	   (Sigma)	  was	   added	   to	   the	  sample	  and	  mixed	  thoroughly	  by	  vortexing	  for	  10	  seconds.	  The	  suspension	  was	  left	   to	   stand	   at	   room	   temperature	   for	   10	   minutes	   before	   centrifugation	   at	  14,000rpm	  for	  10	  minutes	  at	  4OC	  for	  phase	  separation.	  The	  top	  layer	  containing	  the	  RNA	  was	  removed	  by	  pipetting	  into	  a	  new	  1.5mL	  eppendorf	  tube,	  with	  care	  not	  to	  disturb	  the	  underlying	  phases.	  A	  thin	  layer	  of	  the	  RNA	  containing	  phase	  was	  always	  left	  behind	  to	  ensure	  minimal	  contamination.	  An	  1:1	  volume	  of	  70%	  ethanol	  was	   then	   added	   to	   the	   extract	   and	  mixed	  by	   vortexing.	   Samples	  were	  then	  processed	  using	  the	  RNA	  clean	  up	  and	  concentration	  kit	  (Norgen)	  for	  total	  RNA.	   RNA	   quality	  was	   checked	   through	   the	   A260/280	   and	   A260/230	   values.	  RNA	   quality	   was	   deemed	   of	   good	   quality	   if	   A260/280	   and	   A260/230	   values	  were	  above	  1.8.	  	  2.14 cDNA	  synthesis	  
	  
	  cDNA	   was	   made	   using	   the	   High	   Capacity	   cDNA	   Reverse	   Transcription	   Kit	  (Applied	   Biosystems).	   Resulting	   cDNA	   samples	   were	   assumed	   to	   have	   a	   1:1	  concentration	  ratio	  to	  the	  starting	  RNA.	  	  2.15 Quantitative	  PCR	  
	  
	  All	  preparations	  were	  done	  on	   ice	   and	  out	  of	  direct	   sunlight.	   Firstly,	   a	  master	  mix	   of	   5µL	   Taqman	   Fast	   Universal	   Master	   Mix	    (LifeTechnologies),	   0.2µM	  primer	  mix	  (containing	  5µM	  sense-­‐antisense	  oligo	  primers),	  0.1µL	  Roche	  probe	  (Roche	   UPL)	   and	   2.7µL	   of	   ddH2O	   (Life	   Technologies)	   was	   made	   for	   each	  reaction.	   Secondly,	   a	   cDNA	   dilution	   of	   5ng/µL	   was	   made	   in	   ddH2O	   for	   each	  reaction.	  8µL	  of	  the	  first	  master	  mix	  was	  added	  to	  wells	  of	  a	  Fast-­‐96	  or	  384	  well	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plate	  followed	  by	  2µL	  of	  the	  cDNA	  dilution	  for	  a	  total	  of	  10µL.	  The	  plates	  were	  then	   spun	   briefly	   at	   1000rpm.	   The	   plates	  were	   analysed	   using	   a	   QuantStudio	  12K	   Flex	   Real-­‐Time	   PCR	   system	   (LifeTechnologies)	   with	   the	   following	  parameters;	  50OC	  –	  2	  mins,	  95OC	  –	  10	  mins,	  95OC	  –	  15	  secs,	  60OC	  –	  1	  min	  (Fig.	  
1.1).	   Data	   analysis	   was	   performed	   using	   QuantStudio	   12K	   Flex	   software	  provided	  with	  the	  machine.	  The	  raw	  CT	  values	  were	  then	  converted	  to	  Delta-­‐CT	  by	   subtracting	   the	   gene	   of	   interest	   against	   the	   control	   gene	   (Beta-­‐Actin	   in	   all	  cases	  for	  this	  study).	  Delta-­‐CTs	  were	  then	  used	  to	  obtained	  fold	  change	  with	  the	  
ΔΔCt	   method	   (Livak	   &	   Schmittgen	   2001),	   or	   converted	   to	   1/D-­‐CT	   to	   invert	  values	  so	  graphs	  could	  be	  read	  in	  the	  same	  way	  as	  graphs	  using	  fold	  change.	  	  	  	  
	  





	  	  	  	  The	  above	  figure	  details	  the	  temperature	  and	  duration	  of	  the	  pre-­‐amplification	  steps,	  and	  the	  cycling	  steps	  necessary	  for	  use	  in	  quantitative	  PCR	  	  	  	  	  
50OC 2	  mins
95OC 10	  mins 95
OC 15	  secs 60OC 1	  min
Amplification X40	  cycles
Pre-­‐amplification 
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2.16 List	  of	  qPCR	  primers	  
	  
	  qPCR	  primers	  were	  designed	  using	  the	  Primer3	  and	  ProbeFinder	  software	  developed	  by	  UPL	  Roche.	  Wherever	  possible,	  both	  forward	  and	  reverse	  primers	  were	  designed	  to	  contain	  50%	  GC	  content	  and	  to	  span	  intron	  junctions.	  The	  following	  table	  describes	  the	  gene	  name,	  primer	  sequence	  and	  corresponding	  probe	  (UPL).	  	   	  
Table	  1.4.	  Primer/Probe	  combinations	  used	  for	  the	  detection	  of	  mRNA	  
levels	  
	  	  	  
Gene	   Sense	   Anti-­‐sense	   Probe	  B-­‐Actin	   ccaaccgcgagaagatga	   ccagaggcgtacagggatag	   #64	  OCT4	  	   agcaaaacccggaggagt	   ccacatcggcctgtgtatatc	   #35	  NANOG	   agatgcctcacacggagact	   tttgcgacactcttctctgc	   #31	  REX1	   tctgagtacatgacaggcaagaa	   tctgataggtcaatgccaggt	   #65	  GATA4	   ggaagcccaagaacctgaat	   gctggagttgctggaagc	   #69	  GATA6	   aatacttcccccacaacacaa	   ctctcccgcaccagtcat	   #90	  FOXA2	   cgccctactcgtacatctcg	   agcgtcagcatcttgttgg	   #9	  SOX17	   cgccgagttgagcaagat	   ggtggtcctgcatgtgct	   #13	  MIXL1	   gacacagatgaggggcagtt	   cccgttttcagctaccattc	   #6	  PAX6	   cgttggaactgatggagttg	   Agggcaacctacgcaaga	   #12	  SOX1	   accaggccatggatgaag	   cttaattgctggggaattgg	   #37	  SOX7	   ttcctcaccagccaggtc	   atttgcgggaagttgctcta	   #30	  ISL1	   gcagcccaatgacaaaact	   ccgtcgtgtctctctggact	   #83	  CD34	   gcgctttgcttgctgagt	   Gggtagcagtaccgttgttgt	   #8	  DESMIN	   ggagattgccacctaccg	   ggtctggatggggagattg	   #55	  PECAM	   tggaaattggaagagcacaa	   Ttcaagtttcagaatatcccaatg	   #37	  SOX2	   atgggttcggtggtcaagt	   ggaggaagaggtaaccacagg	   #19	  TH	   tcagtgacgccaaggaca	   gtacgggtcgaacttcacg	   #42	  NEUROD1	   acctcgaagccatgaacg	   cttccaggtcctcatcttcg	   #55	  KDR	   gaacatttgggaaatctcttgc	   cggaagaacaatgtagtctttgc	   #18	  AFP	   tgtactgcagagataagtttagctgac	   Tccttgtaagtggcttcttgaac	   #61	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3 Chapter	  3	  	  3.1 Introduction	  	   3.1.1 Development	  of	  a	  defined	  embryoid	  body	  differentiation	  protocol	  	  	  The	  embryonic	  origin	  and	   the	  ability	  of	  hESCs	   to	  differentiate	   into	  all	   somatic	  cell	   types	   makes	   them	   a	   valuable	   tool	   for	   interrogating	   the	   underlying	  mechanisms	  in	  human	  development.	  To	  date,	  much	  knowledge	  has	  been	  gained	  in	   understanding	   the	   signalling	   and	   gene	   expression	   profiles	   in	   cellular	  specification	  using	  monolayer	  based	  directed	  differentiation.	  The	  advantages	  of	  using	  monolayer	  systems	  include	  the	  use	  of	  single	  cells	  that	  can	  be	  seeded	  at	  a	  known	  density,	  and	  the	  use	  of	  specific	  differentiation	  inducing	  factors	  that	  can	  be	  applied	  to	   interact	  uniformly	  across	  cells.	  What’s	  more,	  monolayer	  systems	  have	   advantages	  when	  analysing	  differentiation	   endpoints,	   for	   instance	   in	  situ	  staining	  of	  cells	  for	  specific	  markers	  and	  flow	  cytometric	  analyses.	  Nevertheless,	  there	   are	   significant	   drawbacks	   when	   trying	   to	   recapitulate	   developmental	  processes	  in	  vitro	  using	  a	  2D	  differentiation	  system.	  Embryonic	  development	  is	  a	  process	  that	  exhibits	  strict	  spatial	  and	  temporal	  control,	  which	  occurs	  in	  a	  3D	  format.	  The	  3D	  nature	  of	  the	  embryo	  means	  that	  development	  is	  in	  part	  reliant	  on	   cell-­‐cell	   contacts	   and	   the	   establishment	   of	   polarity.	   For	   example,	   the	  development	   of	   anterior-­‐posterior	   endoderm	   within	   the	   mouse	   embryo	   is	  dependent	  upon	   the	   surrounding	  mesoderm	  and	   ectoderm	  which	   signal	   in	   an	  instructive	   manner.	   Without	   these	   signals,	   endoderm	   fails	   to	   express	   more	  mature	  markers	  of	  endodermal	  derivatives	  such	  as	  PDX1,	  SS	  and	  NeuroD,	  which	  can	  be	  reversed	  upon	  co-­‐culture	  with	  mesoderm	  and	  ectoderm	  of	   the	  epiblast	  (Wells	  &	  Melton	  2000).	   The	   architecture	   of	  monolayer	   culture	  does	  not	   allow	  for	  such	  in-­‐depth	  interactions,	  and	  consequently	  differentiation	  does	  not	  follow	  an	   embryonic-­‐like	   programme.	   The	   discovery	   of	   embryoid	   bodies	   provided	   a	  new	   approach	   to	   ESC	   differentiation.	   Originally	   identified	   in	   mice,	   embryoid	  bodies	  are	  3D	  aggregates	  of	  cells,	  which	  have	  been	  shown	  to	  better	  recapitulate	  
in	  vivo	  like	  embryonic	  differentiation.	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The	  term	  embryoid	  body	  (EB)	  was	  named	  after	  clumps	  of	  cells	  found	  within	  the	  ascites	   fluid	   of	   animals	   bearing	   intraperitoneal	   teratocarcinomas,	   and	   named	  due	   to	   the	   morphologically	   similar	   appearance	   to	   the	   5-­‐6	   day	   old	   mouse	  embryo.	   These	   EBs,	   albeit	   somewhat	   disorganised	   compared	   to	   the	   mouse	  embryo,	   demonstrated	   a	   degree	   of	   self-­‐organisation,	   which	   followed	   an	  embryonic	  program	  not	  dissimilar	  to	  the	  blastocyst	  (G.	  R.	  Martin	  &	  Evans	  1975).	  Two	  morphologically	  different	  types	  of	  EBs	  were	  originally	  observed.	  The	  first	  named	  ‘simple	  embryoid	  bodies’	  which	  showed	  little	  differentiation	  ability	  and	  consisted	   of	   a	   core	   of	   EC	   cells	   surrounded	   by	   primary	   extra-­‐embryonic	  endodermal	   cell	   types.	   Second	  were	   cystic	   EBs	   that	   also	   showed	   endodermal	  differentiation	   on	   the	   surface	   of	   the	   EB,	   but	   also	   contained	   a	   large	   variety	   of	  early	  differentiated	  embryonic	  cell	  types.	  Within	  cystic	  EBs,	  advanced	  structures	  suggestive	  of	  neural	  tube,	  yolk	  sac,	  hematopoietic	   islands	  and	  embryonic	  plate	  were	   all	   identified	   (PIERCE	   &	   Dixon	   1959).	   As	   a	   promising	   tool	   for	   studying	  mammalian	  development,	  work	  began	  to	  culture	  EBs	  in	  vitro.	  It	  was	  found	  that	  the	   formation	  of	  EBs	  could	  be	  achieved	  by	  culturing	  EC	  cells	  on	   tissue	  culture	  dishes,	   in	   the	   absence	   of	   feeder	   cells	   in	   non-­‐adherent	   conditions.	   Single	   cells	  would	   form	   growing	   clumps,	   with	   a	   layer	   of	   endodermal	   differentiation	  surrounding	   an	   inner	   core	   of	   EC	   cells.	   These	   EBs	   had	   strikingly	   similar	  morphology	  to	  both	  in	  vivo	  EBs,	  and	  the	  early	  mouse	  blastocyst	  (G.	  R.	  Martin	  &	  Evans	  1975).	  	  	  After	  the	  derivation	  of	  mouse	  embryonic	  stem	  cells	  (mESCs),	  EBs	  were	  formed	  using	   similar	   techniques	   to	   that	   of	   EC	   cells,	   and	   similarly,	   ES	   cell	   derived	  EBs	  showed	   the	   ability	   to	   form	   cystic	   embryoid	   bodies	   exhibiting	   diverse	  differentiation	   and,	   if	   induced,	   complex	  morphogenesis	   such	   as	   optic	   cup-­‐like	  structures	  (Evans	  &	  Kaufman	  1981;	  Doetschman	  et	  al.	  1985;	  Eiraku	  et	  al.	  2011).	  The	   striking	   similarities	   of	   embryoid	   bodies	   to	   the	   early	   blastocyst	   in	  mouse	  then	  led	  to	  the	  idea	  that	  EBs	  from	  hESCs	  could	  be	  used	  to	  interrogate	  the	  early	  events	  of	  human	  embryogenesis	  and	  better	  understand	  the	  mechanisms	  for	  the	  derivation	   of	   somatic	   cell	   types.	   Although	   some	   aspects	   of	   mammalian	   and	  human	   development	   appear	   similar,	   a	   small	   number	   of	   studies	   demonstrate	  differences	   in	   placental,	   extra-­‐embryonic	   and	   egg	   cylinder	   development	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(Thomson	  et	  al.	  1998).	  Immediately,	  it	  was	  found	  that	  the	  methodology	  used	  to	  form	   EBs	   from	   mESCs	   was	   not	   applicable	   to	   hESCs.	   It	   was	   not	   possible	   to	  generate	   EBs	   from	   single	   cells,	   and	   even	  multiple	   single	   cells	   did	   not	   readily	  form	  aggregates.	  The	  inability	  for	  single	  hESCs	  to	  form	  EBs	  meant	  that	  the	  most	  common	  method	  of	  formation	  was	  to	  scrape	  colonies	  from	  the	  culture	  flask	  and	  culture	   these	   clumps	   in	   non-­‐adherent	   conditions.	   Itskovitz-­‐Eldor	   et	   al	  demonstrated	   that	   scraped	   hESC	   colonies	   could	   aggregate	   on	   non-­‐adherent	  petri	  dishes	  to	  form	  dense	  clusters	  of	  cells,	  which,	  over	  time,	  became	  cavitated	  and	  cystic	  (Itskovitz-­‐Eldor	  et	  al.	  2000).	  There	  were,	  however,	   large	  differences	  in	  the	  morphology	  and	  the	  level	  of	  organisation	  seen	  within	  structures	  derived	  from	   hESCs	   when	   compared	   to	   mESCs.	   Structures	   from	   these	   EBs	   did	   show	  extensive	  differentiation,	  for	  example	  cells	  indicative	  of	  epithelia	  and	  endoderm	  were	   apparent,	   and	   genes	   including	   αFP	   (endoderm)	   and	   ζ-­‐globin	  (hematopoietic)	   were	   expressed	   (Itskovitz-­‐Eldor	   et	   al.	   2000).	   Furthermore,	  somatic	   cell	   types	   including	   cardiomyocytes,	   neurons,	   astrocytes	   and	  oligodendrocytes	   have	   been	   generated	   (Kehat	   et	   al.	   2001;	   Zhang	   et	   al.	   2001),	  nevertheless	   EBs	   did	   not	   show	   blastocyst-­‐like	   structures,	   indicating	   a	   lack	   of	  organisation	  and	  embryonic-­‐like	  differentiation	  programs.	  	  
3.1.2 Refining	  embryoid	  body	  formation	  from	  hESCs	  	  	  	  The	  level	  of	  disorganisation	  in	  EB	  differentiation	  of	  hESCs	  was	  thought	  to	  be	  due	  to	   the	   varying	   sizes,	   geometries	   and	   cell	   numbers	   comprising	   each	   EB.	  Consequently,	  contradictory	  endogenous	  signals,	  the	  interaction	  of	  differing	  cell	  types,	  and	  random	  extra-­‐cellular	  matrices	  formed	  within	  the	  structure	  resulted	  in	   non-­‐embryonic	   like	   differentiation	   (Chen	   et	   al.	   2007;	   Ungrin	   et	   al.	   2008).	  Thus,	   efforts	   were	   made	   to	   identify	   and	   control	   parameters	   in	   EB	   formation	  with	   a	   view	   to	   better	   mimic	   the	   developing	   embryo,	   improve	   differentiation	  uniformity	   and	   reproducibly	   derive	   medically	   relevant	   cell	   types.	   The	   first	  parameter	   to	   be	   controlled	   was	   EB	   size.	   It	   has	   been	   shown	   that	   size	   has	  profound	   effects	   on	   the	   specification	   of	   cells	   within	   EBs.	   By	   controlling	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aggregate	   size	   through	   microfabricated	   stencils,	   Park	   et	   al	   found	   increased	  mesodermal	   differentiation	   in	   larger	   cell	   aggregates	   of	   300-­‐500	   μm,	   whereas	  neuronal	  differentiation	  was	  favoured	  in	  smaller	  cell	  aggregates	  of	  100-­‐300	  μm	  diameter	  (Park	  et	  al.	  2007).	  In	  accordance	  with	  these	  results,	  it	  was	  also	  shown	  that	  higher	  expression	  of	  cardiogenic	  genes	  were	  found	  in	  larger	  cell	  aggregates	  of	  450	  μm	  (Hwang	  et	  al.	  2009).	  Ng	  et	  al	  took	  a	  slightly	  different	  approach	  to	  size	  control	  which	   involved	   counting	   and	   seeding	   a	   known	  density	   of	   cells	   per	   EB	  (Ng	  et	  al.	  2005).	  Referred	  to	  as	  spin	  EBs,	  they	  demonstrated	  that	  erythropoietic	  differentiation	   was	   optimal	   when	   using	   1000	   cells	   per	   aggregate,	   and	   more	  generally,	   efficient	   blood	   differentiation	   required	   a	  minimum	   of	   500	   cells	   per	  aggregate	  (Ng	  et	  al.	  2005).	  	  	  A	   second	   parameter	   in	   controlling	   EB	   formation	   was	   spatial	   organisation.	  Ungrin	  et	  al	  developed	  PDMS	  casts	  in	  which	  the	  number	  of	  cells	  plus	  the	  shape	  of	   the	   EB	   could	   be	   tightly	   controlled.	   EBs	   formed	   in	   this	   manner	   showed	   a	  higher	  degree	  of	   self-­‐organisation,	  with	  blastocyst-­‐like	   features.	   EBs	   consisted	  of	   an	   inner	   domain	   of	  OCT4+	   cells,	   an	   outer	   endodermal	   layer	   and	   a	   laminin	  basement	  membrane	   separating	   the	   two.	   These	   structures	   are	   reminiscent	   of	  the	  epiblast	   and	  visceral	   endoderm	  within	   the	  developing	  embryo,	   confirming	  the	  ability	  of	  supra-­‐cellular	  order	  of	  hESCs.	  Additionally,	   this	  protocol	  allowed	  for	  the	  high-­‐throughput	  generation	  of	  highly	  uniform	  EBs	  (Ungrin	  et	  al.	  2008).	  	  	   3.1.3 Chemically	  defined	  differentiation	  of	  embryoid	  bodies	  	  	  	  Work	  then	  turned	  to	  the	  development	  of	  conditions	  in	  which	  reproducible	  EBs	  could	  be	  generated	  in	  a	  defined	  way.	  The	  development	  of	  a	  serum-­‐free	  medium	  would	  have	  several	  advantages.	  Firstly,	  defined	  conditions	  would	  allow	  for	  the	  proper	   interrogation	  of	  the	  cues	  that	  drive	  embryo-­‐like	  differentiation	   in	  vitro.	  Secondly,	  it	  would	  be	  permissive	  for	  the	  effects	  of	  exogenous	  growth	  factors	  for	  directed	  differentiation	  without	  conflicting	  signals	  from	  serum.	  Thirdly,	  it	  would	  provide	  neutral	  conditions	  to	  better	  understand	  mechanistic	  aspects	  of	  cellular	  specification.	   With	   this	   in	   mind,	   Albumin	   Polyvinylalcohol	   Essential	   Lipids	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(APEL)	   medium	   was	   developed,	   which	   replaced	   animal	   components	   of	  conventional	  media	   with	   recombinant	   human	   counterparts	   and	   also	   included	  the	  important	  component	  polyvinyl	  alcohol	  (PVA).	  The	  addition	  of	  PVA	  greatly	  improved	   reproducibility	   of	   EB	   formation,	   essentially	   by	   acting	   as	   a	   cellular	  adhesive,	   and	   also	   allowed	   the	   generation	   of	   EBs	   without	   the	   addition	   of	   Y-­‐27632	  (Ng	  et	  al.	  2008).	  Recently,	  more	  basic,	  defined	  media	  such	  as	  Essential	  6	  (E6)	   have	   been	   successfully	   used	   for	   EB	   formation,	   but	   the	   addition	   of	   PVA	  remains	  imperative	  (Lin	  &	  G.	  Chen	  2014).	  	  	  With	   methodologies	   to	   generate,	   in	   a	   high-­‐throughput	   fashion,	   reproducible	  embryoid	  bodies,	  we	  wanted	   to	   investigate	  whether	  we	   could	   standardise	   the	  formation	  and	  the	  differentiation	  of	  EBs.	  Using	  defined	  conditions,	  we	  wanted	  to	  assess	  whether	  they	  could	  respond	  to	  extrinsic	  differentiation	  cues	  and	  whether	  we	   could	   reproducibly	   and	   efficiently	   direct	   differentiation	   to	   each	   primary	  germ	   layer	   for	   the	   derivation	   of	   medically	   relevant	   cell	   types.	   Due	   to	   the	  significant	   need	   for	   high-­‐throughput	   predictive	   assays	   to	   predict	   human	  responses	   during	   the	   drug	   development	   process,	   and	   due	   to	   the	   improved	  relevance	  of	  EBs	  to	  the	  embryo,	  we	  also	  wanted	  to	  assess	  the	  use	  of	  this	  assay	  as	  a	  tool	  for	  predictive	  reproductive	  toxicology.	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3.2 Results	  	  	   3.2.1 Development	  of	  a	  protocol	  for	  embryoid	  body	  formation	  	  	  Although	  well	  established	  within	   the	  mESC	   field,	   the	   formation	  of	  defined	  EBs	  from	  single	  hESCs	  has	  been	  notoriously	  difficult,	  due	  to	  their	  high	  mortality	  rate	  upon	   dissociation.	   Firstly,	   we	   wanted	   to	   assess	   whether	   we	   could	   make	   EBs	  from	   single	   cells	   using	   the	   cell	   line	   H9.	   We	   found	   that	   EBs	   from	   single	  dissociated	   hESCs	   grown	   in	   Knockout-­‐DMEM,	   20%	   Knockout	   serum	  replacement	   (KO/SR)	   &	   MEF	   conditions	   could	   be	   formed	   directly	   from	  trypsinisation	   and	   seeding	   alone	   using	   APEL	  media.	   Although	   after	   24h	   post-­‐seeding	   EBs	   had	   formed,	   it	   was	   apparent	   that	   many	   cells	   had	   undergone	  apoptosis,	   and	   the	   EBs	   differed	   quite	   drastically	   in	   size	   and	   shape	   from	   each	  other	  (Fig.	  3.1A.i).	  This	  was	  not	  the	  case	  if	  10	  µM	  of	  the	  Rho	  Kinase	  inhibitor	  Y-­‐27632	  was	  added	  to	  the	  cells.	  In	  this	  case,	  EBs	  formed	  uniformly,	  and	  there	  was	  less	  evidence	  of	  cell	  death/debris	  (Fig.	  3.1A.ii).	  Thus,	  the	  inclusion	  of	  Y-­‐27632,	  and	   consequently	   the	   prevention	   of	   cell	   death	   greatly	   reduced	   inter-­‐well	  variability	  of	  EBs.	  Although	  reproducible	  EBs	  could	  be	  formed	  with	  the	  addition	  of	   Y-­‐27632,	   we	   identified	   two	   problems	   with	   this	   approach.	   Firstly	   was	   the	  continual	   presence	   of	   Y-­‐27632	   in	   a	   toxicological	   assay.	   We	   reasoned	   this	  inhibitor	  may	  have	  unknown	  interactions	  with,	  or	  may	  mask	  the	  toxic	  effects	  of	  drug	   candidates	   in	   toxicological	   assays	   potentially	   through	   its	   anti-­‐apoptotic	  mechanism.	   Secondly	   was	   the	   incorporation	   of	   MEF	   cells	   into	   EBs,	   which	  we	  reasoned	   could	   hinder	   the	   reproducibility	   of	   differentiation.	   To	   circumvent	  these	   issues,	   we	   included	   a	   cell	   ‘pre-­‐attachment	   step’	   devised	   by	   combining	  methodology	   from	   Ng	   et	   al	   as	   well	   as	  methodology	   from	   Andrew	   Elefanty	   at	  Monash	  University,	  Melbourne	   (Unpublished).	  Firstly,	  we	  coated	  ungelatinised	  culture	  treated	  plastic-­‐ware	  overnight	  with	  MEF	  conditioned	  medium,	  referred	  to	   as	   MEF	   coated	   flasks	   (MCFs).	   hESCs	   in	   KO/SR	   &	   MEF	   culture	   were	   then	  trypsinised	  and	  plated	  onto	  MCFs	  without	  the	  addition	  of	  Y-­‐27632.	  This	  process	  both	  eliminated	  MEF	  cells,	  and	  selected	  for	  healthy	  dividing	  hESCs	  (Fig.	  3.1B).	  Using	   this	   new	   method	   of	   pre-­‐attachment	   we	   were	   able	   to	   generate	   more	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uniform	  EBs	  than	  by	  simply	  trypsinising	  cells,	  although	  they	  still	  did	  not	  acquire	  the	  high	   level	  of	  uniformity	  seen	  with	   the	  continued	  presence	  of	  Y-­‐27632.	  We	  next	   tested	  whether	   a	  media	   change	   step	   after	   the	   initial	   hESC	   attachment	   to	  MCFs	  containing	  10	  µM	  Y-­‐27632	  for	  1h	  would	  improve	  EB	  uniformity.	  We	  found	  that	   the	   act	   of	   incubating	   cells	   with	   10	   µM	   Y-­‐27632	   for	   1h	   and	   removing	   it	  before	   EB	   formation	   did	   further	   improve	   the	   uniformity	   of	   EBs.	   In	   fact	   EBs	  generated	  this	  way	  closely	  resembled	  EBs	  formed	  in	  the	  continued	  presence	  of	  Y-­‐27632	  (Fig.	  3.1C).	  To	  assess	  whether	  the	  act	  of	  pre-­‐treating	  cells	  altered	  the	  differentiation	  of	  EBs,	  we	  performed	  qPCR	  analysis	  on	  day	  10	  EBs	  with	  no	  pre-­‐treatment	   (NT),	   pre-­‐treatment	   (PT)	   and	   continued	   presence	   of	   Y-­‐27632	   (RI).	  We	   found	  no	  differences	   in	  gene	  expression	   for	   the	  stem	  cell	  marker	  OCT4,	  or	  the	   lineage	   markers	   GATA6,	   SOX17,	   MIXL1,	   SOX1	   or	   PAX6	   between	   each	  condition	   (Fig.	   3.1D).	   Additionally,	   in	   the	   interest	   of	   high-­‐throughput	  approaches,	  we	  were	  able	  to	  accurately	  seed	  very	  similar	  numbers	  of	  cells	  per	  well	   in	   a	   high-­‐throughput	   way	   using	   this	   methodology	   (Fig.	   3.1E).	   Thus	   our	  modified	  protocol	   allowed	   for	   the	  high-­‐throughput	   generation	   of	   uniform	  EBs	  without	  contaminating	  MEF	  cells	  or	  the	  continued	  presence	  of	  Y-­‐27632.	  	  The	   protocol	   thus	   consisted	   of	   5	   general	   steps.	   1)	   Generation	   of	  MCF,	   2)	   pre-­‐attachment	   of	   single	   hESCs	   to	   MCF	   (without	   Y-­‐27632),	   3)	   pre-­‐incubation	   of	  attached	   hESCs	   with	   10	   µM	   Y-­‐27632,	   4)	   Removal	   of	   Y-­‐27632	   and	   5)	   EB	  formation	  (Fig.	   3.2A).	  Although	  robust,	  we	  did	   identify	   that	  certain	  aspects	  of	  the	   protocol	   were	   sensitive	   for	   the	   reproducibility	   of	   the	   assay,	   ultimately	  resulting	   in	   the	   loss	   of	   uniformity	   of	   EB	   formation,	   or	   the	   complete	   failure	   of	  cells	  to	  aggregate.	  Most	  notable	  was	  the	  quality	  of	  the	  starting	  cell	  populations,	  which	  greatly	  influenced	  aggregation	  of	  the	  EBs	  over	  the	  first	  24h	  (Fig.	  3.2B).	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3.2.2 Gene	  expression	  analysis	  of	  differentiating	  embryoid	  bodies	  	  	  In	   order	   to	   investigate	   the	   early	   differentiation	   events	   that	   were	   occurring	  within	   these	   uniform	   EBs,	   we	   put	   together	   a	   small	   gene	   list	   that	   was	  representative	   of	   the	   stem	   cell,	   endoderm,	   mesoderm	   and	   ectoderm	   lineages	  based	  on	  existing	   literature	  (Fig.	   3.3A).	  We	  then	  generated	  EBs	  under	  neutral	  conditions	  (without	  the	  addition	  of	  inhibitors	  or	  recombinant	  proteins	  to	  direct	  differentiation)	  with	  endpoints	  at	  early	  (day	  4),	  mid	  (day	  10)	  and	  late	  (day	  16)	  differentiation	  stages.	  The	  time-­‐course	  was	  performed	  to	  determine	  which	  time-­‐point	   would	   be	   most	   informative	   for	   the	   expression	   of	   the	   genes	   within	   our	  panel.	  By	  dividing	  genes	   into	   their	   associated	  germ	   layers	  we	   found	   that	  both	  endoderm	  and	  mesoderm	  associated	  genes	  showed	  a	  stepwise	  increase	  in	  their	  expression	  over	  increasing	  time-­‐points	  (Fig.	  3.3B).	  Ectoderm	  associated	  genes	  were	  not	  upregulated	  at	  day	  4,	  but	  saw	  significant	  upregulation	  at	  day	  10	  and	  16	  (Fig.	  3.3B).	  Day	  10	  therefore	  appeared	  to	  be	  the	  earliest	  and	  most	  suitable	  time-­‐point	  to	  assay	  EBs	  using	  our	  gene	  panel.	  	  	  We	   next	  wanted	   to	   assess	  whether	   the	   protocol	  we	   had	   developed	   led	   to	   the	  reproducible	   differentiation	   of	   EBs.	   We	   performed	   qPCR	   analysis	   on	   EBs	  generated	  from	  three	  biological	  repeats	  and	  assessed	  the	  standard	  deviation	  of	  the	   expression	   of	   genes	   within	   our	   panel.	   The	   majority	   of	   genes	   generally	  showed	   low	   standard	   deviations,	   although	   some	   genes	   including	   SOX17,	   ISL1,	  
GATA6	   and	  SOX2	   did	   show	  a	  higher	  degree	  of	  variation	  (Fig.	   3.3C).	  What	  was	  also	   striking	   from	   this	   data	   was	   the	   apparent	   bias	   in	   the	   direction	   of	  differentiation	   within	   EBs.	   Under	   the	   neutral	   conditions	   used,	   EBs	   expressed	  much	  higher	  levels	  of	  ectoderm-­‐associated	  genes	  when	  compared	  to	  endoderm	  and	   mesoderm	   genes	   (Fig.	   3.3B).	   EBs	   were	   generated	   from	   hESCs	   grown	   in	  MEF	   conditions,	   and	   it	   is	   a	   common	   feature	   that	   cells	   undergo	   spontaneous	  differentiation.	  To	  assess	  whether	   contaminating	  heterogeneity	   in	   the	   starting	  population	   of	   cells	   was	   responsible	   for	   the	   observed	   differentiation	   bias,	   we	  sorted	   cells	   for	   the	   stem	   cell	  marker	   SSEA-­‐3	  before	  EB	   formation	   (Fig.	   3.4A).	  We	   found	   that	   the	  addition	  of	  Y-­‐27632	  was	   imperative	   for	  EB	   formation	  after	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SSEA-­‐3	  sorting,	  without	  which	  no	  formation	  occurred	  (Fig.	  3.4B).	  After	  10	  days,	  EBs	   were	   harvested	   and	   qPCR	   analysis	   showed	   that	   the	   distribution	   of	   germ	  layers	   was	   more	   evenly	   spread.	  When	   compared	   to	   EBs	   from	   unsorted	   cells,	  SSEA-­‐3	  sorting	  resulted	  in	  a	  higher	  level	  of	  endoderm	  and	  mesoderm	  associated	  gene	   expression	   coupled	   with	   a	   reduction	   in	   ectoderm	   associated	   gene	  expression,	   although	   importantly,	   ectoderm	   expression	   levels	   were	   still	   high	  
(Fig.	   3.4C).	  We	  also	   found	  that	   there	  was	  reduced	  variability	  across	  biological	  repeats	   in	   the	   expression	  of	   genes	   that	  did	   show	  a	  degree	  of	   variability	  when	  cells	  were	   sorted	   for	   SSEA-­‐3	   (Fig.	   3.4D).	   This,	   however,	  was	   not	   the	   case	   for	  every	   gene	  within	   the	   panel.	   Thus,	   the	   starting	   population	   of	   hESCs	   appeared	  important	   in	   the	   proper	   multi-­‐lineage	   differentiation	   of	   EBs	   as	   well	   as	   the	  reproducibility	   of	   differentiation.	   The	   sorting	   of	   cells	   however	   was	   not	  practicable.	  Firstly	  we	  wanted	  to	  make	  it	  widely	  accessible	  to	  other	  laboratories,	  which	   may	   not	   have	   the	   equipment	   or	   expertise	   to	   perform	   fluorescent	  activated	   cell	   sorting.	   Secondly,	  we	   did	   not	  want	   the	   continual	   presence	   of	   Y-­‐27632	   when	   screening	   drug	   candidates.	   Having	   established	   that	   starting	   cell	  population	  quality	  was	  important,	  we	  set	  a	  threshold	  of	  80%	  SSEA-­‐3	  positivity	  for	   EB	   formation.	   The	   threshold	   of	   80%	   was	   chosen	   as	   it	   represents	   a	   high	  quality	  culture	  and	  is	  routinely	  attainable.	  	  Cells	  were	  stained	  with	  SSEA-­‐3	  and	  FACS	   analysed	   prior	   to	   EB	   formation.	   Cultures	   with	   ≥80%	   SSEA-­‐3	  were	   then	  used	   for	   subsequent	   EB	   experiments.	   If	   cultures	  were	   <80%	   SSEA-­‐3	   positive,	  cells	  were	  discarded.	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3.2.3 Directed	  differentiation	  of	  embryoid	  bodies	  	  	  	  We	   next	   wanted	   to	   assess	   whether	   our	   assay	   was	   permissive	   for	   directed	  differentiation	  to	  each	  of	  the	  three	  primary	  germ	  layers;	  endoderm,	  mesoderm	  and	   ectoderm.	   The	   conditions	   from	   each	   germ	   layer	   were	   constructed	   from	  existing	  literature	  as	  well	  as	  unpublished	  data	  (Fig.	  3.5A).	  EBs	  were	  generated	  using	   the	   previously	   described	  methodology	   using	   lineage	   specific	   conditions.	  EBs	  were	  left	  to	  differentiate	  for	  10	  days,	  before	  harvesting	  and	  RNA	  extraction.	  Samples	  were	  analysed	  by	  qPCR	  for	  the	  panel	  of	  markers	  described	  previously	  
(Fig.	   3.3A).	  We	   categorised	   genes	   according	   to	   their	   germ	   layer	   and	  assessed	  which	   conditions	   resulted	   in	   the	  highest	   expression	  of	   each.	   Firstly,	  we	   found	  that	   mesoderm	   associated	   gene	   expression	   was	   significantly	   higher	   in	  mesoderm	   inducing	   conditions	   when	   compared	   to	   the	   undifferentiated,	  endoderm	   and	   ectoderm	   conditions	   (Fig.	   3.5Bi).	   Secondly,	   ectoderm	   genes	  were	   strongly	   upregulated	   in	   ectoderm	   inducing	   conditions.	   Surprisingly,	  endoderm	  conditions	  also	  resulted	  in	  high	  expression	  of	  ectoderm	  genes,	  albeit	  not	   as	   efficiently	   as	   in	   ectoderm	   conditions.	   Mesoderm	   conditions	   did	   not	  upregulate	  ectodermal	  genes	  (Fig.	  3.5Bii).	  We	  found	  that	  endoderm	  conditions	  resulted	   in	   the	  upregulation	  of	  endoderm	  associated	  genes	  when	  compared	   to	  the	   undifferentiated	   control,	   however	   it	   was	   within	   the	   mesoderm	   inducing	  conditions	  where	  endoderm	  genes	  were	  most	  highly	  expressed	  (Fig.	   3.5B.iii).	  Thus	  it	  appeared	  that	  mesoderm	  and	  ectoderm	  differentiation	  conditions	  were	  effective	  at	  inducing	  genes	  of	  their	  respective	  lineages,	  but	  endoderm	  conditions	  were	   less	   effective	   at	   inducing	   endoderm	  genes.	   Additionally,	   it	  was	   apparent	  that	  there	  was	  not	  a	  clear	  segregation	  of	  the	  endoderm	  and	  mesoderm	  lineages,	  or	  the	  endoderm	  and	  ectoderm	  lineages.	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3.2.4 Optimisation	  of	  embryoid	  body	  differentiation	  	  	  	  In	  an	  attempt	  to	  properly	  segregate	  each	  lineage	  and	  to	  find	  optimal	  conditions	  for	   endoderm	   differentiation,	   we	   used	   two	   separate	   reporter	   lines	   with	   GFP	  heterozygously	   knocked	   into	   the	   GATA6	   or	   MIXL1	   loci	   for	   endoderm	   and	  mesoderm	  read-­‐outs	  respectively.	  Using	  these	  reporter	  lines	  we	  performed	  a	  3	  way	   titration	   of	   2	   recombinant	   proteins,	   Activin	   A	   and	   BMP4	   as	   well	   as	   the	  GSK3β	   inhibitor	  CT	  99021.	  Firstly,	  we	  titrated	  Activin	  A	  and	  BMP4	  between	  0-­‐100ng/mL	  and	  CT	  99021	  between	  1	  µM	  and	  3	  µM,	  on	  the	  GFP:MIXL1	   line.	  We	  found	  that	  EBs	  in	  2	  µM	  CT	  99021	  showed	  the	  highest	  degree	  of	  morphological	  uniformity	  (Fig.	  3.6A),	  and	  were	  further	  analysed	  for	  MIXL1	  expression.	  MIXL1	  expression	  appeared	  highest	   in	   the	   absence	  of	  BMP4	  but	  over	   the	  majority	  of	  ranges	   of	   Activin	   A	   concentrations	   (Fig.	   3.6A	   &	   3.6B).	  We	   found	   that	   in	   the	  absence	   of	   Activin	   A,	  MIXL1	   was	   barely	   induced	   irrespective	   of	   BMP4	   or	   CT	  99021	   concentrations,	   confirming	   the	   importance	   of	   TGFβ	   signalling	   through	  SMAD2/3	   (Fig.	   3.6A).	   Activin	   A,	   however,	   was	   not	   able	   to	   rescue	   MIXL1	  expression	  when	  BMP4	  concentrations	  were	  high,	  and	   in	   the	  presence	  of	  high	  Activin	   A,	   MIXL1	   expression	   increased	   as	   BMP4	   was	   reduced.	   Using	   ImageJ	  analysis	  software,	  we	  identified	  that	  6	  ng/mL	  of	  Activin	  A,	  0	  ng/mL	  BMP4	  and	  2	  
µM	   CT	   99021	   resulted	   in	   the	   brightest	   expression	   of	  MIXL1	   within	   EBs.	   To	  ascertain	  whether	   these	  conditions	  were	   inductive	   for	   the	  expression	  of	  other	  mesoderm-­‐associated	   genes	   and	   whether	   they	   efficiently	   segregate	   the	  endoderm	  and	  mesoderm	  lineages,	  we	  performed	  qPCR	  analysis	  on	  day	  6	  EBs	  differentiated	   in	   the	   new	   conditions.	   We	   found	   that	   mesoderm	   genes	   under	  these	  conditions	  were	  induced	  but	  we	  again	  found	  that	  EBs	  also	  showed	  strong	  expression	   of	   endoderm-­‐associated	   genes.	   Consistently,	   ectoderm	   was	   not	  upregulated	  (Fig.	  3.6C).	  	  	  Having	  not	  been	  able	  to	  efficiently	  segregate	  endoderm	  and	  mesoderm	  lineages	  based	   on	   MIXL1	   expression,	   we	   performed	   the	   same	   experiment	   using	   a	  reporter	   line	   for	   the	   endoderm	   specific	   marker	   GATA6.	   Titrating	   Activin	   A,	  BMP4	   and	   CT	   99021	   in	   the	   same	  manner,	  we	   found	   that	   EBs	  were	   also	  most	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morphologically	  similar	  at	  2	  µM	  CT	  99021	  (Fig.	  3.7A),	  but	  we	  found	  that	  GATA6	  expression	   was	   highest	   in	   quite	   opposite	   conditions	   to	   MIXL1	   (Fig.	   3.7A	   &	  
3.7B).	   At	   low	   concentrations	   of	   BMP4	   there	  was	   lower	  GATA6	   induction	   that	  increased	   as	   BMP4	   increased.	   Similarly	   to	  MIXL1,	   this	   was	   also	   the	   case	   for	  Activin	  A,	  whereby	  GATA6	  was	  not	  strongly	  induced	  in	  its	  absence.	  Using	  ImageJ	  analysis	   software,	  we	   identified	   the	  optimal	   concentration	  of	  GATA6	   induction	  as	   100	   ng/mL	   Activin	   A,	   100	   ng/mL	   BMP4	   and	   2	   µM	   CT	   99021.	   Next	   we	  differentiated	  EBs	   in	   the	   presence	   of	   these	   optimal	   conditions	   and	   performed	  qPCR	   to	   analyse	   gene	   expression.	   We	   found	   gene	   expression	   for	   endoderm	  associated	   genes	   were	   upregulated	   under	   these	   conditions	   compared	   to	   the	  undifferentiated	   cells,	   but	   also	   at	   much	   higher	   levels	   than	   the	   endoderm	  conditions	   before	   optimisation.	   Furthermore,	   we	   did	   not	   see	   an	   increase	   in	  mesoderm-­‐associated	   genes,	   and	   although	   there	   was	   a	   slight	   increase	   in	  ectoderm	  genes,	  they	  were	  not	  expressed	  at	  the	  same	  level	  as	  endoderm	  genes	  
(Fig.	   3.7C).	   GATA6	   therefore	   appeared	   to	   efficiently	   segregate	   the	   endoderm	  and	   mesoderm	   lineages	   and	   its	   expression	   correlated	   with	   more	   efficient	  endoderm	  differentiation.	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3.2.5 An	  assay	  for	  predictive	  toxicology	  	  	   3.2.5.1 Morphological	  analyses	  	  	  	  Having	  developed	   and	   refined	   a	   robust	   and	   reproducible	  differentiation	   assay	  using	   embryoid	   bodies,	  we	   next	  wanted	   to	   assess	  whether	   the	   differentiation	  assay	  could	  be	  used	  as	  a	  tool	  for	  predictive	  toxicology.	  To	  do	  this,	  we	  generated	  EBs	  in	  the	  presence	  of	  known	  teratogens	  and	  known	  non-­‐teratogens	  for	  10	  days	  and	  assessed	  whether	   the	  assay	  would	  be	  perturbed	  by	  and	   could	  distinguish	  between	   harmful	   and	   neutral	   drugs.	   Firstly,	   we	   assessed	   the	   morphology	   of	  exposed	   EBs.	   Images	   from	   control	   and	   test	   samples	   were	   analysed	   by	   5	  individuals	  without	  prior	  knowledge	  of	  which	  EBs	  had	  been	  exposed	  to	  which	  compounds	   or	   concentrations	   used.	   Control	   EBs	   were	   EBs	   that	   had	   been	  generated	   and	   grown	   in	   either	   0.1%	   DMSO	   or	   100uM	   Saccharin	   which	   are	  known	  non-­‐teragogens	  at	   the	  specified	  concentrations.	   Individuals	  were	  asked	  to	  rate	  the	  morphology	  of	  EBs	  from	  the	  test	  samples	  against	  the	  control	  samples	  on	   a	   scale	   of	   1-­‐3.	   1	   indicated	   no	   morphological	   change;	   2,	   noticeable	  morphological	  changes;	  3,	  severe	  morphological	  changes.	  We	  then	  generated	  an	  overall	  ‘teratogenic	  score’	  for	  each	  compound	  at	  each	  concentration	  (Fig.	  3.8A).	  This	  score	  was	  the	  sum	  of	  each	  morphological	  rating	  (1-­‐3)	  from	  each	  of	  the	  five	  individuals.	   Therefore,	   compounds	   that	   were	   deemed	   to	   not	   cause	   any	  observable	   morphological	   changes	   (score	   1)	   by	   all	   of	   the	   five	   individuals	  received	   the	   lowest	   score	   of	   5.	   Compounds	   identified	   as	   causing	   severe	  morphological	   changes	   (score	   3)	   by	   all	   of	   the	   five	   individuals	   received	   the	  highest	  score	  of	  15	  (Fig.	  3.8A).	  The	  rate	  at	  which	  teratogenic	  compounds	  were	  successfully	   identified	   from	  morphological	   changes	   ranged	   from	   70%	   to	   85%	  across	  the	  five	  individuals.	  The	  teratogens,	  Topiramate,	  Warfarin	  Dimethadione	  Dexamethasone,	  Thalidomide	  and	  Lovastatin	  were	  all	  successfully	  identified	  as	  having	  caused	  morphological	  changes	  over	  the	  10-­‐day	  time	  course.	  Fluconazole,	  a	   Category	   C	   teratogen	   (teratogenic)	   was	   not	   identified	   by	   any	   individual	   as	  having	   caused	   a	   morphological	   change.	   Conversely,	   the	   non-­‐teratogen,	  Clozapine,	   was	   consistently	   identified	   by	   all	   individuals	   as	   causing	   severe	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morphological	  changes	  at	  the	  highest	  concentration	  (100	  µM).	  In	  fact,	  Clozapine	  received	  the	  highest	   teratogenic	  score	  of	  all	   the	  compounds	  (18).	  Additionally,	  we	  found	  that	  the	  degrees	  of	  severity	  of	  these	  changes	  were	  different	  between	  compounds	   and	   concentrations.	   Lovastatin	   caused	   severe	   morphological	  changes	  at	  low	  concentrations,	  whereas	  Thalidomide	  and	  Dexamethasone	  were	  found	  to	  cause	  only	  minor	  changes	  at	  mid	  to	  high	  concentrations.	  Warfarin	  and	  Dimethadione	  also	  caused	  only	  minor	  changes	  but	  at	   low	  concentrations	  (Fig.	  
3.8A	  &	  3.8B).	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3.2.5.2 Gene	  Expression	  Analyses	  	  	  	  To	   further	   characterise	   EBs	   that	   had	   shown	   morphological	   changes	   when	  compared	   to	   the	   control,	   the	   lowest	   concentration	   of	   compounds	   that	   caused	  observable	   changes	   were	   carried	   forward	   for	   qPCR	   analysis	   (Fig.	   3.8B).	   In	  concordance	   with	   the	   morphological	   analyses,	   we	   found	   that	   the	   gene	  expression	   profiles	   of	   EBs	   grown	   in	   the	   presence	   of	   teratogens	   showed	  differential	  expression	  of	  genes	  within	  the	  panel	  when	  compared	  to	  control	  EBs	  
(Fig.	   3.9A-­‐C).	   Firstly,	   to	   ensure	   that	   differentiation	   was	   reproducible,	   we	  compared	   two	   control	   samples	   containing	   the	   carrier	   DMSO	   at	   0.1%,	   which	  represents	   the	   highest	   concentration	   used	   within	   the	   assay,	   and	   the	   non-­‐teratogen	   Saccharin	   at	   a	   high	   concentration	   of	   100	   µM.	   EBs	   showed	   no	  significant	  differences	   in	   the	   level	   of	   gene	  expression	  when	   compared	   to	   each	  other,	   except	   for	   the	   stem	   cell	   and	   ectoderm	   gene	   SOX2	   (Fig.	   3.9B)	   The	  ectoderm	  gene	  PAX6,	  although	  not	  significant	  compared	  to	  the	  0.1%	  DMSO	  EBs,	  showed	  high	  variation	  in	  the	  Saccharin	  sample	  (Fig.	  3.9B).	  Thus,	  both	  of	  these	  genes	   were	   excluded	   from	   the	   analysis	   of	   teratogen	   treated	   EBs.	   All	   gene	  expression	  for	  the	  following	  are	  shown	  in	  Fig.	  3.9C.	  	  	  
Warfarin	  Exposure	   of	   EBs	   to	   1	   µM	  warfarin	   showed	   significant	   changes	   in	   two	   of	   the	  genes	  analysed	  within	  the	  panel.	  When	  compared	  to	  controls,	  MIXL1,	  a	  primitive	  streak	   associated	   gene	   and	   NEUROD1,	   an	   ectoderm	   associated	   gene	   were	  significantly	  upregulated	  when	   compared	   to	   control	  EBs.	  The	   relatively	  minor	  changes	  in	  the	  morphology	  of	  EBs	  from	  Warfarin	  exposure	  may	  correlate	  with	  the	  expression	  changes	  in	  only	  a	  few	  genes.	  	  	  
Dimethadione	  Exposure	   of	   EBs	   to	   0.1	   µM	   of	   Dimethadione	   resulted	   in	   the	   differential	  expression	  of	  three	  genes	  within	  the	  panel.	  Firstly,	  when	  compared	  to	  controls,	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the	  stem	  cell	  marker	  OCT4	  was	  not	  downregulated	  to	  the	  same	  level	  of	  control	  EBs,	   implying	  a	  hindrance	   in	  the	  differentiation	  of	  hESCs.	  The	  primitive	  streak	  associated	   gene	   MIXL1	   and	   the	   ectodermal	   gene	   NEUROD1	   were	   both	  significantly	  upregulated.	  No	  other	  genes	  showed	  altered	  expression	  patterns.	  	  	  
Dexamethasone	  EBs	  in	  the	  presence	  of	  100	  µM	  Dexamethasone	  showed	  differential	  expression	  in	   four	   genes	  within	   the	  panel.	  When	   compared	   to	   controls,	   the	   expression	  of	  the	  stem	  cell	  marker	  OCT4	  was	  downregulated	  at	  a	  higher	  rate	  than	  the	  control	  EBs,	   implicating	   Dexamethasone	   with	   a	   negative	   effect	   on	   pluripotency.	   The	  mesoderm	   and	   ectoderm	   genes	   CD34	   and	   NEUROD1	   respectively	   were	  upregulated,	  whereas	  the	  early	  endodermal	  marker	  SOX17	  was	  downregulated.	  	  	  
Thalidomide	  Thalidomide	   at	   10	  µM	   induced	   changes	   in	   a	   relatively	   large	   number	   of	   genes.	  When	  compared	  to	  controls,	  the	  stem	  cell	  gene	  OCT4	  was	  not	  downregulated	  at	  the	  same	  rate	  as	  that	  of	  control	  EBs,	  indicating	  slower	  differentiation,	  similar	  to	  that	  of	  Dimethadione	  exposure.	  The	  endoderm	  and	  mesoderm	  associated	  genes,	  
AFP	   and	  CD34	   respectively,	  were	  downregulated,	  but	   the	  primitive	   streak	  and	  ectoderm	   genes	  MIXL1,	   NEUROD1	   and	   TH	   respectively,	   were	   all	   significantly	  upregulated.	   The	  most	   significant	   change	  was	   in	   the	   expression	   of	  NEUROD1.	  The	  changes	  in	  the	  relatively	  large	  number	  of	  genes	  within	  the	  panel	  induced	  by	  Thalidomide	   may	   be	   representative	   of	   the	   compounds	   extreme	   teratogenic	  properties	  to	  the	  human	  embryo.	  	  	  
Lovastatin	  Lovastatin	  also	  showed	  differential	  gene	  expression	  in	  a	  large	  number	  of	  genes	  within	  the	  panel.	  Similarly	  to	  thalidomide,	  lovastatin	  at	  1	  µM,	  when	  compared	  to	  controls,	  appeared	  to	  have	  reduced	  levels	  of	  differentiation	  as	  shown	  by	  higher	  levels	  of	  OCT4	  expression.	  The	  early	  endoderm	  gene	  SOX17,	  primitive	  streak	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3.3 Differentiation	  heterogeneity	  of	  embryoid	  bodies	  	  	  Upon	   further	   interrogation	   of	   the	   morphology	   of	   EBs	   in	   the	   screen,	   we	   did	  notice	  that	  single	  EBs	  exposed	  to	  the	  same	  conditions	  did	  vary	  somewhat	  from	  each	  other.	  We	  also	   looked	  at	   the	  morphology	  of	  EBs	  that	  had	  been	   formed	   in	  neutral	  conditions	  as	  well	  as	  EBs	  that	  had	  been	  under	  directed	  differentiation,	  and	   found	   the	   same	   trend.	   By	   performing	   qPCR	   on	   pooled	   EBs,	   the	   gene	  expression	   levels	  become	  averaged,	   and	   consequently	   standard	  deviations	  are	  generally	   reduced.	  We	   therefore	  wanted	   to	   assess	   in	   single	   EBs	   how	   variable	  gene	  expression	  really	  was	  and	  whether	  directed	  differentiation	  was	  specifying	  cells	  in	  a	  uniform	  manner	  between	  EBs.	  	  To	   investigate	   the	   heterogeneity	   between	   single	   EBs,	   we	   performed	   qPCR	  analysis	   on	   EBs	   under	   neutral	   conditions	   for	   196	   genes	   using	   the	   Fluidigm	  system.	   We	   found	   that	   single	   EBs	   did	   show	   substantial	   differences	   in	   the	  expression	  of	  the	  majority	  of	  the	  genes	  within	  the	  panel	  (Fig.	  3.10).	  It	  is	  known	  that	  the	  differentiation	  of	  hESCs	  in	  EBs	  under	  neutral	  conditions	  can	  occur	  in	  a	  relatively	   chaotic,	   stochastic	   manner,	   so	   in	   an	   attempt	   to	   reduce	   the	   random	  nature	   of	   differentiation,	   we	   generated	   EBs	   under	   directed	   differentiation	  conditions	   for	   endoderm,	   mesoderm	   and	   ectoderm.	   We	   found	   that	   EBs	   even	  under	  directed	  conditions	  showed	  variation	  in	  gene	  expression	  (Fig.	  3.10).	  	  	  Thus,	   the	   variation	   seen	   between	   single	   EBs	   in	   neutral	   and	   in	   directed	  differentiation	   conditions	   demonstrated	   that	   by	   just	   applying	   uniform	  conditions	  does	  not	  necessarily	   result	   in	  uniform	  differentiation.	  We	  reasoned	  that	   as	   the	   single	   EBs	   were	   all	   generated	   from	   the	   same	   starting	   population,	  there	   must	   be	   a	   more	   inherent	   heterogeneity	   within	   stem	   cells	   that	   was	  generating	   the	   variable	   differentiation.	   In	   order	   to	   further	   refine	   this	  differentiation	   assay,	   we	   became	   interested	   in	   investigating	   the	   more	  fundamental	  aspects	  of	  stem	  cell	  lineage	  decisions.	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3.4 Discussion	  	  	  	  Within	  this	  study,	  we	  have	  developed	  a	  reproducible	  differentiation	  assay	  using	  embryoid	   bodies,	   which	   shows	   potential	   as	   a	   tool	   for	   predictive	   toxicology.	  Reproductive	  toxicology	  currently	  consists	  of	   in	  vitro	  and	   in	  vivo	  assays,	  which	  involve	   the	   exposure	   of	   drugs	   to	   pregnant	   animal	  models,	   and	   the	   use	   of	   cell	  lines	   in	   culture,	   late	   on	   in	   the	   drug	   development	   process.	   Although	   valuable,	  data	   obtained	   from	   in	   vivo	   animal	   studies	   are	   extrapolated	   to	   the	   human	  context,	   which	   can	   have	   disastrous	   consequences,	   as	   shown	   by	   Thalidomide.	  	  Here	  we	  have	  developed	  an	  assay	  with	  hESCs,	   in	   embryoid	  body	   format	   so	   to	  better	  mimic	  embryonic	  development,	  which	  correctly	  identified	  80%	  of	  known	  teratogenic	   drugs.	   This	   assay	   showed	   high	   concordance	   with	   existing	  toxicological	  data,	  and	  existing	  assays.	  	  	  The	  development	  of	   the	  assay	  was	   initially	  hindered	  by	   the	  high	   sensitivity	  of	  hESCs	  to	  single	  cell	  dissociation,	  which	  has	  been	  previously	  reported	  (Watanabe	  et	   al.	   2007).	   Myosin	   hyperactivation	   induced	   by	   single	   cell	   dissociation	   is	   a	  direct	  cause	  of	  apoptosis	  in	  hESCs,	  which	  can	  be	  effectively	  blocked	  through	  the	  use	  of	  Rho-­‐associated	  protein	  kinase	  inhibitors	  such	  as	  Y-­‐27632	  (Ohgushi	  et	  al.	  2010).	   Although	   not	   reported,	   the	   inclusion	   of	   Y-­‐27632	  within	   the	   assay	   had	  potential	   to	   either	   increase	   the	   survival	   of	   cells	   in	   the	   presence	   of	   toxic	  compounds,	  due	  to	  its	  anti-­‐apoptotic	  effects	  (Watanabe	  et	  al.	  2007),	  or	  interact	  with	   drugs	   through	   unknown	   mechanisms,	   enhancing	   or	   dampening	   their	  effects	   leading	   to	   false	   positives	   or	   more	   concerning,	   false	   negatives	  respectively.	   To	   circumvent	   the	   potential	   issues	   of	   Y-­‐26732	   being	   present	   for	  the	  duration	  of	  the	  assay,	  we	  found	  that	  initial	  pre-­‐treatment	  with	  the	  inhibitor	  noticeably	   improved	   the	  morphological	   reproducibility	   of	   EBs	   by	   significantly	  reducing	  the	  level	  of	  cell	  death	  after	  dissociation.	  Moreover,	  we	  did	  not	  notice	  a	  difference	  in	  differentiation	  potential	  of	  hESCs	  pre-­‐treated	  with	  Y-­‐27632	  when	  compared	   to	  un-­‐treated	  cells,	   in	  concordance	  with	  existing	  reports	   (Watanabe	  et	  al.	  2007).	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As	  MEF	  cells	  are	  known	  to	  secrete	  growth	  factors	  (Greber	  et	  al.	  2007),	  involved	  in	   self-­‐renewal	   and	   specification	   of	   hESCs,	   and	   as	   our	   assay	   used	   cells	  specifically	   from	  MEF	  cultures,	  we	  devised	  a	  method	   in	  which	  MEF	  cells	  could	  be	  eliminated	  for	  more	  defined	  differentiation.	  The	  elimination	  of	  MEF	  cells	  was	  achieved	   by	   seeding	   dissociated	   hESCs	   onto	   flasks	   pre-­‐incubated	   with	   MEF	  conditioned	   media.	   Components	   in	   the	   conditioned	   media	   allowed	   the	  attachment	  of	  hESCs	  although	  the	  mechanisms	  of	  exactly	  how	  are	  unknown.	  It	  has	   been	   reported	   that	   MEF	   cells	   secrete	   a	   large	   array	   of	   matrix	   forming	  proteins,	   including	   collagens,	   which	   may	   provide	   a	   suitable	   environment	   for	  hESCs	   to	   adhere	   (J.	  W.	  E.	   Lim	  &	  Bodnar	  2002).	  Thus,	   the	  pre-­‐attachment	   step	  plus	   pre-­‐treatment	  with	   Y-­‐27632	   appeared	   to	   efficiently	   circumvent	   the	   need	  for	  Y-­‐27632	  throughout	  differentiation	  and	  eliminate	  MEF	  cells.	  	  After	  having	  established	  a	  protocol	  for	  the	  formation	  and	  differentiation	  of	  EBs,	  we	   found	   that	   differentiation	   under	   neutral	   conditions	   (no	   addition	   of	  recombinant	   proteins	   or	   chemical	   inhibitors	   to	   direct	   differentiation)	   showed	  good	   reproducibility	   between	   biological	   experiments.	   EBs	   in	   these	   conditions	  seemed	   to	   have	   a	   bias	   strongly	   in	   favour	   of	   the	   ectoderm	   lineage,	  which	  was	  eradicated	  upon	  sorting	  for	  the	  stem	  cell	  marker	  SSEA-­‐3.	  It	  is	  known	  that	  hESC	  cultures	  tend	  to	  be	  contaminated	  by	  spontaneous	  differentiation,	  but	  stem	  cells	  themselves	   can	   also	   exhibit	   a	   high	   level	   of	   heterogeneity	   in	   gene	   expression	  which	  has	  been	  shown	  to	  alter	  the	  functional	  behaviour	  of	  cells	  (Toyooka	  et	  al.	  2008;	   Chambers	   et	   al.	   2007).	   For	   example,	   hESCs	   in	   culture	   show	   graded	  expression	  of	  the	  stem	  cell	  surface	  marker	  SSEA-­‐3.	  Upon	  fractionation	  of	  hESCs	  on	   SSEA-­‐3	   it	   has	   been	   shown	   that	   high	   SSEA-­‐3	   expression	   correlates	   with	  clonogenic	  stem	  cells,	  whereas	  SSEA-­‐3	  low	  and	  SSEA-­‐3	  negative	  do	  not	  (Tonge	  et	  al.	  2011).	  By	  sorting	  cells	  for	  high	  SSEA-­‐3	  expression	  before	  EB	  formation	  to	  reduce	  heterogeneity,	  we	   found	   that	  differentiation	  was	  not	  only	  more	  evenly	  distributed	   between	   each	   primary	   germ	   layer,	   thereby	   eradicating	   ectoderm	  bias,	   but	   also	   led	   to	   a	   decrease	   in	   the	   standard	   deviation	   of	   gene	   expression	  between	  biological	  replicates.	  Yet	  we	  did	  find	  that	  cells,	  which	  had	  been	  sorted	  for	  SSEA-­‐3,	  did	  not	  aggregate	  without	  the	  addition	  of	  Y-­‐27632.	  This	  observation	  has	   also	   been	   reported	   in	   cells	   sorted	   for	   uniformly	   high	   OCT4	   expression.	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Similar	   to	   our	   findings,	   this	   could	   be	   rectified	   using	   Y-­‐27632	   (Ungrin	   et	   al.	  2008).	   The	   reasons	   for	   why	   highly	   pure	   populations	   of	   stem	   cells	   do	   not	  aggregate	  are	  currently	  unknown,	  but	  may	  be	  in	  part	  related	  to	  the	  absence	  of	  cell	  surface	  proteins	  involved	  in	  cell	  adherence.	  	  	  Having	  established	  a	  reproducible	  protocol	  for	  the	  formation	  of	  EBs	  from	  single	  hESCs,	  we	  investigated	  whether	  the	  assay	  could	  be	  perturbed	  using	  established	  protocols	   for	   specific	   lineage	   differentiation	   through	   the	   addition	   of	  recombinant	  proteins	  and/or	  chemical	   inhibitors.	  Although	  highly	  effective	  for	  ectoderm	   specification,	  we	  were	  unable	   to	   efficiently	   segregate	   the	   endoderm	  and	  mesoderm	  lineages.	  We	  used	  two	  reporter	   lines	   for	   the	  GATA6	  and	  MIXL1	  genes	   in	   an	   attempt	   to	   optimise	   differentiation	   conditions	   for	   endoderm	   and	  mesoderm	  respectively.	  The	  action	  and	  gradients	  of	  Activin	  A,	  BMP4	  and	  WNT	  in	   endoderm	   and	   mesoderm	   specification	   has	   been	   well	   established,	   as	  reviewed	  by	  (Wells	  &	  Melton	  1999),	  therefore	  we	  titrated	  these	  morphogens	  in	  an	  attempt	  to	  segregate	  the	  two	  lineages.	  We	  found	  that	  Activin	  A	  was	  vital	  for	  the	  induction	  of	  both	  MIXL1	  and	  GATA6,	  supported	  by	  its	  use	  in	  mesoderm	  and	  endoderm	  differentiation	  protocols	  (Evseenko	  et	  al.	  2010;	  D'Amour	  et	  al.	  2005).	  This	   is	   also	   consistent	   with	   the	   findings	   that	   TGFβ	   signalling	   is	   involved	   in	  directing	  mesendoderm	  destined	  cells	  to	  the	  primitive	  streak	  in	  vivo	  (Arnold	  &	  Robertson	   2009).	   It	   was	   BMP4,	   however,	   that	   appeared	   to	   induce	   a	   lineage	  switch	  in	  EBs	  such	  that	  lower	  levels	  induced	  MIXL1	  and	  higher	  levels	  GATA6.	  	  	  qPCR	   analysis	   on	   day	   10	   EBs	   grown	   in	   optimised	   mesoderm	   conditions	   did	  show	   upregulation	   of	   mesodermal	   genes,	   however	   endodermal	   genes	   also	  remained	   highly	   expressed.	   Although	   heavily	   involved	   in	   mesodermal	  progenitors,	   such	   as	   haematopoietic	   cells	   (Ng	   et	   al.	   2005),	   MIXL1	   has	   been	  shown	   to	  activate	   the	  promoter	  of	  endoderm	  associated	  genes	  SOX17	  and	  GSC	  
(Goosecoid)	   (Lim	   et	   al.	   2009).	   Additionally,	  MIXL1-­‐null	   mouse	   embryos	   show	  deficiencies	  in	  definitive	  endoderm	  formation,	  and	  null	  ES	  cells	  show	  a	  reduced	  potency	  to	  colonise	  the	  embryonic	  gut,	  an	  endoderm	  derived	  structure	  (Lim	  et	  al.	  2009;	  Hart	  et	  al.	  2002).	  Together,	  this	  suggests	  an	  important	  role	  of	  MIXL1	  in	  endoderm	   specification,	   whether	   direct	   or	   indirect,	   which	   may	   explain	   the	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appearance	   of	   high	   endodermal	   gene	   expression	   in	   MIXL1(+)	   EBs.	   We	   also	  titrated	  Activin	  A,	  BMP4	  and	  CT	  99021	  on	  a	  reporter	  line	  harbouring	  GFP	  at	  the	  
GATA6	   locus.	  We	   found	   that,	  unlike	  MIXL1,	  GATA6	  was	  efficient	  at	   segregating	  the	   endoderm	   and	   mesoderm	   lineages,	   and	   also	   correlated	   with	   improved	  endoderm	  differentiation.	  Although	  GATA6	  is	  involved	  in	  mesodermally	  derived	  cells	  such	  as	  cardiomyocytes	  later	  on	  in	  development	  (Koutsourakis	  et	  al.	  1999),	  it	  would	  appear	  at	   this	  early	  differentiation	   time-­‐point	   it	   is	   almost	  exclusively	  involved	  in	  endoderm	  specification.	  	  Using	   the	   assay	   that	  we	   developed,	  we	  wanted	   to	   assess	   its	   use	   as	   a	   tool	   for	  predictive	   toxicology.	   In	   order	   to	   assess	   how	   sensitive	   the	   EB	   differentiation	  assay	  was	   to	  known	  teratogenic	  compounds,	  we	   tested	  a	  variety	  of	  drugs	   that	  have	   previously	   been	   classed	   as	   teratogenic	   or	   non-­‐teratogenic	   by	   the	   FDA.	  Drugs	  were	  selected	   from	  an	  existing	   library	  of	   compounds	   to	   represent	  wide	  chemical	  diversity,	   including	  physiochemical	  properties,	  molecular	  weight	  and	  polar	   surface	   areas	   (Gustafson	   et	   al.	   2012).	   Five	   individuals	   were	   asked	   to	  blindly	   analyse	   the	   morphology	   of	   EBs	   after	   exposure	   to	   control	   and	   test	  samples,	  which	  resulted	  in	  the	  identification	  of,	  on	  average,	  80%	  of	  teratogenic	  drugs.	  One	  drug,	  Clozapine,	  was	  identified	  by	  each	  individual	  at	  100	  μM	  to	  cause	  severe	   morphological	   changes	   of	   EBs,	   even	   though	   it	   is	   classed	   as	   non-­‐teratogenic	   and	   falls	   into	  Category	  B	  of	   FDA	   classifications.	   Category	  B	  means	  that	  there	  have	  been	  no	  animal	  reproduction	  studies	  demonstrating	  a	  risk	  to	  the	  foetus,	   however,	   there	   are	   equally	   no	   adequately	   well-­‐controlled	   studies	   in	  pregnant	  women.	  Our	  data	   from	  this	  particular	  assay	  would	  classify	  Clozapine	  as	   potentially	   teratogenic	   and/or	   embryotoxic	   to	   the	   human	   embryo	   at	   high	  concentrations.	  Although	  FDA	  guidelines	  state	  no	  adverse	  effects	  of	  Clozapine	  in	  animal	   models,	   it	   should	   be	   recalled	   that	   the	   highly	   teratogenic	   drug,	  Thalidomide,	   also	   showed	   no	   adverse	   effects	   in	   animal	   models	   until	  administered	   at	   extremely	   high	   concentrations	   (Bailey	   et	   al.	   2005).	   This	  highlights	   the	   importance	   of	   humanised	   assays,	   as	   model	   organisms	   do	   not	  always	   accurately	   predict	   human	   responses	   to	   drugs.	   Conversely,	   the	   drug	  Fluconazole	   was	   not	   picked	   up	   by	   any	   individual	   as	   causing	   morphological	  changes	   in	   EBs,	   even	   though	   Fluconazole	   falls	   into	   Category	   C	   of	   FDA	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classifications.	   Category	   C	   means	   that	   animal	   models	   have	   shown	   adverse	  effects,	   but	   there	   are	   no	   adequately	   controlled	   studies	   in	   humans.	  One	  poorly	  controlled	  clinical	  study	  does	  exist	  which	  describes	  fluconazole	  exposure	  during	  early	  gestation	  (weeks	  4-­‐9)	  with	  further	  exposure	  at	   later	  gestation	  (week	  22)	  resulting	  in	  child	  abnormalities	  (Aleck	  &	  Bartley	  1997).	  Conversely	  a	  study	  into	  brief	  fluconazole	  intake	  at	  the	  time	  of	  conception	  from	  239	  women	  reported	  no	  abnormalities	   to	   the	   resulting	   child	   (Inman	   et	   al.	   1994).	   Similarly	   to	  Thalidomide,	   Fluconazole	   may	   have	   a	   tight	   window	   in	   which	   it	   exhibits	  teratogenic	  behaviour,	  which	  according	  to	   the	  existing	  case	  studies,	  would	  not	  appear	   to	   be	   early	   on	   in	   development.	  Making	   the	   assumption	   that	   our	   assay	  correlates	  to	  the	  earliest	  stages	  of	  embryonic	  development,	  these	  reports	  would	  support	   the	   absence	   of	  morphological	   change	  within	   the	   EB	   assay.	   A	   parallel	  study	   in	   zebrafish	   using	   the	   drugs	   Clozapine	   and	   Fluconazole	   also	   saw	   that	  Clozapine	   showed	   teratogenic	   behaviour,	   whereas	   Fluconazole	   did	   not.	   They	  found	   that	   Fluconazole	   had	   a	   very	   low	   uptake	   within	   zebrafish	   embryos,	  whereas	  Clozapine	  was	  very	  high,	  reasoned	  to	  have	  contributed	  to	  the	  observed	  phenotypes	  (Gustafson	  et	  al.	  2012).	  It	  should	  therefore	  be	  emphasised	  that	  this	  assay	   is	   probably	  most	   relevant	   to	   the	   earliest	   stages	   of	   human	  development;	  therefore	  care	  should	  be	  taken	  when	  extrapolating	  data	  from	  this	  assay	  for	  the	  entire	   human	   gestation	   period.	   We	   believe	   this	   assay	   shows	   potential	   to	   be	  used,	   specifically,	   in	   conjunction	   with	   existing	   in	   vitro	   and	   in	   vivo	   assays	   to	  identify	  teratogenic	  drugs.	  	  	  Nevertheless,	   we	   do	   postulate	   that	   this	   assay	   may	   be	   predictive	   of	   potential	  teratogenic	   effects	   later	   in	   gestation	   if	   the	   particular	   drug	   interferes	   with	  pathways	   also	   involved	   in	   hESC	   self-­‐renewal	   and/or	   differentiation.	   The	  compound	   Thalidomide,	   which	   is	   known	   to	   have	   very	   specific	   teratogenic	  effects	  in	  later	  development	  (Miller	  &	  Strömland	  1999)	  did	  show	  morphological	  and	  gene	  expression	  changes	  within	  this	  assay.	  Although	  many	  mechanisms	  of	  action	   have	   been	   published,	   as	   reviewed	   by	   (Stephens	   1988),	   the	  mechanism	  which	  may	  explain	  our	  observed	  effect	   is	   through	  Thalidomide	  binding	   to	  and	  blocking	   the	   IGF-­‐1	   and	   FGF-­‐2	   promoters,	   both	   of	   which	   are	   involved	   in	  angiogenesis	   during	   limb	   formation	   and	   are	   involved	   in	   maintaining	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pluripotency	   and	   early	   lineage	   specification	   in	   hESCs	   (Stephens	   et	   al.	   2000;	  Bendall	  et	  al.	  2007).	  	  	  Although	   highly	   successful	   in	   identifying	   teratogenic	   drugs,	   upon	   analysis	   of	  individual	  EBs	  generated	  from	  the	  same	  starting	  cell	  population	  under	  uniform	  conditions,	   different	  morphologies	   were	   apparent.	   In	   concordance	  with	   these	  morphologies,	  the	  gene	  expression	  heterogeneity	  within	  EBs	  was	  quite	  striking.	  Of	   the	   192	   genes	   analysed,	   many	   showed	   differential	   expression	   even	   in	  conditions	  directing	  differentiation.	  Relating	  back	  to	  our	  data	  showing	  that	  the	  variation	  in	  gene	  expression	  could	  be	  reduced	  upon	  sorting	  cells	  for	  SSEA-­‐3,	   it	  would	  appear	  that	  the	  starting	  cell	  heterogeneity	  might	  be,	  in	  part,	  responsible	  for	   the	   observed	   differentiation	   heterogeneity.	   In	   order	   to	   further	   refine	   this	  assay,	  we	  wanted	   to	  ascertain	  whether	  heterogeneity	  was	   indeed	  an	  aspect	  of	  stem	  cell	  culture,	  and	  whether	  this	  heterogeneity	  had	  functional	  consequences	  on	  the	  differentiation	  of	  hESCs.	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4 Chapter	  4	  	  4.1 Introduction	  	   4.1.1 GATA6	  Heterogeneity	  in	  hESCs	  	  	  The	   differentiation	   of	   lineage	   specific	   cells	   in	   vivo	   is	   an	   intricate,	   yet	   precise	  process	  through	  which	  cells	  of	  the	  ICM	  firstly	  enter	  gastrulation	  deriving	  each	  of	  the	   three	   primary	   germ	   layers,	   and	   later,	   further	   specification	   to	   terminal	  somatic	   cell	   types.	   A	   step-­‐wise	   process	   of	   events	   allows	   cells	   to	   choose	   a	  particular	   fate	   whereby	   gene	   regulatory	   networks	   are	   established	   and	   cells	  eventually	  become	  fixed	  to	  a	  particular	  cell	  type,	  residing	  within	  a	  stable	  state,	  for	   example	   fibroblasts.	   This	   step-­‐wise	   process	   involves	   the	   cell	   receiving	   a	  signal,	   signal	   transduction,	   and	   subsequently	   gene	   activation	   or	   repression.	  These	  signalling	  pathways	  have	  been	  the	  subjects	  of	  much	  research	  in	  order	  to	  try	   and	   recapitulate	   in	   vitro,	   decision-­‐making	   that	   occurs	   during	   embryonic	  development	   in	   vivo.	   This	   has	   proven	   relatively	   successful,	   for	   example	   in	  endodermal,	   mesodermal	   and	   ectodermal	   specification	   (D'Amour	   et	   al.	   2005;	  Laflamme	  et	  al.	  2007;	  Chambers	  et	  al.	  2009),	  but	  the	  efficiency	  with	  which	  cells	  arrive	  at	   the	  same	  destination	  at	   the	  same	  time	  varies	  dramatically.	  Following	  on	   from	   our	   data	   showing	   the	   heterogeneous	   differentiation	   of	   EBs,	   and	   the	  importance	  of	   the	   starting	  quality	  of	   cells,	   an	  outstanding	  question	  within	   the	  field	  is	  why	  hESCs	  show	  a	  large	  disparity	  in	  lineage	  specification	  under	  uniform	  conditions.	   A	   large	   body	   of	   work	   describes	   functional	   heterogeneity	   within	  populations	  of	  mESCs	  and	  hESCs	  with	  respect	  to	  stem	  cell	  associated	  markers,	  but	  there	  are	  gaps	  in	  our	  knowledge	  with	  respect	  to	  the	  role	  of	  lineage	  specific	  genes	  which	  have	  been	  shown	  to	  be	  expressed	   in	  hESCs	  (Gokhale	  et	  al.	  2015).	  We	   believe	   that	   heterogeneity	   in	   the	   stem	   cell	   compartment	   may	   account	   at	  least	  in	  part	  for	  differentiation	  heterogeneity;	  therefore	  we	  investigated	  the	  role	  of	   the	   expression	   of	   the	   transcription	   factor	   GATA6	   in	   hESCs,	   which	   displays	  extensive	  expression	  heterogeneity	  in	  culture.	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4.1.2 Heterogeneity	  of	  human	  embryonic	  stem	  cells	  	  	  	  The	  apparent	  ability	  to	  maintain	  hESCs	  in	  states	  that	  perhaps	  represent	  varying	  stages	   of	   embryonic	   development	   in	   vitro	   has	   brought	   into	   question	  whether	  states	  may	   exist	   in	  which	   cells	   are	  biased	   to	  particular	   fates.	   Previous	   studies	  have	   reported	   that	   transcription	   factors,	   surface	   markers	   and	   signalling	  pathways,	  which	  are	  strongly	  correlated	  with	  the	  stem	  cell	  state,	  are	  expressed	  in	  a	  heterogeneous	  fashion	  (Stewart	  et	  al.	  2006;	  Fischer	  et	  al.	  2010;	  Bhatia	  et	  al.	  2013;	  Blauwkamp	  et	  al.	  2012;	  Tonge	  et	  al.	  2011).	  	  	  	  One	   example	   is	   that	   of	   Nanog	   expression	   in	   both	   mESCs	   as	   well	   as	   hESCs,	  whereby	  10-­‐20%	  of	  cells	  in	  culture	  actually	  do	  not	  express	  the	  gene	  (Chambers	  et	   al.	   2007;	   Fischer	   et	   al.	   2010).	   These	   Nanog(-­‐)	   cells	   do	   not	   necessarily	  represent	  a	  differentiated	  cell	  type,	  as	  they	  can	  convert	  to	  a	  Nanog(+)	  state	  and	  remain	   pluripotent.	   There	   are,	   however,	   functional	   differences	   between	   these	  two	  states,	  such	  that	  Nanog(-­‐)	  cells	  differentiate	  at	  a	  higher	  rate	  than	  Nanog(+)	  (Chambers	  et	  al.	  2007).	  Similar	  observations	  have	  also	  been	  made	  in	  mESCs	  and	  the	  expression	  of	  the	  stem	  cell	  transcription	  factor	  Rex1,	  whereby	  two	  separate	  functionally	  different	   states	  were	   identified.	  The	   first	  whereby	  cells	   expressed	  
Rex1	   and	  Oct4	  which	  were	  postulated	   to	   be	   analogues	   of	   cells	  within	   the	   ICM	  and	   the	   second	   where	   cells	   only	   expressed	   Oct4	   but	   not	   Rex1,	   which	   were	  deemed	   to	   be	   primitive	   endoderm	   like	   (Toyooka	   et	   al.	   2008).	   Similar	   to	   the	  observations	  made	  with	  Nanog,	  when	  purified	  into	  Rex1(-­‐)	  Oct4(+)	  and	  Rex1(+)	  
Oct4(+),	   both	   states	   could	   regenerate	   each	   other	   resulting	   in	   the	   re-­‐establishment	   of	   the	   original	   culture	   heterogeneity.	   	   Interestingly,	   when	  performed	   on	   hESCs,	   it	   was	   found	   that	   REX1(+)	   cells	   were	   able	   to	   generate	  
REX1(-­‐)	   cells,	   but	   not	   vice	   versa,	   even	   under	   prolonged	   culture	   highlighting	  potential	   differences	   in	   state	   residence	  between	   the	   two	   species	   (Bhatia	   et	   al.	  2013).	  	  	  Additionally,	   the	   stem	   cell	   surface	   markers	   PECAM-­‐1	   and	   SSEA-­‐1	   have	   been	  shown	  to	  exhibit	  heterogeneous	  expression	  patterns	  on	  mESCs.	  The	  expression	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of	  PECAM-­‐1	  and	  SSEA-­‐1	  correlates	   strongly	  with	   the	  pluripotency	  of	   cells	   and	  their	   ability	   to	   form	   chimerae	   in	   the	   epiblast	   of	   mouse	   embryos.	   The	   loss	   of	  SSEA-­‐1	   or	   more	   importantly	   PECAM-­‐1	   results	   in	   an	   increase	   in	   lineage	  associated	  genes	  within	  cells,	  but	  does	  not	  mean	  the	  loss	  of	  their	  ability	  to	  self-­‐renew.	  Nevertheless,	  cells	  did	  exhibit	  a	  shift	  in	  the	  probabilities	  of	  self-­‐renewal	  versus	   differentiation	   such	   that	   differentiation	  was	   favoured	   (Furusawa	   et	   al.	  2004).	  What	   is	  more,	   the	   expression	   of	   PECAM-­‐1	   showed	   near	   correlation	   to	  
Rex1	  providing	  a	  useful	  link	  between	  surface	  marker	  expression	  and	  core	  stem	  cell	   transcription	   factor	   expression	   (Toyooka	   et	   al.	   2008).	   Heterogeneity	   was	  also	  found	  to	  exist	  in	  the	  expression	  of	  the	  stem	  cell	  and	  germ	  cell	  specific	  gene	  
Stella.	  Stella	  is	  strongly	  down	  regulated	  and	  methylated	  in	  epiblast-­‐like	  cells,	  but	  highly	  expressed	  alongside	  PECAM-­‐1	  and	  NANOG	  in	  ICM-­‐like	  cells.	  Most	  striking	  from	  this	  study	  was	  the	  re-­‐equilibration	  of	  Stella(+)	  cells	  at	  a	  stable	  20-­‐30%	  of	  total	  culture	  even	  upon	  purification	  and	  re-­‐seeding	  of	  Stella(-­‐)	  PECAM-­‐1(-­‐)	  and	  
Stella(+)	   PECAM-­‐1(+)	   cells	   (Hayashi	   et	   al.	   2008).	   From	   our	   lab,	   it	   has	   been	  shown	  that	  hESCs	  also	  show	  heterogeneity	  of	  SSEA-­‐3,	  similar	  to	  that	  of	  mouse	  and	  SSEA-­‐1.	  SSEA-­‐3(+)	  and	  SSEA-­‐3(-­‐)	  cells	  were	  found	  to	  interconvert	  and	  thus	  regenerate	   each	   other,	   but	   the	   SSEA-­‐3(-­‐)	   cells	   showed	   impaired	   self-­‐renewal	  capacity.	  Nevertheless,	   a	   small	  proportion	  of	  SSEA-­‐3(-­‐)	   cells	  were	  able	   to	   self-­‐renew	  (Tonge	  et	  al.	  2011).	  	  	  Thus,	   there	   would	   appear	   to	   be	   a	   large	   overlap	   between	   the	   network	   of	  transcription	  factors	  governing	  self-­‐renewal	  and	  with	  stem	  cell	  surface	  markers,	  which	  ultimately	  correlates	  with	  the	  functional	  status	  and	  developmental	  stage	  of	   ESCs.	   These	   reports	   specifically	   looked	   at	   the	   heterogeneity	   in	   stem	   cell	  associated	   markers,	   which	   then	   prompted	   a	   study	   to	   assess	   lineage	   marker	  expression	   in	   hESCs.	   The	   examination	   of	   single	   hESCs	   fractionated	   by	   their	  expression	   of	   SSEA-­‐3	   revealed	   extensive	   heterogeneity	   of	   lineage	   marker	  expression	   including	   genes	   associated	  with	   endoderm	   such	   as	  GATA6,	  GATA4	  and	   SOX17	   (Gokhale	   et	   al.	   2015).	   The	   co-­‐expression	   of	   OCT	   and	   NANOG	  alongside	   lineage	   genes	   provided	   initial	   evidence	   of	   discreet	   substates	  within	  the	   stem	   cell	   compartment	   that	   are	   potentially	   lineage	   specific.	   The	   early	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endoderm	   gene	   GATA6	   was	   particularly	   interesting	   due	   to	   the	   high	   degree	   of	  heterogeneity	  observed	  in	  SSEA-­‐3(+)	  cells.	  	  	  	   4.1.3 The	  transcription	  factor	  GATA6	  	  	  
GATA6	   is	  a	  zinc	  finger	  transcription	  factor	  that	  has	  DNA	  binding	  capabilities	  to	  the	   consensus	   sequence	   A/TGATA/G,	   (Koutsourakis	   et	   al.	   1999).	   	   It	   plays	  crucial	  roles	  in	  the	  specification	  and	  development	  of	  tissue	  types	  during	  various	  stages	   of	   development,	   in	   particular	   the	   formation	   of	   the	   primitive	   endoderm	  during	   the	  mid	   to	   late	   blastocyst.	   In	  mouse	   development,	   zygotic	  GATA6	   gene	  expression	  has	   been	  detected	   as	   early	   as	   the	   4-­‐cell	   embryo	   (Guo	   et	   al.	   2010),	  with	   clear	   protein	   expression	   at	   the	   8-­‐cell	   stage	   (Plusa	   et	   al.	   2008).	   	   The	  endoderm-­‐specific	   marker	   GATA6	   increases	   in	   expression	   in	   the	   majority	   of	  cells	   up	   to	   the	   32-­‐cell	   stage	   alongside	   the	   opposing	   epiblast	   lineage	   specific	  marker	  NANOG.	  This	  co-­‐expression	  of	  opposing	   lineages	  continues	  throughout	  the	   morula	   into	   the	   early	   blastocyst,	   but	   by	   the	   mid	   blastocyst,	   GATA6	   and	  NANOG	  become	  increasingly	  mutually	  exclusive,	  creating	  a	  salted	  and	  peppered	  expression	  phenotype	  within	  cells	  of	  the	  ICM	  (Rossant	  et	  al.	  2003;	  Chazaud	  et	  al.	  2006).	  At	  this	  point	  in	  development,	  cells	  expressing	  GATA6	  appear	  destined	  for	  a	   primitive	   endoderm	   fate	   (PrE)	   by	   showing	   a	   down	   regulation	   of	   NANOG	  alongside	  an	  up-­‐regulation	  of	   other	  PrE	  associated	  markers,	   including	  GATA4,	  SOX17,	  Dab2	   and	  Pdgfrα	   (Artus	   et	   al.	   2012).	   By	   the	   time	  of	  GATA4	   induction,	  very	  few	  cells	  within	  the	  ICM	  are	  co-­‐expressing	  PrE	  markers	  and	  NANOG	  (Plusa	  et	   al.	   2008).	   Initially,	   it	   is	   believed	   that	   GATA6	   is	   induced	   through	   a	   signal-­‐transduction	   pathway	   involving	   the	   signal	   adaptor	   protein,	   growth	   receptor	  bound	   protein	   2	   (Grb2)	   (Cheng	   et	   al.	   1998).	   Grb2	   functions	   to	   link	   receptor	  tyrosine	   kinase	   activation	   to	   the	   downstream	   Ras-­‐MAP	   kinase-­‐signalling	  pathway.	   Indeed,	   both	   in	   vivo	   and	   in	   vitro,	   the	   Ras/MAP	   kinase	   pathway	   has	  been	  shown	  to	  direct	  mESCs	  towards	  the	  endodermal	  lineage	  (Yamanaka	  et	  al.	  2010).	  It	  is	  likely	  that	  FGF	  signalling	  works	  up-­‐stream	  of	  Grb2,	  and	  is	  therefore	  important	  in	  PrE	  specification,	  as	  seen	  by	  PrE	  defects	  in	  FGF4	  mutant	  embryos	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(Feldman	   et	   al.	   1995).	   Furthermore,	   the	   ICM	   of	   Grb2	   mutant	   embryos	  completely	  lacks	  the	  expression	  of	  GATA6	  (Rappolee	  et	  al.	  1994).	  A	  critical	  role	  of	   GATA6	   at	   this	   stage	   of	   development	   is	   for	   the	   correct	   formation	   of	   the	  primitive	  endoderm,	  which	  is	  required	  for	  proper	  patterning,	  as	  well	  as	  nutrient	  exchange	   in	   the	  developing	  embryo	   (Koutsourakis	  et	  al.	  1999;	  Rossant	  &	  Tam	  2009).	   By	   E4.5	   GATA6	   positive	   cells	   relocate	   onto	   the	   surface	   of	   the	   ICM,	  forming	  a	  basement	  membrane	  between	  the	  ICM	  and	  blastocoel	  (Rossant	  et	  al.	  2003).	  This	  relocation	  arises	  from	  GATA6	  activated	  Dab2	  which	  is	  required	  for	  proper	  epithelial	  organisation	  (Fujikura	  et	  al.	  2002),	  as	  well	  as	  the	  roles	  of	  the	  extracellular	  matrix	  protein	  Laminin	  C1	  and	  Pdgfrα	  (Plusa	  et	  al.	  2008).	  Mutant	  forms	   of	   Dab2	   and	   Laminin	   C1	   allow	   the	   normal	   expression	   of	  GATA6	   within	  cells	  of	  the	  ICM,	  but	  spatial	  organisation	  does	  not	  occur	  so	  that	  GATA6	  positive	  cells	   remain	  mixed	   throughout	   the	   ICM	   (Smyth	   et	   al.	   1998;	   Yang	   et	   al.	   2002).	  Additionally,	  at	  E4.5,	  a	  new	  site	  of	  GATA6	  expression	  appears	  within	  the	  parietal	  endoderm	   on	   Reichert’s	  membrane.	   This	   expression	   however	   is	   lost	   by	   E5.5,	  demonstrating	  strict	  spatial	  and	  temporal	  control	  of	  the	  gene	  (Koutsourakis	  et	  al.	   1999).	   	   As	   development	   continues,	  GATA6	   becomes	   crucial	   in	  mesodermal	  cell	   types	  such	  as	  cardiomyocytes.	  By	  E8.0,	  GATA6	   is	  expressed	  in	   lateral	  plate	  mesoderm,	  which	  houses	  the	  cardiogenic	  plate,	  and	  remains	  present	  during	  the	  differentiation	   and	   migration	   of	   cardiomyocytes	   that	   form	   the	   heart	   tube	  (Koutsourakis	   et	   al.	   1999).	   GATA6	   is	   then	   strongly	   expressed	   within	   the	  developing	   intestine,	   stomach,	   aorta	   and	   bladder	   which	   are	   all	   derived	   from	  endodermal	  and	  mesodermal	  precursors	  (Morrisey	  et	  al.	  1996).	  	  	  In	  humans	  very	  little	  is	  known	  about	  exactly	  how	  the	  early	  blastocyst	  develops,	  and	  how	  the	  expression	  of	  GATA6	  comes	  about,	  due	  to	  the	  lack	  of	  access	  and	  the	  ethical	  concerns	  over	  the	  use	  of	  human	  embryos.	  Although	  the	  early	  segregation	  events	   are	   thought	   to	   progress	   in	   a	   similar	   fashion	   to	   that	   of	   the	  mouse,	   the	  timing	   of	   events	   appears	   delayed	   (Cockburn	   &	   Rossant	   2010).	   Even	   less	   is	  known	   about	   EPI	   and	   PrE	   segregation	   events.	   There	   is	   no	   strong	   evidence	   to	  support	   exactly	  when	  GATA6	   expression	   is	   initiated,	   or	   even	  whether	   the	   PrE	  formation	  during	  gastrulation	  is	  the	  same	  as	  the	  mouse.	  For	  these	  reasons,	  the	  majority	  of	  our	  understanding	  about	  this	  early	  stage	  of	  human	  development	  has	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been	  investigated	  using	  in	  vitro	  hESC	  lines.	  Certainly,	  results	  from	  hESC	  studies	  indicate	   at	   a	   basic	   level	   that	   the	  mechanisms	   of	   PrE	   and	   EPI	   segregation	   are	  similar	   between	   the	   two	   species.	   For	   example,	   the	   knockdown	   of	   NANOG	   in	  hESCs	   induces	   extraembryonic	   endoderm,	   and	   the	  upregulation	  of	  GATA6	   and	  
GATA4	   (Hyslop	   et	   al.	   2005).	   Conversely,	   if	   NANOG	   is	   over	   expressed,	   hESCs	  follow	   a	   primitive	   ectodermal	   fate	   at	   the	   expense	   of	   endoderm	   (Darr	   et	   al.	  2006).	   Additionally,	   the	   derivation	   of	   stable	   hESCs,	  with	   close	   resemblance	   to	  mESCs,	  and	  with	  high	  expression	  of	  NANOG	  and	  GATA6,	  indicates	  the	  stable	  co-­‐expression	   of	   these	   opposing	   lineage	   specific	  markers,	   as	   is	   found	  within	   the	  early	  mouse	  blastocyst	  but	  within	  the	  human	  context	  (Chan	  et	  al.	  2013).	  	  With	  the	  observation	  that	  GATA6	   is	  expressed	  alongside	  genes	  of	  pluripotency,	  and	   given	   the	   role	   of	   GATA6	   in	   early	   endoderm	   specification,	   we	   wanted	   to	  follow	   the	   dynamics	   of	   GATA6	   expression	   in	   routine	   hESC	   culture	   to	   better	  understand	   its	   role	   during	   development	   and	   also	   to	   investigate	   whether	   we	  could	  identify	  functionally	  discreet	  substates	  within	  the	  stem	  cell	  compartment	  that	  could	  bias	  cell	  fate	  decisions.	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4.2 Results	  	  	   4.2.1 Generation	  and	  characterisation	  of	  a	  GATA6	  reporter	  line	  	  	  In	  order	  to	  track	  the	  expression	  of	  the	  early	  endodermal	  marker	  GATA6	  in	  vitro	  and	  in	  real-­‐time,	  we	  used	  a	  reporter	  line	  whereby	  a	  GFP	  construct	  was	  knocked	  into	  the	  ATG	  site	  of	  the	  second	  exon	  of	  one	  allele	  at	  the	  GATA6	  locus,	  creating	  a	  heterozygous	   GATA6:GFP	   cell	   line.	   The	   targeting	   of	   the	   ATG	   site	   had	   been	  performed	   using	   zinc	   finger	   nucleases	   by	   Dr	   Andrew	   Smith	   (University	   of	  Edinburgh/Oxford)	  to	  create	  a	  double	  stranded	  break	  at	  the	  specific	  integration	  site.	   The	   GFP	   cassette	   (Fig.	   4.1)	  was	   electroporated	   into	   the	   Shef4	   line	   with	  induced	  DSBs,	  and	  the	  process	  of	  integration	  was	  dependent	  upon	  homologous	  recombination	   by	   the	   internal	   cell	   machinery.	   Cells	   with	   a	   successfully	  integrated	   GFP	   cassette	   had	   been	   selected	   for	   neomycin	   resistance,	   and	   the	  resulting	   cells	   sub-­‐cloned	   to	   make	   clonal	   lines.	   Two	   clonal	   lines	   were	   used	  during	  this	  project,	  the	  first	  named	  S4G6	  4/F-­‐9,	  and	  a	  further	  sub-­‐clone	  of	  S4G6	  4/F-­‐9,	  S4G6	  4/-­‐F9	  A3.	  The	  A3	  subclone	  had	  the	  neomycin	  resistance	  removed	  and	  was	  used	  for	  all	  functional	  experiments.	  	  	  To	   ensure	   that	   the	   new	   S4G6	   4/F-­‐9	   reporter	   line	   behaved	   similarly	   to	   the	  parental	   Shef4	   line,	   the	   reporter	   was	   screened	   against	   a	   panel	   of	   stem	   cell	  markers	   after	   several	   passages	   of	   the	   cell	   line	  with	   GFP	   integration.	   The	   line	  expressed	  high	   levels	   of	   the	   stem	   cell	  markers	   SSEA-­‐3,	   TRA-­‐1-­‐60,	   SSEA-­‐4	   and	  TRA-­‐1-­‐81,	  but	  low	  levels	  of	  the	  early	  differentiation	  markers	  SSEA-­‐1,	  similar	  to	  that	   of	   the	   parental	   Shef4	   line	   (Fig.	   4.2A).	   Secondly,	   we	   tested	   whether	   the	  reporter	  line	  had	  still	  retained	  the	  capacity	  for	  multi-­‐lineage	  differentiation.	  The	  formation	  of	  EBs	  from	  single	  hESCs	  has	  been	  shown	  to	  allow	  the	  specification	  of	  cells	   from	  each	  of	   the	   three	  primary	  germ	   layers	   (Itskovitz-­‐Eldor	   et	   al.	   2000),	  therefore	  S4G6	  4/F-­‐9	  were	  dissociated	  and	  re-­‐aggregated	  in	  ultra-­‐non-­‐adherent	  plates	  for	  EB	  formation.	  	  After	  10	  days	  of	  differentiation,	  both	  the	  Shef4	  parental	  and	  the	  S4G6	  4/F-­‐9	  line	  showed	  expression	  of	  genes	  associated	  with	  endoderm	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4.2.2 Detection	  of	  GATA6	  in	  hESCs	  in	  routine	  culture	  	  	  	  We	  performed	  FACS	  analysis	  on	  the	  reporter	  line	  and	  found	  that	  a	  small	  subset	  of	  cells	  did	  appear	  to	  be	  expressing	  GATA6	  (Fig	  4.3A).	  As	  our	  reporter	  line	  was	  measuring	  the	  expression	  levels	  of	  GATA6	  mRNA	  with	  GFP	  as	  the	  read-­‐out,	  we	  sought	   to	   assess	   the	   relationship	   of	   GFP	   to	   that	   of	   GATA6	   protein	   levels.	  We	  found	  that	   there	  was	  no	   linear	  correlation	  between	  the	  expression	  of	  GFP	  and	  the	   expression	   of	   GATA6	   protein.	   Thus,	   GFP(+)	   cells	   were	   not	   necessarily	  translating	  the	  protein	  (Fig.	  4.3B).	  We	  then	  categorised	  the	  GFP	  expressing	  cells	  into	   low,	   mid	   and	   high	   expression	   levels	   to	   assess	   whether	   increasing	   GFP	  intensity	   showed	   an	   increase	   in	   the	   expression	  of	  GATA6	  protein,	   even	   if	   this	  trend	   was	   not	   linear	   (Fig	   4.3C).	   As	   expected,	   cells	   that	   did	   not	   have	   GFP	  expression	   showed	   negligible	   expression	   of	   GATA6	   protein.	   As	   cells	   began	   to	  express	  low-­‐level	  GFP,	  GATA6	  protein	  did	  appear,	  with	  5.5%	  of	  this	  population	  being	   protein	   positive.	   At	  mid-­‐level	   GFP,	   a	   further	   increase	   of	   GATA6	   protein	  was	  found,	  as	  8.3%	  of	  cells	  became	  positive,	  however	  the	  largest	  increase,	  and	  the	  highest	  levels	  of	  protein	  were	  found	  within	  the	  high	  GFP	  fraction,	  at	  23.2%	  of	  the	  population	  (Fig.	  4.3D	  &	  4.3E).	  Therefore,	  a	  stepwise	  increase	  in	  GATA6	  protein	  was	  apparent	  as	  GFP	  intensity	  increased.	  The	  expression	  of	  GFP	  will	  be	  referred	  to	  herein	  as	  GATA6.	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4.2.3 Stem	  Cell	  marker	  and	  GATA6	  co-­‐expression	  	  	  	  Having	   established	   that	   GATA6	   is	   expressed	   by	   a	   subset	   of	   cells	   within	   the	  reporter	   culture,	   we	   went	   on	   to	   investigate	   whether	   these	   cells	   were	   simply	  spontaneously	   differentiating	   following	   an	   endodermal	   lineage	   program,	   or	  whether	   all	   or	   a	   proportion	   of	   the	   cells	  were	  bona	   fide	  stem	   cells.	   Firstly,	  we	  wanted	  to	  assess	  whether	  cells	  of	  the	  S4G6	  4/F-­‐9	  and	  S4G6	  4/F-­‐9	  A3	  clones	  co-­‐expressed	  GATA6	  alongside	  characterised	  surface	  stem	  cell	  markers.	  We	  used	  a	  panel	  of	  markers	  consisting	  of	  SSEA-­‐3,	  SSEA-­‐4	  and	  TRA-­‐1-­‐81	  using	  two	  clones	  of	  the	   reporter	   line.	   As	   expected,	   both	   clones	   were	   positive	   for	   each	   stem	   cell	  marker	  tested	  and	  in	  both	  clones	  we	  found	  a	  subset	  of	  cells	  co-­‐expressing	  each	  stem	   cell	   marker	   tested	   with	   GATA6	   (Fig.	   4.4A).	   The	   percentage	   of	   co-­‐expressing	  cells	  did	  not	  appear	   to	  change	  depending	  upon	   the	  surface	  marker	  used,	  but	  there	  was	  a	  higher	  percentage	  of	  co-­‐expressing	  cells	  in	  the	  4/F-­‐9	  clone	  than	   the	   A3	   clone.	   With	   previous	   reports	   describing	   the	   interference	   of	  antibiotic	  resistance	  in	  reporter	  lines	  we	  continued	  with	  the	  A3	  clone	  that	  had	  the	   neomycin	   construct	   removed.	   We	   used	   the	   stem	   cell	   marker	   SSEA-­‐3	   for	  subsequent	  experiments	  as	  it	  has	  been	  characterised	  as	  one	  of	  the	  first	  markers	  to	   be	   lost	   upon	  differentiation,	   demonstrating	   its	   high	   specificity	   for	   the	   stem	  cell	   compartment,	   but	   also	   because	   SSEA-­‐3	   fractionated	   cells	   have	   previously	  been	   shown	   to	   exhibit	   heterogeneity	   in	  GATA6	   expression	   (Enver	   et	   al.	   2005;	  Gokhale	  et	  al.	  2015).	  	  	  Next,	   we	   stained	   the	   reporter	   line	   with	   SSEA-­‐3	   and	   ran	   large	   cell	   numbers	  through	   FACS	   analysis	   to	   identify	   distinct	   regions	   where	   potential	   stable	   cell	  populations	   existed.	   We	   found	   a	   new	   degree	   of	   heterogeneity	   within	   the	  cultures	  based	  on	  SSEA-­‐3	  and	  GATA6	  expression	  and	  through	  visual	  analysis	  of	  the	  plot	  identified	  several	  distinct,	  high-­‐density	  cell	  populations	  (Fig.	  4.4B).	  We	  found	  that	  the	  area	  with	  the	  highest	  density	  of	  cells	  was	  the	  SSEA-­‐3(+)	  GATA6(-­‐)	  fraction	  (3+6-­‐).	  We	  hypothesised	  that	  these	  cells	  were	  the	  most	  stable	  state	  for	  cells	  to	  reside	  in	  under	  self-­‐renewal	  conditions	  as	  the	  highest	  percentage	  of	  cells	  resided	   within	   this	   fraction.	   Secondly	   a	   distinct	   population	   of	   SSEA-­‐3(-­‐),	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GATA6(-­‐),	   cells	   (3-­‐6-­‐)	  existed	  which	  we	  classed	  as	  cells	   that	  had	  differentiated	  away	   from	   the	   endoderm	   lineage.	   Thirdly,	   a	   clear	   population	   of	   SSEA-­‐3(-­‐),	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4.2.4 GATA6	  is	  co-­‐expressed	  alongside	  stem	  cell	  genes	  	  	  	  Due	  to	  our	  interest	  in	  GATA6	  expression	  in	  stem	  cells,	  we	  took	  the	  3+6-­‐,	  3+6L,	  3+6H	  and	  3-­‐6+	  fractions	  forward	  for	  further	  analysis.	  We	  wanted	  to	  investigate	  whether,	  across	  the	   four	  cell	   fractions,	   there	  was	  uniformly	  high	  expression	  of	  stem	   cell	   associated	   genes,	   even	   with	   increasing	   GATA6	   expression.	   We	  performed	  qPCR	  for	  the	  core	  stem	  cell	  transcription	  factors,	  OCT4,	  NANOG	  and	  
SOX2.	  We	  found	  that	  compared	  to	  the	  3+6-­‐	  fraction,	  the	  3+6L	  fraction	  had	  very	  similar	   levels	   of	   all	   core	   transcription	   factors	   (Fig.	   4.5A).	   The	  3+6H	  and	  3-­‐6+	  fractions,	  however,	  saw	  a	  significant	  reduction	  in	  all	  genes,	  most	  notable	  within	  the	   3-­‐6+	   fraction	   (Fig.	   4.5A).	   Thus	   low	   GATA6	   expression	   did	   not	   appear	   to	  correlate	  with	   a	   reduction	   in	   stem	  cell	   gene	   expression,	   however,	   high	  GATA6	  expression	   did.	   As	   GATA6	   is	   expressed	   in	   cells	   of	   the	   morula	   and	   early	  blastocyst,	   we	   also	   looked	   at	   genes	   that	   are	   expressed	   at	   this	   stage	   of	  development	   within	   our	   GATA6	   fractions.	   Although	   the	   3+6L	   fraction	   didn’t	  show	   a	   reduction	   in	   core	   stem	   cell	   gene	   expression,	   this	   fraction	   did	   show	   a	  slight	   reduction	   in	   the	   naïve	  marker	   TFCP2L1	   (Fig.	   4.5A).	   TFCP2L1	   was	   also	  reduced	  in	  the	  3+6H	  and	  3-­‐6+	  fractions.	  Counter-­‐intuitively,	  the	  remaining	  ‘naïve’	  markers,	  KFL2,	  KFL4	  and	  TBX3	  were	  all	  upregulated	  in	  the	  3+6L	  and	  3+6H	  and	  3-­‐6+	  fractions	  (Fig.	  4.5A).	  To	  confirm	  whether	   GATA6(+)	   fractions	   represented	   more	   primed-­‐like	   cells,	   we	   then	  looked	  at	  several	  markers	  associated	  with	  early	  differentiation.	  We	   found	  that	  the	   3+6L	   and	   3+6H	   fractions	   both	   showed	   upregulation	   of	   SOX17	   and	  GATA4	  (endoderm),	  T	  and	  MIXL1	  (primitive	  streak)	  and	  GATA2	  (mesoderm).	  The	  3-­‐6+	  fraction	   also	   showed	   upregulation	   of	   SOX17,	  GATA4	   and	  GATA2,	   but	   not	  T	   or	  
MIXL1.	  Endoderm	  genes	  were	  most	  highly	  expressed	  in	  the	  GATA6(+)	  fractions.	  Thus,	   the	   3+6L	   fraction,	   although	   having	   similar	   levels	   of	   stem	   cell	   genes	  compared	  to	  the	  3+6-­‐	  fraction,	  did	  show	  an	  increase	  in	  lineage	  associated	  genes.	  The	   3+6H	   fraction	   saw	   an	   increase	   in	   lineage	   associated	   genes,	   but	   also	   a	  decrease	  of	  stem	  cell	  genes	  (Fig.	  4.5B).	  Thus,	  the	  readout	  of	  SSEA-­‐3	  and	  GATA6	  appeared	  to	   identify	  discreet,	   incremental	  stages	  of	  cells	   transitioning	  through	  early	  differentiation.	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4.2.5 Stem	  cell	  protein	  analysis	  of	  four	  fractions	  	  	  	  To	  corroborate	  our	  findings	  from	  the	  qPCR,	  we	  performed	  FACS	  analysis	  on	  the	  protein	   levels	   of	   the	   core	   stem	   cell	   transcription	   factors,	   OCT4,	   NANOG	   and	  SOX2	  within	  each	   fraction.	  We	   found	  that	  as	  GATA6	   intensity	   increased	  within	  cells,	   the	   levels	  of	  OCT4	  protein	  decreased.	  The	  OCT4	  profiles	  of	   the	  3+6-­‐	  and	  3+6L	  fractions	  were	  very	  similar,	  with	  98%	  and	  93%	  of	  cells	  expressing	  OCT4A	  protein	  respectively,	  but	  within	  the	  3+6H	  fraction,	  this	  level	  dropped	  to	  63%	  of	  the	   cells.	   This	   was	   further	   reduced	   in	   the	   3-­‐6+	   fraction	   to	   only	   12%	   of	   cells,	  consistent	   with	   the	   quantified	   mRNA	   levels	   (Fig.	   4.6A).	   We	   found	   a	   slightly	  different	   trend	   with	   the	   marker	   SOX2.	   The	   3+6-­‐	   fraction	   again	   was	   highly	  positive	  at	  95%,	  but	  the	  3+6L	  was	  significantly	  reduced	  to	  66%.	  This	  reduction	  was	   more	   apparent	   in	   the	   3+6H	   fraction	   at	   43%,	   and	   SOX2	   was	   effectively	  switched	  off	  within	  the	  3-­‐6+	  fraction	  with	  only	  8%	  positive	  cells	  (Fig.	  4.6B).	  We	  also	  analysed	  the	  3-­‐6-­‐	  fraction	  and	  found	  that	  the	  majority	  of	  cells	  (87%)	  were	  expressing	  SOX2.	  As	  well	  as	  a	  pluripotent	  stem	  cell	  marker,	  SOX2	  is	  expressed	  in	  neural	  stem	  cells	  and	  thus	  implied	  the	  3-­‐6-­‐	  fraction	  to	  be	  neural-­‐like	  cell	  types	  
(Fig.	   4.6B).	   Therefore	   it	   would	   appear	   that	   GATA6	   is	   an	   effective	   marker	   to	  efficiently	  segregate	  neural	  and	  endodermal	  destined	  cells	  in	  culture.	  Finally,	  we	  analysed	   the	   expression	   of	   NANOG.	   It	   has	   been	   reported	   that	   GATA6	   and	  NANOG	   are	   mutually	   exclusive	   and	   therefore	   we	   expected	   to	   see	   a	   similar	  downregulation	   of	   protein	   levels	   as	  GATA6	  expression	   increased.	  We	   actually	  saw	  the	  opposite	  such	  that	  NANOG	  protein	  levels	  were	  not	  downregulated	  at	  all	  until	   SSEA-­‐3	   expression	   was	   lost	   (3+6-­‐:	   95%,	   3+6L:	   95%,	   3+6H:	   98%,	   3-­‐6+:	  23%)	  (Fig.	  4.6C).	  	  In	  conclusion,	  the	  quantification	  of	  the	  protein	  levels	  of	  the	  core	  stem	  cell	  genes	  correlated	   with	   qPCR	   data,	   with	   the	   exception	   of	   NANOG,	  which	   appeared	   to	  remain	  within	  all	  fractions	  even	  when	  mRNA	  was	  reduced.	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4.2.6 Lineage	  specific	  gene	  expression	  within	  the	  four	  fractions	  	  	  	  To	   investigate	   further	   the	   gene	   expression	   profiles	   of	   each	   fraction,	  we	   ran	   a	  low-­‐density	   TLDA	   array	   for	   stem	   cell,	   early	   and	   late	   lineage	   specific	  markers.	  Hierarchical	   analysis	   indicated	   that	   gene	   expression	   within	   the	   fractions	  clustered	  strongly	  into	  two	  groups.	  Group	  A	  contained	  predominantly	  stem	  cell	  specific	  markers	  (Fig.	  4.7A);	  and	  group	  B,	  predominantly	  consisting	  of	   lineage	  associated	  markers	  (Fig.	  4.7B).	  We	  found	  that	  the	  3+6-­‐	  fraction	  predominantly	  showed	   high	   expression	   of	   group	   A	   and	   low	   expression	   of	   group	   B	   and	   that	  these	   expression	   patterns	  were	   reversed	   in	   the	   3-­‐6+	   fraction.	   This	   correlated	  with	   the	   notion	   that	   the	   3+6-­‐	   fraction	   represented	   a	   more	   pristine	   like	   cell	  population,	   and	   the	   3-­‐6+	   a	   differentiated	  population.	  Upon	   analysis	   of	   SSEA-­‐3	  and	  GATA6	   co-­‐expressing	   cells,	  we	   found	   that	   as	  GATA6	   expression	   increased,	  there	  was	   an	   increased	   loss	   of	   stem	   cell	   marker	   expression,	   coupled	  with	   an	  increased	  gain	  in	  lineage	  marker	  expression.	  The	  hierarchical	  clustering	  by	  gene	  expression	  analysis	  across	  individual	  fractions	  showed	  that	  the	  3+6-­‐	  and	  3+6L	  fractions	   clustered	   together,	   whilst	   the	   3+6H	   and	   3-­‐6+	   fractions	   clustered	  together	  (Fig.	  4.7A).	  Therefore,	  the	  3+6L	  fraction	  had	  a	  gene	  expression	  profile	  more	   similar	   to	   pristine	   stem	   cells,	   whereas	   the	   3+6H	   fraction	   has	   a	   profile	  more	  similar	  to	  differentiated	  cells.	  	  	  With	  the	  knowledge	  that	  GATA6	  is	  involved	  in	  endodermal	  specification	  during	  lineage	   segregation	   of	   the	   ICM,	   we	   next	   wanted	   to	   investigate	   whether	   the	  
GATA6(+)	  cells	  were	  also	  showing	   increased	  expression	  of	  other	   lineage	  genes	  and	  whether	  these	  genes	  were	  also	  endoderm	  associated.	  Genes	  were	  grouped	  according	  to	  their	  associated	  germ	  layers	  (endoderm,	  mesoderm	  or	  ectoderm)	  and	   each	   fraction	   was	   analysed	   for	   individual	   germ	   layer	   expression	   profiles	  (Fig.	  4.7C).	  We	  found	  that	  the	  3+6-­‐	  and	  3+6L	  fractions	  did	  not	  show	  any	  notable	  upregulation	   in	   genes	   associated	   with	   any	   one	   specific	   germ	   layer.	   However,	  within	   the	   3+6H	   population	   we	   noted	   a	   significant	   upregulation	   of	   genes	  associated	  with	  the	  endoderm	  lineage	  but	  not	  genes	  indicative	  of	  mesoderm	  and	  ectoderm.	  Similarly,	  the	  3-­‐6+	  fraction	  showed	  increased	  endoderm	  lineage	  gene	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expression.	  Ectoderm	  associated	  activity	  was	  unchanged	  across	   fractions	   (Fig.	  
4.7C).	  	  Overall,	   these	   findings	   indicate	   that	   GATA6	   appears	   to	   correlate	   with	   a	   gene	  expression	   profile	   more	   representative	   of	   a	   differentiated	   cell	   type,	   which	   is	  exemplified	  as	  GATA6	  expression	  increases.	  Nevertheless,	  stem	  cell	  genes	  were	  still	   expressed	   in	   GATA6(+)	   cell	   fractions,	   which	   would	   indicate	   that	   GATA6	  expression	  may	  not	  necessarily	  correlate	  with	  differentiation.	  Additionally,	  cells	  expressing	  GATA6	  appeared	  to	  preferentially	  upregulate	  other	  genes	  associated	  with	  the	  endoderm	  lineage	  only.	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4.2.7 Functional	  testing	  of	  GFP	  expressing	  cells	  	  	  	  Having	  established	  that	  a	  subset	  of	  cells	  in	  normal	  culture	  conditions	  exist	  that	  co-­‐express	  the	  surface	  stem	  cell	  marker	  SSEA-­‐3	  and	  the	  lineage	  marker	  GATA6,	  and	  that	  endodermal	  associated	  genes	  are	  significantly	  upregulated	  within	  the	  3+6H	   and	   3-­‐6+	   fractions,	   we	   wanted	   to	   investigate	   whether	   functional	  differences	   existed	   across	   each	   of	   the	   fractions	   in	   terms	   of	   their	   self-­‐renewal	  potential.	  We	  performed	  functional	  testing	  of	  the	  four	  cell	  fractions	  (3+6-­‐,	  3+6L,	  3+6H	   &	   3-­‐6+)	   to	   assess	   differences	   in	   self-­‐renewal	   capacities	   of	   the	   sub-­‐populations	   using	   a	   quantitative	   single	   cell	   clonogenic	   assay.	   FACS	   sorting	  obtained	   pure	   cell	   populations,	   and	   single	   cells	   were	   seeded	   at	   a	   clonogenic	  density	  of	  500	  cells/cm2	  in	  the	  presence	  of	  10	  μM	  Y-­‐27632	  for	  24h.	  After	  24h,	  media	  was	  changed	  to	  remove	  the	  inhibitor.	  Colonies	  were	  left	  to	  develop	  over	  4	  days,	  and	  resulting	  colonies	  were	  fixed	  and	  stained	  using	  OCT4	  as	  a	  marker	  for	  stem	  cells.	  If	  the	  resulting	  colonies	  contained	  at	  least	  one	  OCT4	  positive	  cell,	  we	  classed	   that	   colony	   as	   having	   originated	   from	   a	   stem	   cell.	   OCT4(+)	   colonies	  resulted	  from	  each	  of	  the	  four	  fractions,	  including	  the	  3-­‐6+,	  which	  we	  previously	  classed	   as	   a	   differentiated	   population	   (Fig.	   4.8A).	   The	   efficiency	   of	   cloning	  however	  was	  influenced	  as	  GATA6	  expression	  increased.	  The	  3+6-­‐	  fraction	  was	  the	  most	  clonogenic	  with	  a	  cloning	  efficiency	  of	  6.1%	  (±	  0.8%).	  Consistent	  with	  the	   clustering	   of	   3+6-­‐	   with	   3+6L	   from	   the	   qPCR	   analysis,	   the	   3+6L	   fraction	  cloned	   with	   a	   very	   similar	   efficiency	   of	   6.3%	   (±0.5%).	  We	   saw	   a	   statistically	  significant	   reduction	   in	   cloning	   efficiency	   of	   the	   3+6H	   fraction	   and	   the	   3-­‐6+	  fraction	  at	  2.5%	  (±0.3%)	  and	  0.2%	  (±0.07%)	  respectively	  (Fig.	  4.8B).	  In	  order	  not	   to	   rely	   solely	   on	   the	   use	   of	   OCT4	   as	   a	   stem	   cell	  marker,	  we	   repeated	   the	  clonogenic	   assays	   in	   exactly	   the	   same	   way,	   but	   this	   time	   stained	   with	   SOX2.	  Firstly,	   as	   we	   saw	   with	   OCT4,	   each	   fraction	   was	   able	   to	   generate	   SOX2(+)	  colonies	   (Fig.	   4.8A).	  We	   found	   very	   similar	   patterns	   of	   cloning	   efficiencies	   of	  our	   4	   fractions	   when	   using	   SOX2	   as	   the	   stem	   cell	   marker.	   The	   3+6-­‐	   fraction	  proved	  most	  clonogenic	  at	  7.2%	  (±2.2%),	  and	  the	  3+6L	  fraction	  cloned	  at	  6.2%	  (±0.5%).	   As	   in	   the	   case	   of	   OCT4,	   the	   cloning	   efficiency	   of	   the	   3+6H	   fraction	  dropped	   dramatically	   to	   2.2%	   (±0.1%)	   and	   the	   3-­‐6+	   cells	   remained	   the	   least	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clonogenic	   at	  0.4%	  (±0.2%),	  both	  of	  which	  were	   statistically	   significant	   to	   the	  3+6-­‐	   fraction	   (Fig.	   4.8B).	   All	   analyses	  were	   automated	   to	  prevent	   any	  bias	   in	  colony	  classification.	  	  Importantly,	   this	   assay	   showed	   that	   a	   large	  proportion	  of	   cells	   that	   expressed	  SSEA-­‐3	   together	   with	   the	   lineage	   marker	   GATA6	   at	   low	   levels,	   and	   a	   smaller	  proportion	  of	  cells	  expressing	  GATA6	  at	  high	  levels,	  were	  clonogenic	  stem	  cells	  capable	   of	   self-­‐renewal.	   The	   increasing	   expression	   of	   GATA6	   did	   alter	   the	  functional	  behaviour	  of	  the	  cells,	  as	  the	  percentage	  of	  stem	  cells	  within	  the	  3+6H	  fraction	  decreased.	  The	  loss	  of	  the	  surface	  marker	  SSEA-­‐3	  then	  correlated	  with,	  in	   the	  most	  part,	   the	   inability	   to	  self-­‐renew.	  We	  found	  that	   the	   functional	  data	  correlated	   well	   with	   the	   hierarchical	   clustering	   of	   the	   qPCR	   data	   for	   each	  fraction	  in	  that	  the	  3+6-­‐	  and	  3+6L	  behaved	  similarly,	  whilst	  the	  3+6H	  and	  3-­‐6+	  behaved	  similarly.	  	  	  We	  then	  performed	  a	  detailed	  analysis	  for	  the	  percentage	  of	  OCT4+	  cells	  within	  stem	   cell	   colonies	   derived	   from	   each	   fraction.	   We	   noticed	   the	   appearance	   of	  colonies	   that	  had	  a	  decrease	   in	   the	  overall	  percentage	  of	  OCT4+	  cells	   in	  3+6H	  and	   3-­‐6+	   fractions	   	   (Fig.	   4.8C).	   We	   quantified	   changes	   in	   the	   distribution	   of	  OCT4+	  cells	  using	  Kullback-­‐Leibler	  symmetric	  divergence.	  This	  measure	  is	   low	  for	   similar	  distributions	   and	  high	   for	  divergent	  distributions.	  As	   expected,	   the	  level	   of	   change	  was	  most	   prominent	   in	   3+6H	   and	  3-­‐6+	   fractions	   compared	   to	  3+6-­‐	  and	  3+6L	  cells	  in	  agreement	  with	  the	  reduced	  cloning	  efficiency	  levels	  (Fig.	  
4.8D).	   We	   performed	   the	   same	   analysis	   on	   colonies	   stained	   with	   SOX2	   from	  each	  of	  the	  four	  fractions,	  where	  we	  saw	  the	  same	  trend	  as	  OCT4.	  There	  was	  an	  increase	  in	  the	  number	  of	  colonies	  with	  a	  reduction	  in	  SOX2	  expressing	  cells	  in	  the	  3+6H	  and	  3-­‐6+	  compared	  to	  3+6-­‐	  and	  3+6L	  (Fig.	  4.8E).	  The	  Kullback-­‐Leiber	  symmetric	   divergence	   showed	   that	   the	  most	   distinct	   fractions	  were	   again	   the	  3+6H	   and	   3-­‐6+	   when	   compared	   to	   3+6-­‐	   and	   3+6L	   (Fig.	   4.8F),	   which	   again	  correlated	  well	  with	  decreasing	  cloning	  efficiency	  levels	  (Fig.	  4.8B).	  	  	  	  In	   conclusion,	   we	   found	   that	   the	   3+6H	   and	   3-­‐6+	   fractions	   generated	   more	  colonies	   that	   consisted	  of	   fewer	  OCT4(+)	   and	  SOX2(+)	   cells	   than	   the	  3+6-­‐	   and	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3+6L	   fractions.	   Thus,	   the	   stem	   cells	   within	   these	   fractions	   showed	   a	   higher	  propensity	  to	  differentiate.	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4.2.8 Sub-­‐Cloning	  of	  GATA6	  expressing	  cells	  	  	  	  	  Having	   demonstrated	   through	   the	   use	   of	   a	   single	   cell	   quantitative	   clonogenic	  assay	   that	   a	   proportion	   of	   GATA6	   expressing	   cells	   had	   the	   ability	   to	   produce	  colonies	   positive	   for	  OCT4	   and	  SOX2,	  we	   then	  wanted	   to	   investigate	   the	   long-­‐term	   functional	   potential	   of	   these	   cells.	   We	   wanted	   to	   ascertain	   whether	  
GATA6(+)	   hESCs	   retained	   the	   ability	   for	   efficient	   multi-­‐germ	   layer	  differentiation,	   or	   whether	   cells	   represented	   a	   more	   restricted	   cell	   type,	   and	  whether	   GATA6	   expressing	   cells	   showed	   culture	   reconstitution	   capacity.	   To	  address	   these	   points,	  we	   sub-­‐cloned	   the	   S4G6	   4/F-­‐9	  A3	   line	   from	   cells	   of	   the	  3+6-­‐,	  3+6L	  and	  3+6H	  fractions,	  using	  high	  stringency	  single	  cell	  deposition	  (Fig.	  
4.9A).	   Due	   to	   the	   very	   low	   cloning	   efficiency	   of	   3-­‐6+	   cells,	   we	   excluded	   this	  fraction	  from	  sub-­‐cloning	  experiments.	  	  Achieving	  a	  high	  sorting	  purity	  in	  this	  assay	  was	  imperative	  to	  ensure	  that	  the	  sub-­‐clones	  were	   truly	   derived	   from	   the	   said	   cell	   type	   of	   origin.	  We	   therefore	  developed	  a	  control	  assay	  to	  run	  alongside	  the	  sorting	  of	  the	  four	  hESC	  fractions	  to	  track	  any	  mis-­‐classification	  during	  the	  sorting	  procedure.	  By	  using	  CHO	  cells,	  which	  have	  a	  high	  plating	  efficiency,	  we	  were	  able	   to	  over-­‐estimate	  any	  miss-­‐classification	   that	   occurred	   during	   the	   sorting	   process,	   and	   accurately	   predict	  the	  level	  of	  error	  during	  hESC	  single	  cell	  deposition.	  CHO	  cells	  were	  transfected	  with	   either	   pCAG-­‐TOMATO	   or	   pCAG-­‐GFP	   plasmids	   so	   cells	   could	   be	   easily	  tracked.	   Clonal	   CHO	   lines	   harbouring	   the	   GFP	   or	   Tomato	   cassette	   were	   then	  sub-­‐cloned	   and	   the	   brightest	   clones	   were	   picked	   and	   maintained	   for	  experimental	  use.	  (Fig.	  4.9B).	  Single	  CHO-­‐GFP	  and	  CHO-­‐TOM	  cells	  were	  mixed	  together	   and	   then	   CHO-­‐GFP	   cells	  were	   sorted	   into	   half	   of	   a	   96-­‐well	   plate	   and	  CHO-­‐TOM	  cells	   into	   the	  second	  half	  of	   the	  plate.	  These	  cells	  were	   fixed	  3	  days	  after	  sorting	  and	  imaged.	  We	  then	  quantitated	  the	  number	  of	  colonies	  per	  well,	  and	  also	  checked	  that	  the	  correct	  CHO	  reporter	  had	  been	  sorted.	  We	  found	  that	  the	  vast	  majority	  of	  the	  wells	  contained	  single	  colonies	  with	  no	  instances	  of	  mis-­‐classification.	  One	  well	  was	   found	  to	  contain	   the	  wrong	  CHO	  cell	  giving	  a	  mis-­‐classification	  of	  0.6%	  overall.	  Doublets	  were	  also	  found	  in	  5.6%	  of	  the	  wells,	  but	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each	   colony	  was	   derived	   from	   the	   correct	   CHO	   cell	   type.	   	  We	  were	   therefore	  confident	  that	  hESC	  clones	  derived	  from	  the	  four	  fractions	  were	  truly	  from	  the	  said	  fraction.	  (Fig	  4.9C).	  	  
	  Single	  cells	  from	  the	  3+6-­‐,	  3+6L	  and	  3+6H	  subsets	  were	  sorted	  into	  single	  wells	  of	  a	  96-­‐well	  plate	  in	  several	  conditions.	  Firstly,	  we	  tried	  to	  derive	  sub-­‐clones	  on	  feeders	  and	  under	  feeder-­‐free	  conditions.	  Using	  MEFs	  and	  hESC	  media,	  we	  were	  able	  to	  derive	  sub-­‐clones	  with	  cloning	  efficiencies	  of	  15%,	  8%	  and	  2.5%	  for	  the	  3+6-­‐,	   3+6L	   and	   3+6H	   fractions	   respectively	   (Fig.	   4.10A).	  We	  were	   unable	   to	  derive	   any	   sub-­‐clones	   on	   feeder-­‐free	   conditions	   irrespective	   of	   the	   conditions	  tried	  (Fig.	  4.10B).	  The	  number	  of	  cells	  sorted	  and	  the	  resulting	  clones,	  based	  on	  colony	   morphology	   are	   quantified	   in	   Fig.	   4.10C.	   Six	   clones	   that	   had	   hESC	  colony-­‐like	  morphology	   from	  each	   fraction	  were	   randomly	  picked	  and	   carried	  forward	  for	  continued	  culture.	  Clones	  in	  continued	  culture	  showed	  typical	  hESC	  morphology	   with	   dense,	   compacted	   colonies,	   and	   individual	   cells	   showing	   a	  high	  nuclear	  to	  cytoplasmic	  ratio	  (Fig.	  4.10D).	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4.2.9 Characterisation	  of	  sub-­‐clones	  	  	  	  We	   then	   characterised	   these	   sub-­‐cloned	   lines	   to	   investigate	   whether	   they	  behaved	   in	   a	   similar	   manner	   to	   the	   unsorted	   parent	   population.	   Firstly,	   the	  expression	  of	  a	  series	  of	  stem	  cell-­‐associated	  surface	  markers	  were	  analysed	  on	  the	   sub-­‐clones	  and	  compared	   to	   the	  parental	   line.	   	  Four	  clones	   irrespective	  of	  the	  cell	  of	  origin	  expressed	  SSEA-­‐3,	  TRA-­‐1-­‐81	  and	  SSEA4,	  at	  similar	  levels	  to	  the	  unsorted	   parental	   population	   (Fig.	   4.11A).	   Subtle	   differences	   in	   the	   levels	   of	  expression	  for	  each	  marker,	  in	  particular,	  SSEA-­‐3	  were	  apparent	  between	  clones	  and	  the	  parental	  line,	  but	  were	  more	  likely	  differences	  in	  culture	  conditions	  as	  opposed	   to	   something	   more	   intrinsic	   to	   clones,	   as	   not	   all	   of	   the	   four	   clones	  analysed	  from	  the	  same	  fraction	  showed	  such	  changes	  from	  the	  parental	  line.	  	  We	  then	   looked	  at	   the	  expression	   levels	  of	  core	  stem	  cell	   transcription	   factors	  
OCT4,	  NANOG,	  SOX2	  and	  REX1	   in	  two	  clones	  from	  each	  fraction.	  We	  found	  that	  all	  clones	  irrespective	  of	  their	  cell	  of	  origin,	  expressed	  similarly	  high	  levels	  of	  all	  stem	  cell	  genes	  analysed,	  and	  looked	  similar	  to	  the	  unsorted	  parental	  line	  (Fig.	  
4.12A).	   Additionally,	   we	   analysed	   the	   levels	   of	   lineage	   specific	   genes	   to	  determine	  whether	  sub-­‐clones	  from	  GATA6(+)	  cells	  were	  showing	  higher	  rates	  of	  spontaneous	  differentiation	  than	  the	  parental	  lines.	  We	  found	  that	  all	  clones	  had	  low	  expression	  levels	  for	  genes	  indicative	  of	  each	  primary	  germ	  layer,	  and	  were	  again	  similar	  to	  the	  unsorted	  parental	  line	  (Fig.	  4.12B).	  	  	  We	   then	  wanted	   to	  ensure	   that	  our	   clones	  had	   remained	  pluripotent	  and	   that	  they	   did	   not	   represent	   a	  more	   restricted	   endodermal	   progenitor	   cell	   type.	   To	  test	   pluripotency,	   we	   made	   EBs	   from	   two	   clones	   of	   each	   fraction	   under	   a	  defined	  EB	  protocol	  (see	  chapter	  1).	  Resulting	  EBs	  were	  morphologically	  similar	  between	   all	   clones	   and	   the	   parental	   line	   and	   formed	   round,	   dense	   cellular	  aggregates	  (Fig.	  4.13A).	  Upon	  qPCR	  analysis	  EBs	  from	  the	  parental	  and	  all	  sub-­‐cloned	   lines	   from	  each	   fraction	  had	  downregulated	   stem	  cell	   associated	  genes	  
(Fig.	   4.13Bi)	   and	   had	   upregulated	   genes	   associated	  with	   both	   the	  mesoderm	  
(Fig.	  4.13Bii)	  and	  ectoderm	  lineages	  (Fig.	  4.13Biii)	  with	  high	  efficiency.	  Clonal	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lines	   from	  each	   cell	   fraction	  were	   therefore	  pluripotent	   cell	   lines,	   and	  did	  not	  represent	  endoderm	  restricted	  cell	  types.	  	  Having	   established	   that	   clonal	   lines	   could	   be	   derived	   from	  GATA6	   expressing	  cells,	  and	  that	  these	  clones	  were	  indeed	  pluripotent	  and	  resembled	  closely	  the	  parental	  line,	  we	  sought	  to	  assess	  the	  ability	  of	  SSEA-­‐3(+)	  GATA6(+)	  expressing	  cells	  to	  convert	  back	  to	  an	  SSEA-­‐3(+)	  GATA6(-­‐)	  state.	  We	  stained	  our	  clonal	  lines	  with	  SSEA-­‐3	  to	  assess	  the	  redistribution	  of	  the	  original	  heterogeneity	  within	  the	  FACS	   plots	   of	   the	   parental	   line	   before	   sub-­‐cloning.	   We	   found	   that	   clones,	  irrespective	  of	   their	   initial	  GATA6	  status,	  or	  the	  conditions	   in	  which	  they	  were	  maintained,	  were	  able	  to	  redistribute	  entirely	  the	  starting	  culture	  heterogeneity	  
(Fig.	  4.14A).	  To	  confirm	  the	  FACS	  analysis,	  we	  performed	  qPCR	  for	  the	  GATA6	  gene	   comparing	   two	   clones	   from	   each	   fraction	   directly	   after	   sorting	   with	  established	  clones	  from	  each	  fraction.	  We	  found	  negligible	  GATA6	  expression	  in	  the	  3+6-­‐	   fraction	  directly	   after	   sorting,	   but	   in	   clones	   the	   expression	  of	  GATA6	  had	   increased,	   indicating	   a	   re-­‐establishment	   of	   GATA6	   expressing	   cells	   in	  culture.	   In	   the	   3+6H	   fraction	   directly	   after	   sorting,	  GATA6	   levels	   were	   higher	  than	   in	   all	   clones	   analysed.	   Cells	   from	   this	   fraction	   had	   therefore	   inter-­‐converted	   to	   a	  GATA6(-­‐)	   state	   upon	   culture	   (Fig.	   4.14B).	   	   The	   3+6L	   fraction	  showed	   the	   same	   levels	   of	   GATA6	   directly	   after	   sorting	   and	   within	   clones.	  Analysis	  of	  GATA6	  gene	  expression	  therefore	  corroborated	  the	  re-­‐expression	  or	  reduction	  in	  GATA6	  of	  clones	  from	  each	  fraction	  within	  the	  FACS	  analysis.	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4.2.10 Discussion	  	  	  	  A	  large	  amount	  of	  published	  data	  is	  now	  convincingly	  pointing	  towards	  the	  idea	  that	   populations	   of	   hESCs	   are	   heterogeneous	   and	   are	   composed	   of	   cells	   that	  differ,	   at	   times	   quite	   drastically,	   in	   terms	   of	   their	   gene	   expression	   profiles,	  surface	   marker	   expression	   patterns	   and	   their	   response	   to	   signalling	  activation/repression.	   This	   has	   evolved	   the	   idea	   of	   the	   existence	   of	   discreet	  substates	  within	  the	  stem	  cell	  compartment	  that	  functionally	  alter	  a	  single	  cell’s	  interpretation	   of	   extrinsic	   inputs	   and	   consequently	   functional	   behaviour.	  However,	   most	   of	   the	   work	   that	   has	   been	   done	   on	   hESC	   heterogeneity	   has	  mainly	   focussed	   on	   exploring	   surface	   stem	   cell	   markers	   and	   transcription	  factors.	  Here	  we	  provide	  evidence	  that	  the	  lineage	  marker	  GATA6	  also	  shows	  a	  large	   degree	   of	   expression	   heterogeneity	   within	   hESCs	   in	   culture,	   and	   this	  heterogeneity	   proves	   to	   have	   functional	   consequences	   at	   the	   single	   cell	   level.	  We	  were	   interested	   in	   looking	  at	   the	  early	  endodermal	  marker	  GATA6,	   as	   this	  marker	   has	   previously	   shown	   to	   be	   co-­‐expressed	   at	   high	   levels	   together	  with	  the	  stem	  cell	  markers	  OCT4	  and	  NANOG	  (Gokhale	  et	  al.	  2015).	  Our	  results	  show	  that	  GATA6	  does	  appear	   to	  be	  expressed	   in	  culture	  and	   its	   co-­‐expression	  with	  SSEA-­‐3,	   typically	   within	   the	   range	   of	   5-­‐10%	   of	   the	   total	   population,	   gave	  preliminary	   evidence	   of	   functionally	   discreet	   GATA6(+)	   substates	   within	   the	  stem	  cell	  compartment.	  We	  did	  see	  that	  the	  4/F-­‐9	  clone	  had	  higher	  levels	  of	  co-­‐expressing	  cells	  than	  the	  neo-­‐excised	  clone	  (4/F-­‐9	  A3).	  Although	  the	  differences	  between	  the	  clones	  could	  have	  been	  due	  to	  slightly	  different	  culture	  conditions	  at	  the	  time	  of	  analysis,	  it	  has	  been	  shown	  that	  PGKneo	  can	  directly	  alter	  targeted	  gene	   transcription	   as	   well	   as	   closely	   associated	   genes	   within	   knock-­‐out	   or	  reporter	   lines	   (Olson	   et	   al.	   1996).	   As	   a	   precautionary	   measure,	   we	   therefore	  proceeded	  with	  the	  clone	  whereby	  PGKneo	  had	  been	  removed	  (4/F-­‐9	  A3).	  	  Firstly,	  we	  assessed	  the	  correlation	  between	  GATA6	  mRNA	  and	  GATA6	  protein	  expression.	  We	   found	   that	   there	  was	  no	   linear	   correlation	  with	  GATA6	  mRNA	  and	  GATA6	  protein	  expression,	  although	  protein	  did	  increase	  as	  GFP	  increased.	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Cells	  were	  therefore	  transcribing	  from	  the	  GATA6	  locus,	  but	  translation	  of	  these	  transcripts	  was	  low.	  	  	  We	   then	   looked	   at	   the	   gene	   expression	   profiles	   of	   SSEA-­‐3	   and	   GATA6	   co-­‐expressing	   cells.	   During	   very	   early	   mouse	   development,	   GATA6	   has	   been	  detected	  from	  the	  4-­‐8	  cell	  stage	  of	  the	  embryo	  (Plusa	  et	  al.	  2008),	  alongside	  the	  pluripotency	  marker	  NANOG,	   and	   this	   co-­‐expression	   continues	   until	   the	   early	  ICM	   where	   GATA6	   cells	   lose	   NANOG	   expression	   and	   become	   destined	   for	   a	  primitive	  endodermal	  fate	  (Koutsourakis	  et	  al.	  1999).	  A	  recent	  study	  by	  Chan	  et	  al	   reported	   conditions	   in	  which	   ‘naïve-­‐like’	   hESCs	  expressing	  GATA6	   could	  be	  stabilized	  and	  it	  was	  possible	  therefore	  that	  our	  GATA6(+)	  cells	  could	  represent	  a	  naïve	  cell	  type.	  According	  to	  our	  qPCR	  data,	  the	  3+6L	  and	  3+6H	  fractions	  did	  not	   appear	   naïve	   in	   nature,	   due	   to	   the	   downregulation	   of	   core	   stem	   cell	  associated	  genes	  and	  the	  naïve	  marker	  TFCP2L1,	  coupled	  with	  the	  upregulation	  of	  lineage	  associated	  genes.	  Although	  KLF2,	  KLF4	  and	  TBX3,	  all	  naïve	  associated	  markers,	  were	  upregulated	   in	  GATA6(+)	   fractions,	   this	   is	  probably	  attributable	  to	  the	  role	  of	  these	  transcription	  factors	  in	  early	  mesoderm	  and	  extraembryonic	  endoderm	  specification	  respectively.	  Furthermore,	  all	  of	  these	  lineages	  involve	  
GATA6	   (Chiplunkar	   et	   al.	   2013;	  Aksoy	  et	   al.	   2014;	  Teo	  et	   al.	   2011).	   SSEA-­‐3(+)	  
GATA6(+)	  cells	  therefore	  appear	  to	  represent	  primed	  cells,	  which	  are	  mediating	  the	   transition	   between	   the	   3+6-­‐	   and	   3-­‐6+	   profiles.	   This	   is	   consistent	   with	  reports	  of	  hESCs	  in	  KO/SR	  and	  MEF	  conditions	  exhibiting	  a	  functional	  hierarchy	  of	   pluripotent	   cells	   in	   culture,	  whereby	   cells	   can	   be	   fractionated	   according	   to	  their	   expression	   of	   the	   surface	   markers	   CD9	   and	   GCTM2,	   whereby	   high	  expression	  correlates	  with	  more	  pristine,	  clonogenic	  stem	  cell	  states.	  (Gokhale	  et	  al.	  2015;	  Laslett	  et	  al.	  2007).	  	  	  We	  also	  looked	  at	  the	  levels	  of	  core	  stem	  cell	  transcription	  factors	  at	  the	  protein	  level	  through	  FACS	  analysis,	  which	  further	  corroborated	  our	  qPCR	  data,	  but	  also	  provided	  supportive	  evidence	  of	  the	  importance	  of	  stem	  cell	  associated	  genes	  in	  lineage	   decision	   processes	   (Wang	   et	   al.	   2012).	   The	   seemingly	   endodermal	  nature	  of	  GATA6(+)	  cells	  correlated	  with	  the	  rapid	  reduction	   in	  the	  embryonic	  stem	   cell	   and	   neural	  marker	   SOX2	   (Pevny	   &	   Nicolis	   2010),	   whereas	   all	   these	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fractions	  retained	  equal	  levels	  of	  NANOG	  protein.	  NANOG	  has	  been	  reported	  to	  be	   involved	   in	   the	   repression	   of	   neuroectodermal	   and	   neural	   crest	  differentiation,	   thereby	   promoting	   the	   differentiation	   of	   cells	   towards	   the	  endodermal	  lineage	  (Wang	  et	  al.	  2012).	  Our	  data	  supports	  this	  concept.	  We	  did	  find	   that	  although	   the	   levels	  of	  NANOG	  mRNA	  had	  decreased	  within	   the	  3+6H	  fraction,	  the	  protein	  levels	  hadn’t.	  NANOG	  can	  be	  post-­‐translationally	  modified	  to	   increase	  the	  stability	  of	   the	  protein	  (Moretto-­‐Zita	  et	  al.	  2010),	  and	  although	  speculative,	   this	   may	   be	   a	   cellular	   mechanism	   involved	   to	   enforce	   early	  mesendoderm	  differentiation	  in	  hESCs.	  Further	  work	  is	  required	  to	  validate	  this	  hypothesis.	   Evidence	   supportive	   of	   the	   conclusion	   that	   GATA6(+)	   cells	   were	  beginning	   to	   show	   endoderm	   bias	   came	   from	   studying	   the	   expression	   of	   the	  stem	  cell	  and	  neural	  marker	  SOX2	  within	  the	  SSEA-­‐3(-­‐)GATA6(-­‐)	  fraction.	  Within	  this	   fraction,	   cells	   were	   found	   to	   have	   high	   SOX2	   expression,	   implying	   neural	  differentiation.	  GATA6	  therefore	  appears	  to	  be	  an	  efficient	  marker	  to	  dissect	  two	  opposing	  lineages	  in	  culture.	  	  	  Upon	   comparing	   gene	   expression	   changes	   the	   four	   fractions	   demonstrated	   a	  transition	  from	  a	  relatively	  pure	  stem	  cell	  state	  to	  one	  of	  a	  more	  differentiated	  state	  as	  GATA6	  expression	  increased.	  The	  overall	  changes	  in	  gene	  expression	  of	  stem	  cell	  associated	  markers,	  however,	  did	  not	  differ	  hugely	  between	   the	   four	  fractions.	   This	   could	   explain	   the	   ability	   for	   a	   proportion	   of	   cells	   from	   all	  fractions	   to	   remain	   within	   the	   stem	   cell	   compartment.	   In	   conclusion,	   these	  results	  point	  to	  the	  existence	  of	  discreet	  pluripotent	  substates	  in	  hESCs,	  which	  span	  from	  a	  more	  pristine	  stem	  cell,	  to	  a	  more	  differentiated	  cell	  type.	  	  Upon	   analysis	   of	   which	   genes	   showed	   the	   greatest	   increase	   in	   expression	  between	   GATA6(+)	   and	   GATA6(-­‐)	   hESCs,	   we	   found	   that	   only	   genes	   of	   the	  endoderm	   lineage,	   including	  SOX17,	  GATA4,	  FOXA2	   and	  AFP	  were	   significantly	  upregulated.	  Genes	  associated	  with	  mesodermal	  lineages	  were	  also	  upregulated,	  including	   CD34	   and	  NPPA,	   but	   not	   to	   the	   extent	   of	   endoderm	   genes.	   As	   cells	  transition	   through	   early	   differentiation,	   there	   is	   evidence	   that	   they	   first	   pass	  through	  a	  bipotent	  mesendodermal	  stage,	  which	  then	  segregates	  to	  form	  either	  endoderm	   or	   mesoderm	   precursors	   (Tada	   et	   al.	   2005).	   It	   is	   unsurprising	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therefore	   that	   genes	   involved	   in	   both	   these	   lineages	   were	   upregulated	   in	  
GATA6(+)	   cells,	   as	   these	  GATA6(+)	   substates	   all	   appear	   to	   relate	   to	   very	   early	  differentiation.	   Furthermore,	   GATA6	   is	   heavily	   involved	   in	   cardiac	  differentiation	   (Koutsourakis	   et	   al.	   1999),	   a	  mesodermal	   cell	   type,	   and	   so	  we	  cannot	  not	  rule	  out	  that	  at	   least	  a	  proportion	  of	   these	  cells	  are	  mesodermal	   in	  nature.	  The	  use	  of	  genes	  as	  markers	  of	  specific	  cell	  types	  is	  often	  very	  difficult,	  especially	  in	  the	  case	  of	  endoderm	  and	  mesoderm,	  as	  they	  can	  overlap.	  	  Following	  on	  from	  the	  gene	  expression	  data,	  we	  then	  went	  on	  to	  investigate	  the	  functional	   behaviour	   of	   each	   of	   the	   four	   fractions.	   We	   hypothesised	   two	  scenarios.	   Firstly,	   these	   fractions	   represent	   cells	   co-­‐expressing	   a	   stem	   cell	  marker	   and	  GATA6	   that	   have	   already	   committed	   to	   differentiate	   towards	   the	  endodermal	  lineage.	  This	  co-­‐expression	  may	  represent	  very	  early	  time	  points	  in	  commitment,	   such	   that	   cells	  have	  not	  had	   time	   to	   switch	  off	   and	   shed	  SSEA-­‐3	  from	  the	  cell	  surface.	  This	  observation	  would	  be	  indicative	  of	  a	  substate	  residing	  outside	   of	   the	   stem	   cell	   compartment	   resulting	   in	   non-­‐clonogenic	   cells.	   	   The	  second	  is	  that	  the	  co-­‐expression	  we	  see	  represents	  a	  sub-­‐state	  that	  does	  reside	  within	   the	   stem	   cell	   compartment,	   and	   these	   cells	   retain	   the	   capacity	   to	   self-­‐renew	   and	   the	   expression	   of	   GATA6	   does	   not	   necessarily	   correlate	   with	  differentiation	  commitment.	  	  We	  found	  that	  each	  of	  the	  four	  fractions	  generated	  stem	  cell	  colonies	  providing	  evidence	   for	   the	   second	   scenario	   outlined	   above.	   We	   found	   that	   functional	  changes	  were	   only	   apparent	  when	  GATA6	   expression	  was	   high,	   such	   that	   the	  3+6L	   fraction	   did	   not	   show	   significant	   differences	   in	   self-­‐renewal	   potential.	  Therefore,	   it	   would	   appear	   that	   the	   functional	   effects	   of	   GATA6	   is	   dose	  dependent	  and	  must	  be	  present	  above	  a	  certain	  expression	  threshold	  in	  order	  to	  overtly	  alter	  cell	  functional	  behaviour.	  This	  may	  be	  explained	  from	  our	  data	  on	  the	  protein	  levels	  of	  GATA6	  within	  the	  fractions.	  The	  3+6L	  fraction	  did	  not	  show	  noticeable	   expression	   of	  GATA6	  protein,	  whereas	   3+6H	  did	   begin	   to	   translate	  the	  protein.	   	  As	  GATA6	   is	  proposed	   to	  be	  one	  of	   the	   first	   transcription	   factors	  involved	  in	  endoderm	  specification	  (Schrode	  et	  al.	  2014),	  the	  absence	  of	  GATA6	  protein	   in	  the	  3+6L	  fraction	  would	  mean	  a	   lack	  of	  enforcement	  of	   the	  chain	  of	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events	  to	  induce	  this	  lineage.	  Conversely,	  the	  3+6H	  fraction	  did	  have	  detectable	  levels	   of	   GATA6	   protein	   in	   some	   cells,	   which	   would	   correlate	   in	   the	   reduced	  cloning	  efficiency.	  	  	  Upon	  further	  analysis	  of	  the	  colonies	  derived	  from	  each	  of	  the	  four	  fractions,	  we	  found	   that	   within	   the	   3+6H	   and	   3-­‐6+	   fractions	   there	   were	   an	   increased	  percentage	  of	  colonies	  containing	   fewer	  OCT4(+)	  cells	   than	  the	  3+6-­‐	  and	  3+6L	  fraction.	  This	  would	   imply	   that	   stem	  cells	  within	   the	  3+6H	  and	  3-­‐6+	   fractions	  show	  higher	  probabilities	  of	  differentiation	  than	  stem	  cells	  within	  the	  3+6-­‐	  and	  3+6L	   fractions.	   This	   supports	   the	   notion	   that	   differentiation	   is	   a	   probabilistic	  rather	  than	  a	  deterministic	  process.	  The	  probabilistic	  nature	  of	  differentiation	  is	  also	   supported	   in	   that	   the	   3-­‐6+	   fraction,	   which	   we	   assumed	   to	   consist	   of	  differentiated	  cells,	  was	  capable	  of	  producing	  stem	  cell	   colonies,	  albeit	  at	  very	  low	   levels.	  Thus	   the	  probabilities	   in	  cellular	  behaviour	  within	   this	   fraction	  are	  largely	  shifted	  towards	  differentiation,	  although	  some	  cells	  can	  self-­‐renew.	  The	  existence	  of	  clonogenic	  SSEA-­‐3(-­‐)	  cells	  has	  also	  been	  reported	  elsewhere	  (Enver	  et	  al.	  2005).	  	  	  Furthermore,	  from	  the	  clonogenic	  data,	  we	  found	  that	  although	  the	  3+6H	  and	  3-­‐6+	  fractions	  did	  have	  a	  proportion	  of	  cells	  that	  were	  capable	  of	  long-­‐term	  self-­‐renewal,	  equally	  there	  were	  cells	  that	  were	  not.	  The	  existence	  of	  clonogenic	  and	  non-­‐clonogenic	   cells	   within	   these	   fractions	   indicate	   further	   degrees	   of	  functional	  heterogeneity	  within	  the	  same	  fraction	  and	  the	  probable	  existence	  of	  further	   substates.	   This	   has	   been	   previously	   described	   in	   stem	   cells	   of	   the	  hematopoietic	   system.	   By	   sorting	   cells	   for	   Sca1lo	   and	   Sca1hi,	   erythroid	   biased	  and	  myeloid	  biased	  states	  can	  be	  captured	  respectively.	  The	  Sca1lo	  fraction	  was	  found	   to	   exhibit	   culture	   reconstitution	   capacity	   and	   also	   showed	   high	  expression	  of	  the	  erythroid	  gene	  GATA1.	  Upon	  analysis	  of	  this	  fraction	  at	  single	  cell	   level,	   it	   became	   apparent	   the	   Sca1lo	   population	   was	   heterogeneous	   for	  GATA1.	   Further	   fractionation	   of	   the	   Sca1lo	   state	   using	   CD34	   revealed	   two	  distinct	   compartments.	   Sca1lo	   CD34-­‐	   containing	   almost	   all	   the	   GATA1	   protein	  expression	  with	  no	  culture	  reconstitution	  capacity,	  and	  Sca1lo	  CD34+	  containing	  minimal	  GATA1	  protein	  and	  culture	  reconstitution	  capacity	  (Pina	  et	  al.	  2012).	  It	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is	  possible	  therefore	  that	  an	  appropriate	  third	  dimension	  within	  the	  3+6H	  and	  3-­‐6+	   fractions	   would	   allow	   for	   further	   fractionation	   of	   these	   cell	   populations	  that	  may	  led	  to	  the	  complete	  dissection	  of	  functionally	  discreet	  compartments.	  	  	  The	  quantitative	   clonogenic	   assay,	   although	  particularly	  useful	   to	  quantify	   the	  short-­‐term	   self-­‐renewal	   potential	   of	   GATA6	   expressing	   cells	  was	   restricted	   in	  that	  the	  long-­‐term	  functional	  ability	  of	  GATA6(+)	  cells	  could	  not	  be	  assessed.	  For	  this	   reason	   we	   sub-­‐cloned	   three	   fractions,	   3+6-­‐,	   3+6L,	   3+6H	   and	   maintained	  clones	   for	   analysis	   after	   several	   passages.	   The	   only	   conditions	   in	   which	   sub-­‐clones	  could	  be	  derived	  were	  KO/SR	  and	  MEF	  culture	  conditions.	  This	  indicates	  that	   either	   a	   component	   of	   KO	   serum	   or	   something	   that	   the	   MEFs	   were	  secreting	  was	   responsible	   for	   the	   survival	   of	   single	   hESCs	   that	  was	   lacking	   in	  serum	   free/MEF	   free	  conditions.	  Nevertheless,	   sub-­‐clones	  were	  obtained	   from	  the	  three	  fractions,	  in	  concordance	  with	  results	  from	  the	  quantitative	  clonogenic	  assay.	   Analyses	   of	   clones	  were	   performed	   between	   5-­‐8	   passages	   of	   the	   initial	  seeding,	  and	  we	  found	  that	  clones	  derived	  from	  GATA6	  expressing	  cells	  showed	  long-­‐term	  propagation,	  stem	  cell	  surface	  marker	  expression,	  and	  pluripotency,	  comparable	   to	   that	   of	   the	   original,	   unsorted	   parental	   line.	   As	   has	   been	  demonstrated	  in	  cells	  of	  the	  hematopoietic	  stem	  cell	  system	  as	  well	  as	  in	  mESCs	  (Chang	  et	  al.	  2008;	  Pina	  et	  al.	  2012;	  Hayashi	  et	  al.	  2008),	  these	  clonal	  lines	  also	  demonstrated	  interconversion.	  Single	  GATA6(+)	  cells	  were	  able	  to	  revert	  back	  to	  a	  GATA6(-­‐)	  state	  to	  repopulate	  each	  of	  the	  original	  fractions	  in	  culture.	  Thus,	  it	  would	   seem	   that	   single	   hESCs	   have	   the	   capacity	   to	   activate	   genes	   associated	  with	   a	   lineage	   program,	   whilst	   retaining	   a	   high	   degree	   of	   plasticity	   so	   that	  pluripotency	  is	  retained.	  Furthermore,	  the	  expression	  of	  these	  lineage	  programs	  can	  be	  reversed.	  	  	  Having	   shown	   the	   existence	   of	   GATA6(+)	   substates	   within	   the	   stem	   cell	  compartment,	   and	   that	   GATA6	   correlates	   with	   alterations	   in	   self-­‐renewal	  potential,	  the	  next	  question	  was	  whether	  the	  3+6H	  and	  3-­‐6+	  substates	  showed	  any	  lineage	  bias	  upon	  differentiation	  commitment,	  or	  whether	  cells	  were	  rather	  just	  biased	  for	  general	  non-­‐directional	  differentiation.	  We	  hypothesised	  that,	  as	  
	   130	  
GATA6	  is	  a	  marker	  of	  endoderm,	  cells	  would	  have	  a	  higher	  probability	  of	  moving	  towards	  the	  endodermal	  lineage.	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5 Chapter	  5	  	  	  5.1 Introduction	  	  	   5.1.1 Lineage	  Bias	  of	  GATA6+	  cells	  	  	  The	   mechanisms	   by	   which	   hESCs	   balance	   self-­‐renewal	   and	   differentiation	  remain	   unanswered	   questions.	   A	   growing	   body	   of	   research	   has	   convincingly	  shown	   that	   hESCs	   in	   vitro	   are	   heterogeneous	   and	   this	   heterogeneity	   has	  functional	   significance	   for	   cell	   behaviour	   (Hayashi	   et	   al.	   2008;	   Canham	   et	   al.	  2010;	   Tonge	   et	   al.	   2011).	   The	   concept	   that	   cells	   can	   express	   lineage	   specific	  markers	  that	  bias	  their	  eventual	  fate	  decisions,	  commonly	  referred	  to	  as	  lineage	  priming,	   has	   been	   well	   documented	   within	   several	   systems,	   including	   the	  haematopoietic	  stem	  cell	  system.	  One	  such	  well	  established	  model	  is	  that	  of	  the	  inhibitory	  feedback	  loop	  of	  a	  cell	  population	  based	  model	  for	  the	  transcription	  factors	   GATA1	   and	   PU.1	   involved	   in	   erythrocyte	   and	   myeloid	   specification	  respectively	   (Zhang	   et	   al.	   1999).	   Multipotency	   is	   achieved	   by	   the	   negative	  regulation	   of	   one	   lineage	   specific	   factor	   to	   another	   (GATA1	   to	   PU.1	   and	   vice	  versa)	  through	  protein-­‐protein	  and	  protein-­‐DNA	  interactions.	  The	  expression	  of	  one	  protein	   can	   therefore	  poise	   cells	   for	   lineage	   specification	  without	  actually	  losing	   multipotency	   if	   the	   other	   is	   expressed.	   Only	   when	   signalling	   cues	   are	  received,	   and	   one	   transcription	   factor	   accumulates	   do	   cells	   transition	   to	   the	  differentiated	   state	   (Zhang	   et	   al.	   1999).	   This	   concept	   of	   multilineage	   priming	  was	  subsequently	  shown	  at	  the	  single	  cell	  level	  which	  identified	  that	  transcripts	  for	  the	  genes	  globin	  and	  MPO	  (erythroid	  and	  granulocytic	  lineages	  respectively)	  as	  well	  as	  other	  key	  lineage	  regulators,	  could	  be	  expressed	  within	  the	  same	  cell.	  Thus,	   multipotent	   cells	   appeared	   to	   be	   expressing	   key	   markers	   for	   multiple	  lineages	   within	   a	   stem	   cell	   phenotype	   (Hu	   et	   al.	   1997;	   Delassus	   et	   al.	   1999).	  Functional	  evidence	  of	  lineage	  priming	  was	  then	  shown	  using	  the	  leukemic	  line	  HL60	  and	  DMSO	  induced	  neutrophil	  differentiation.	  These	  findings	  identified	  a	  
‘primed’	   state	   in	   which	   cells	   expressed	   the	   neutrophil	   marker	   CD11b,	   which	  became	   more	   sensitive	   to	   further	   differentiation	   stimuli	   without	   necessarily	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losing	   the	   stem	   cell	   phenotype.	   This	   developed	   a	   model	   in	   which	   cells	   exist	  along	  a	  path	  of	  differentiation,	  whereby	  priming	  is	  both	  closer	  to	  differentiation	  but	   also	   reversible	   away	   from	   differentiation	   such	   that	   cells	   have	   not	  necessarily	  made	  a	  permanent	   switch	   to	   the	  neutrophilic	   lineage	   (Chang	  et	  al.	  2006).	  	  Within	   the	  pluripotent	   context,	   the	   concept	  of	  biased	   states	  was	   shown	   in	   the	  embryonal	   carcinoma	   line	   NTERA2	  whereby	   pro-­‐neural	   and	   non-­‐neural	   fates	  were	  shown	  to	  exist	  at	  the	  single	  cell	  level.	  Single	  NTERA2	  cells	  were	  shown	  to	  behave	   in	   a	   non-­‐uniform	  manner	  when	   exposed	   to	   retinoic	   acid,	  where	   some	  cells	   formed	  homogeneous	  TuJ1+	  neuronal	   colonies,	   and	  others	  homogeneous	  TuJ1-­‐	   colonies.	   Retinoic	   acid	   was	   then	   delayed	   to	   allow	   one	   round	   of	   cell	  division,	  resulting	  in	  two	  cells	  each	  with	  the	  potential	  to	  reside	  within	  a	  pro	  or	  non-­‐neural	   substate.	   This	   time	   a	   proportion	   of	   NTERA2	   cells	   generated	  heterogeneous	   TuJ1(+)/TuJ1(-­‐)	   colonies	   demonstrating	   pro	   and	   non-­‐neural	  substate	  interconversion	  (Tonge	  et	  al.	  2010).	  Thus	  cells	  appeared	  to	  have	  made	  lineage	   decisions	   even	   before	   commitment,	   indicative	   of	   discreet	   functional	  interconvertible	  substates	  within	  the	  stem	  cell	  compartment.	  	  In	  concordance	  with	  the	  existence	  of	  lineage	  directing	  substates	  within	  NTERA2,	  studies	  examining	  the	  expression	  of	  lineage	  genes	  in	  mESCs	  have	  also	  pointed	  to	  the	   idea	   that	   the	  pluripotency	  of	   stem	  cells	   spans	  a	  broad	   state	   space	  divided	  into	   substates	   that	   does	   not	   simply	   represent	   cells	   with	   equal	   lineage	  probabilities.	  A	  study	  by	  Hayashi	  et	  al	   found	  that	  a	  subset	  of	  mESCs	   in	  culture	  conditions	   containing	   serum	   expressed	   the	   gene	   STELLA	   under	   self-­‐renewing	  conditions.	   STELLA	   is	   a	   germ	   cell	   specific	   marker	   expressed	   in	   the	   pre-­‐implantation	   embryo	   but	   repressed	   within	   the	   epiblast.	   Upon	   fractionation,	  
STELLA(-­‐)	   cells	   were	   shown	   to	   have	   an	   increased	   propensity	   to	   form	  differentiating	   EBs,	   enhanced	   neural	   specification,	   and	   an	   increased	   ability	   to	  form	  trophectoderm.	  STELLA(-­‐)	  cells,	  although	  found	  to	  be	  more	  permissive	  for	  differentiation	   were	   not	   necessarily	   committed	   cells	   (Hayashi	   et	   al.	   2008).	  Furthermore,	   the	  gene	  HEX,	   a	  marker	   for	  anterior	  visceral	  endoderm was	  also	  found	   to	   be	   expressed	   at	   low	   levels	   in	   mESC	   cultures	   (Canham	   et	   al.	   2010).	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HEX(+)	  cells	  showed	  a	  PrE	  like	  transcriptome,	  through	  the	  expression	  of	  GATA4,	  Dab2,	   SOX7	   and	   Hnfα,	   and	   were	   found	   to	   have	   a	   significant	   impairment	   in	  chimeric	   embryo	   contribution	   when	   compared	   to	   HEX(-­‐)	   cells.	   Furthermore,	  
HEX(+)	  cells	  upon	  chimeric	  EB	  formation	  were	  found	  to	  segregate	  to	  the	  surface	  of	   EBs	   and	   expressed	   endodermal	  markers	   such	   as	  GATA6,	  FOXA2	   and	   SOX17	  (Canham	  et	  al.	  2010).	  This	  pattern	  of	  endoderm	  formation	  is	  consistent	  with	  in	  
vitro	  cultured	  ICMs	  of	  the	  mouse	  blastocyst,	  which	  form	  a	  layer	  of	  endoderm	  on	  the	  surface	   (Cockburn	  &	  Rossant	  2010).	  Similarly	   to	  Stella	   expression,	  HEX(+)	  cells	  were	  not	  necessarily	  committed	  to	  differentiation,	  but	  showed	  directional	  lineage	  specification	  if	  they	  did	  commit.	  Lineage	  priming	  has	  also	  been	  observed	  within	  the	  hESC	  context.	  Blauwkamp	  et	  al	  demonstrated	  that	  different	  levels	  of	  Wnt	   signalling	   conferred	   distinct	   lineage-­‐specific	   differentiation	   propensities.	  Cells	  with	  low	  WNT	  activation	  showed	  an	  enhanced	  ability	  to	  differentiate	  into	  neural	   cells	   using	   a	   directed	   differentiation	   protocol,	   whereas	   cells	   with	   high	  WNT	  activation	  acquired	  primitive	  streak-­‐like	  characteristics	  and	  were	  found	  to	  rapidly	   differentiate	   into	   mesodermal	   and	   endodermal	   cells.	   Furthermore,	  stabilization	  of	  hESCs	  with	  high	  WNT	  activation	  differentiated	  into	  mesodermal	  and	   endodermal	   cells	   with	   greater	   speed	   and	   efficiency	   than	   heterogeneous	  populations	   (Blauwkamp	   et	   al.	   2012).	   Although	   this	   study	   provided	   strong	  evidence	   that	   heterogeneity	   of	   WNT	   signaling	   in	   hESCs	   did	   cause	   directed	  lineage	  bias,	  it	  was	  only	  performed	  at	  a	  population	  level.	  	  	  The	   functional	   consequences	   of	   lineage	   priming	   may	   also	   be	   pertinent	   when	  trying	   to	   explain	  why	   there	   is	   such	   disparity	   in	   the	   behaviour	   between	   hESC	  lines.	   Subtle	   differences	   in	   lineage	  marker	   expression	  between	   cell	   lines	  were	  found	   upon	   the	   characterisation	   of	   59	   established	   cell	   lines	   from	   17	   labs	  worldwide.	  The	  lines	  H14,	  H7,	  H13	  and	  H9,	  showed	  higher	  levels	  of	  endoderm	  specific	  gene	  expression,	  in	  particular	  AFP,	  than	  other	  lines	  tested	  (International	  Stem	   Cell	   Initiative	   et	   al.	   2007).	   Reports	   also	   describe	   substantial	   differences	  between	  cell	  lines	  in	  directed	  differentiation.	  For	  example,	  it	  was	  found	  that	  the	  HSF1	  line	  was	  much	  more	  efficient	  at	  producing	  functional	  forebrain	  cell	  types,	  primarily	   GABAergic	   synaptic	   networks	   than	   the	   HSF6	   line,	   which	   produced	  primarily	  glutamergic	  networks	  under	  a	  standard	  differentiation	  assay.	  The	  cell	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lines	   exhibited	   distinctly	   different	   differentiation	   potentials	   that	   led	   to	   the	  speculation	   that	   each	   cell	   line	   may	   be	   ‘pre-­‐programmed’	   for	   lineage	  specification	   (Wu	   et	   al.	   2007).	   A	   further	   study	   assessed	   the	   differentiation	  propensities	   of	   17	  HUES	   lines,	   resulting	   in	   the	   finding	   that	  HUES	   8	  was	  most	  efficient	   at	   pancreatic	   differentiation,	   and	   HUES	   3	   for	   cardiac	   differentiation.	  Gene	  expression	  differences	  after	  differentiation	  were	  often	  quite	  large	  at	  >100	  fold	   between	   cell	   lines	   directed	   to	   the	   same	   lineage.	   The	   conclusion	  here	  was	  that	   the	  disparity	  between	   lines	  was	  most	   likely	   reflective	  of	   the	   considerable	  genetic	   variation	   between	   hESC	   lines	   as	   well	   as	   variable	   epigenetic	   statuses	  (Osafune	   et	   al.	   2008).	   This	   altered	  propensity	   for	  HUES	   lines	   to	  preferentially	  differentiate	   to	  a	  specific	   lineage	  has	  also	  been	  shown	  in	  blood	  differentiation.	  HuES	   8,	   14,	   15	   and	   a	   non-­‐HuES	   line,	   H1,	   were	   more	   efficient	   at	   producing	  CD34+CD45+	   hematopoietic	   precursors	   than	   other	   lines	   tested,	   even	   using	  multiple	   differentiation	   protocols	   (Melichar	   et	   al.	   2011).	   Functional	  heterogeneity	  has	  also	  been	  observed	  at	  the	  protein	  level	  of	  hESCs.	  It	  has	  been	  reported	  that	   the	  cell	   line	  HES2,	  when	   induced	  to	  different	   to	  cardiomyocytes,	  produces	  a	  significantly	  higher	  level	  of	  ventricular-­‐like	  cells	  than	  atrial-­‐like	  and	  pacemaker-­‐like	   cells.	   In	   contrast,	   the	   H1	   line	   generated	   a	   much	   more	   even	  distribution	  of	  these	  cells	  types.	  Upon	  protein	  analysis	  of	  undifferentiated	  HES2	  and	  H1	  cells,	  it	  was	  found	  that	  HES3	  had	  higher	  levels	  of	  troponin	  and	  annexin	  II,	  both	  cardiac	  specific	  proteins	  (Moore	  et	  al.	  2008).	  These	  observations	  raise	  the	   possibility	   that	   the	   expression	   of	   certain	   cardiac	   proteins	   in	   pluripotent	  hESCs	  may	  bias	  their	  cardiogenic	  outcomes.	  	  From	   the	   existing	   reports	   detailing	   lineage	   directed	   differentiation	   in	  haemotopoetic	   stem	   cells,	   embryonal	   carcinoma	   cells,	   mESCs	   and	   hESCs,	   and	  with	  our	  data	  providing	  evidence	  that	  GATA6	  can	  be	  expressed	  in	  bona	  fide	  stem	  cells,	   we	   wanted	   to	   ascertain	   whether	   GATA6	   expression	   caused	   a	   lineage	  specific	  differentiation	  bias.	  As	  GATA6	   is	  primarily	   involved	  in	  the	  endodermal	  lineage	   during	   early	   mouse	   development,	   and	   as	   our	   data	   demonstrated	   a	  significant	  increase	  in	  other	  genes	  of	  the	  endodermal	  lineage	  but	  not	  mesoderm	  or	   ectoderm,	   we	   hypothesised	   that	   GATA6(+)	   cells,	   if	   they	   committed	   to	  differentiate,	  would	  preferentially	  choose	  the	  endodermal	  lineage.	  In	  this	  study,	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5.2 Results	  	  	   5.2.1 GATA6	  expressing	  cells	  exhibit	  endoderm	  population	  bias	  	  	  	  To	   assess	   whether	   each	   of	   the	   four	   fractions	   of	   cells	   showed	   similar	  differentiation	   propensities	   at	   the	   population	   level,	   we	   used	   FACS	   sorting	   to	  isolate	   each	   fraction	   (3+6-­‐,	   3+6L,	   3+6H	   &	   3-­‐6+)	   for	   seeding	   into	   a	   defined,	  neutral	   spin-­‐EB	   protocol	   (Ng	   et	   al.	   2008).	   Neutral	   within	   this	   context	   meant	  without	   the	   addition	   of	   exogenous	   growth	   factors	   or	   chemical	   inhibitors	   to	  direct	  differentiation.	  Cells	  were	  aggregated	  over	  a	  24h	  period	  and	  were	  left	  to	  differentiate	   for	   10	   days.	   We	   found	   differences	   in	   the	   morphology	   of	   EBs	  depending	   upon	   their	   fraction	   of	   origin	   (Fig.	   5.1A).	   EBs	  made	   from	   the	   3+6-­‐	  fraction	   showed	   a	   dense,	   compacted	   morphology	   with	   a	   degree	   of	   structural	  organisation	  consisting	  of	  a	  dense	  inner	  core,	  a	  distinct	  outer	  border	  and	  a	  less	  dense	  middle	   layer	  of	   cells	   separating	   the	   two	   (Fig.	   5.1B).	   EBs	   from	   the	  3-­‐6+	  fraction	  were	  much	  more	  cystic	  and	  showed	   less	  structural	  organisation,	   such	  that	  the	  three	  layers	  seen	  within	  the	  3+6-­‐	  EBs	  were	  not	  present	  (Fig.	  5.1B).	  The	  3+6L	  fraction	  showed	  morphology	  more	  similar	  to	  that	  of	  the	  3+6-­‐	  fraction,	  and	  the	  3+6H	  cells	  showed	  morphology	  more	  similar	  to	  that	  of	  the	  3-­‐6+	  fraction.	  	  	  We	  then	  analysed	  gene	  expression	  of	  EBs	  from	  the	  3+6-­‐,	  3+6L,	  3+6H	  and	  3-­‐6+	  fractions.	  Although	  the	  morphology	  of	   the	  3+6L	  EBs	  were	  similar	   to	  3+6-­‐	  EBs,	  when	   the	   gene	   expression	  was	   compared,	  we	   found	   an	   upregulation	   of	   genes	  associated	  with	   endoderm.	   Similarly,	  we	   found	   that	   EBs	  made	   from	   the	   3+6H	  and	  3-­‐6+	   fractions	   also	   showed	  more	  efficient	   endoderm	  differentiation	  when	  compared	   to	   3+6-­‐	   (Fig.	   5.2).	   Genes	   including	  GATA6,	   AFP,	   SOX17	   and	   FOXA2	  were	   all	   upregulated	   in	   the	   3+6L,	   3+6H	   and	   3-­‐6+	   fractions.	   Also	   upregulated,	  but	  not	  to	  the	  same	  extent	  as	  the	  endoderm	  genes	  were	  mesoderm	  genes.	  Genes	  including	  PECAM,	  KDR,	  and	  DESMIN	  were	  all	  upregulated	  in	  the	  3+6L,	  3+6H	  and	  3-­‐6+	   fractions.	   We	   also	   looked	   at	   the	   expression	   of	   ectodermally	   associated	  markers.	  The	  3+6L,	  3+6H	  and	  3-­‐6+	  EBs	  all	  showed	  downregulation	  of	  ectoderm	  associated	  markers,	  which	  was	  most	   striking	   in	   EBs	   from	   the	   3+6H	   and	   3-­‐6+	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fractions	   (Fig.	   5.2).	   EBs	   from	   the	   3+6H	   and	   3-­‐6+	   fractions	   did	   not	   show	   any	  detectable	  expression	  of	  NEUROD1,	  and	  3-­‐6+	  EBs	  also	  did	  not	  show	  detectable	  expression	   of	   SOX2	   or	   PAX6	   (Fig.	   5.2).	   We	   therefore	   concluded	   that	   under	  differentiation	  conditions,	  EBs	  from	  the	  3+6L,	  3+6H	  and	  3-­‐6+	  fractions	  showed	  a	   strong	   endoderm	  differentiation	   bias	  when	   compared	   to	   EBs	   from	   the	   3+6-­‐	  fraction.	   These	   fractions	   also	   showed	   a	   moderate	   upregulation	   of	   mesoderm	  genes.	   Conversely,	   ectoderm	   genes	   were	   strongly	   downregulated	   within	  
GATA6(+)	  fractions	  and	  this	  bias	  away	  from	  ectoderm	  appeared	  graded,	  so	  that	  increasing	  GATA6	  expression	  resulted	  in	  a	  stronger	  bias	  away	  from	  ectoderm.	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5.2.2 Stem	  cells	  of	  the	  3+6H	  fraction	  show	  single	  cell	  endoderm	  bias	  	  	  	  From	   the	   experiments	   performed	   on	   EBs,	   it	   became	   apparent	   that	   cells	  expressing	   GATA6	   did	   show	   a	   bias	   towards	   endoderm	   and	   although	   less	  pronounced	  mesoderm	   at	   the	   expense	   of	   ectoderm.	  What	  we	  were	   unable	   to	  establish	   from	  these	  experiments,	  however,	   is	  whether	   the	  differentiation	  bias	  was	  a	  result	  of	  already	  committed	  cells	  or	  was	  due	  to	  biased	  stem	  cells.	  In	  order	  to	   answer	   this	   question,	   we	   devised	   an	   assay	   in	   which	   we	   analysed	   colonies	  resulting	   from	  single	  cells	  of	   the	  3+6-­‐,	  3+6L,	  3+6H	  and	  3-­‐6+	   fractions,	   looking	  specifically	  for	  colonies	  containing	  cells	  positive	  for	  the	  stem	  cell	  marker	  OCT4,	  and	  the	  endodermal	  markers,	  SOX17	  or	  GATA4.	  These	  colonies	  would	  provide	  evidence	  that	  the	  initial	  cell	  was	  a	  stem	  cell,	   through	  the	  functional	  generation	  of	   OCT4(+)	   colonies,	   but	   would	   also	   allow	   the	   detection	   of	   spontaneous	  differentiation	  to	  the	  endoderm	  lineage.	  We	  reasoned	  that	  if	  GATA6	  expressing	  cells	  showed	  a	  higher	  percentage	  of	  OCT4(+)/SOX17(+)	  and	  OCT4(+)/GATA4(+)	  colonies,	  then	  stem	  cells	  within	  these	  fractions	  were	  endoderm	  biased.	  The	  four	  fractions	  of	  cells	  were	  FACS	  sorted	  and	  seeded	  at	  clonogenic	  density.	  Colonies	  were	   left	   to	   develop	   over	   four	   days	   and	   cells	   were	   then	   fixed	   and	   stained	   in	  OCT4/SOX17	  or	  OCT4/GATA4	  combinations.	  	  There	  were	  4	  types	  of	  colonies	  that	  resulted	  after	  staining	  in	  these	  combinations	  
(Fig.	   5.3A).	   Colonies	   either	   did	   not	   express	   OCT4	   or	   SOX17	   (Fig.	   5.3Ai),	  expressed	  either	  OCT4	  (Fig.	  5.3A.ii)	  or	  SOX17	  (Fig.	  5.3A.iii),	  or	  expressed	  both	  
(Fig.	  5.3A.iv).	  The	  percentage	  of	  each	  colony	  type	  was	  then	  quantified	  for	  each	  fraction	  (Fig.	  5.3B).	  We	  found	  that	  only	  when	  GATA6	  expression	  was	  high,	  did	  percentages	   of	   each	   colony	   type	   change	   from	   the	   3+6-­‐	   fraction.	   Firstly,	   we	  analysed	  the	  percentage	  of	  colonies	  across	  the	  four	  fractions	  showing	  OCT4(+)	  staining	   only.	   Colonies	   derived	   from	   the	   3+6L	   fraction,	   showed	   no	   noticeable	  decrease	  in	  the	  percentage	  of	  OCT4(+)	  only	  colonies	  when	  compared	  to	  the	  3+6-­‐	  fraction	  (Fig.	  5.3B.i).	  This	  is	  consistent	  with	  our	  previous	  clonogenic	  data	  that	  the	  3+6L	  fraction	  clones	  as	  efficiently	  as	  the	  3+6-­‐	  fraction.	  Within	  the	  3+6H	  and	  3-­‐6+	  fractions,	  there	  was	  a	  decrease	  in	  the	  percentage	  of	  colonies	  that	  contained	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OCT4(+)	  cells	  only	  (Fig.	  5.3B.i).	  Again	  this	  correlates	  with	  previous	  clonogenic	  data	  that	  high	  GATA6	  expression	  resulted	  in	  a	  lower	  cloning	  efficiency.	   Next,	  we	  analysed	  colonies	  with	  SOX17(+)	  staining	  only.	  We	  saw	  very	  little	  change	  in	  the	  percentages	   of	   OCT4(-­‐)	   SOX17(+)	   colonies	   from	   the	   3+6L	   fraction	   when	  compared	  to	  the	  3+6-­‐	  fraction,	  but	  the	  percentage	  of	  these	  colonies	  did	  increase	  within	  the	  3+6H	  fraction	  and	  more	  so	  in	  3-­‐6+	  fraction	  when	  compared	  to	  3+6-­‐.	  This	   implied	   a	   higher	   rate	   of	   endoderm	   differentiation	  within	   these	   fractions	  
(Fig.	   5.3B.i).	  Thirdly,	  we	  analysed	  colonies,	  which	  did	  not	  contain	  OCT4(+)	  or	  SOX17(+)	  cells.	  In	  this	  instance,	  we	  found	  no	  real	  differences	  between	  the	  3+6-­‐,	  3+6L	   or	   3+6H	   fractions,	   however	   this	   colony	   type	   did	   increase	   in	   the	   3-­‐6+	  fractions.	   Finally	   we	   found	   that	   OCT4(+)	   SOX17(+)	   colonies	   only	   increased	  within	   the	   3+6H	   and	   3-­‐6+	   fractions	   when	   compared	   to	   the	   3+6-­‐.	   The	   3+6H	  fraction	  consistently	   showed	  statistically	   significant	  higher	  percentages	  of	   this	  colony	  type	  for	  all	  biological	  replicates	  (Fig.	  5.3C.i).	  The	  replacement	  of	  SOX17	  with	   GATA4	   as	   a	   marker	   of	   endoderm	   also	   showed	   the	   same	   pattern	   of	  percentage	  colony	  types	  within	  each	  fraction,	  although	  one	  biological	  repeat	  did	  not	   show	   statistical	   significance	   (Fig.	   5.3B.ii,	   Fig.	   5.3C.ii).	   This	   demonstrates	  that	   the	   3+6H	   fraction,	   specifically,	   consists	   of	   the	   largest	   percentage	   of	  endoderm	  biased	  stem	  cells	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5.2.3 3+6H	  and	  3-­‐6+	  fractions	  generate	  more	  colonies	  with	  a	  higher	  percentage	  of	  SOX17(+)	  and	  GATA4(+)	  cells	  	  	  	  	  We	  then	  performed	  a	  detailed	  analysis	  of	   the	  distribution	  of	  SOX17(+)	  cells	   in	  OCT4(+)/SOX17(+)	   colonies	   by	   histogram	   counts	   (Fig.	   5.4A).	   By	   quantitating	  the	   changes	   in	   the	   shape	   of	   the	   frequency	   distribution	   graphs	   using	   the	  Kullback-­‐Leibler	   measure,	   we	   noted	   that	   although	   overall	   values	   were	   low	  implying	   subtle	   changes,	   differences	   were	   evident	   between	   fractions	   (Fig.	  
5.4B).	   The	   trend	   in	   divergence	   was	   most	   apparent	   in	   the	   3+6H	   and	   3-­‐6+	  fractions	   when	   compared	   to	   the	   3+6-­‐	   fraction.	   This	   indicated	   that	   a	   higher	  percentage	  of	  cells	  per	  stem	  cell	  colony	  within	  the	  3+6H	  and	  3-­‐6+	  fractions	  were	  SOX17	   positive.	   Similarly,	   we	   noted	   a	   similar	   trend	   when	   analysing	   the	  distributions	   of	   OCT4(+)/GATA4(+)	   colonies	   (Fig.	   5.4C).	   In	   the	   context	   of	  GATA4	   bias,	   the	   Kullback-­‐Leibler	  measure	   indicated	   that	   the	  most	   prominent	  differences	  occurred	  again	  in	  colonies	  arising	  from	  the	  3+6H	  and	  3-­‐6+	  fractions	  when	   compared	   to	   3+6-­‐	   (Fig.	   5.4D).	   For	   both	   SOX17	   and	   GATA4,	   the	   3+6L	  fraction	   resembled	  3+6-­‐,	   consistent	  with	   the	   finding	   that	   these	   fractions	  were	  functionally	  similar.	  	  	  In	   conclusion,	   the	   3+6L	   fraction	   under	   self-­‐renewal	   conditions	   did	   not	   show	  functionally	   different	   behaviour	   in	   terms	   of	   self-­‐renewal	   capacity	   or	  differentiation	   bias	   from	   the	   3+6-­‐	   fraction.	   In	   contrast,	   the	   3+6H	   and	   3-­‐6+	  fractions	  did	  show	  a	  decrease	  in	  self-­‐renewal	  potential	  coupled	  with	  an	  increase	  in	   endoderm	   differentiation.	   Most	   interestingly,	   the	   3+6H	   and	   3-­‐6+	   fractions	  also	   showed	   an	   increase	   in	   endoderm	   differentiation	   bias	   within	   stem	   cell	  colonies.	  This	  was	  most	  apparent	  within	  the	  3+6H	  fraction.	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5.2.4 Identification	  of	  signalling	  pathways	  that	  induce	  GATA6	  expression	  	  	  	  From	  single	  cell	   clonogenic	  data	  we	   found	   that	  a	  proportion	  of	   stem	  cells	   that	  were	   expressing	   GATA6	   at	   high	   levels	   had	   a	   differentiation	   bias	   towards	   the	  endodermal	  lineage.	  The	  actual	  percentage	  of	  stem	  cells	  in	  the	  3+6H	  fraction	  in	  culture	  however	  is	  relatively	  low	  at	  around	  5%	  of	  the	  total	  population,	  and	  the	  percentage	   of	   biased	   stem	   cells	   within	   this	   fraction	   is	   even	   smaller.	   We	  therefore	   wanted	   to	   understand	   the	   mechanism	   through	   which	   these	   cells	  appear	  in	  routine	  culture,	  to	  develop	  strategies	  in	  order	  to	  enrich	  and	  stabilise	  these	  biased	  stem	  cells.	  We	  set	  up	  a	  screen	  using	  chemical	   inhibitors	  targeting	  various	  pathways	  active	   in	  hESC,	   to	  ascertain	  which	  signalling	  pathways	  were	  important	  in	  the	  expression	  of	  GATA6	  (Fig.	  5.5A).	  The	  screen	  was	  performed	  in	  fully	  defined	  conditions	  (Vitronectin	  &	  E8)	  on	  single	  cells	  to	  eliminate	  unknown	  parameters	   present	   in	   KO/SR	   and	   MEF	   conditions,	   or	   matrigel	   cultures.	    We	  screened	  each	   inhibitor	  at	   two	  concentrations	  (1	  μM	  &	  2	  μM)	   for	   two	  days	  on	  SSEA-­‐3(+)	   sorted	   cells	   and	   performed	   FACS	   analysis	   for	   the	   induction	   of	   GFP	  against	  the	  untreated	  control	  sample.	  Firstly,	  we	  noticed	  that	  the	  expression	  of	  
GATA6	   was	   reduced,	   and	   almost	   lost	   in	   feeder	   free	   conditions	   before	   the	  addition	   of	   any	   inhibitors	   (Fig.	   5.5B).	   After	   screening,	   we	   found	   that	   the	  induction	  of	  WNT,	  inhibition	  of	  MEK/ERK	  and	  inhibition	  of	  BMP	  pathways	  were	  effective	  at	   inducing	  GATA6	  expression	  (Fig.	   5.5C).	  Firstly,	  CT	  99021,	  a	  GSK3β	  inhibitor,	  caused	  a	  large	  increase	  at	  43%	  of	  GATA6	  expressing	  cells.	  The	  effect	  of	  CT	   99021	   was	   dose	   dependent,	   as	   lower	   concentrations	   resulted	   in	   fewer	  
GATA6(+)	   cells	   (Fig.	   5.5D).	   Secondly,	   PD	   0325901,	   a	   MEK/ERK	   inhibitor,	  induced	  40%	  of	  cells	  to	  express	  GATA6	  (Fig.	  5.5D).	  PD	  0325901	  did	  not	  seem	  to	  function	  in	  a	  dose	  dependent	  manner,	  at	   least	  at	  the	  concentrations	  we	  tested.	  Finally,	  Dorsomorphin	  also	  induced	  GATA6	  and	  similarly	  to	  CT	  99021	  appeared	  dose	  dependent	  (Fig.	  5.5D).	  In	  order	  to	  validate	  these	  results,	  we	  again	  treated	  SSEA-­‐3(+)	   sorted	   cells	   with	   CT	   99021,	   PD	   0325901	   and	   Dorsomorphin	   at	  optimal	   concentrations	   (2	   μM,	   0.5	   μM	   and	   2	   μM	   respectively)	   and	   analysed	  
GATA6	   induction	   using	   flow	   cytometry	   (Fig.	   5.6A).	   Both	   CT	   99021	   and	   PD	  0325901	   showed	   robust	   induction	   of	   GATA6	   expressing	   cells,	   whereas	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Dorsomorphin	   did	   not	   (Fig.	   5.6B).	   In	   both	   repeats	   of	   the	   validation	   assay,	  Dorsomorphin	   failed	   to	   induce	  GATA6	  above	   control	   levels	   and	  was	   therefore	  treated	   as	   a	   false	   positive	   and	   eliminated	   from	   further	   study	   (Fig.	   5.6B).	   The	  loss	   of	   SSEA-­‐3(+)/GATA6(+)	   expression	   in	   fully	   defined	   conditions	   then	  prompted	  the	  question	  of	  the	  mechanism	  behind	  how	  these	  cells	  arise	  in	  KO/SR	  and	  MEF	  conditions.	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5.2.5 WNT	  signalling	  induces	  SSEA-­‐3(+)	  GATA6(+)	  fractions	  in	  defined	  conditions	  	  	  	  To	  better	  understand	  the	  mechanism	  of	  how	  the	  four	  fractions	  are	  generated	  in	  KO/SR	   &	   MEF	   conditions,	   we	   assessed	   whether	   the	   addition	   of	   the	   GATA6	  inducing	  inhibitors	  identified	  previously	  (CT	  99021	  for	  WNT	  activation	  and	  PD	  0325901	   for	  MEK/ERK	   inhibition)	   could	   recapitulate	   each	   fraction	   in	   defined	  conditions.	  Furthermore,	   as	  we	  have	  previously	   shown	   that	   the	  3+6H	   fraction	  specifically	   exhibited	   differentiation	   bias,	   we	   wanted	   to	   assess	   whether	   CT	  99021	  and/or	  PD	  0325901	  could	  induce	  this	  particular	  fraction.	  We	  performed	  FACS	   analysis	   of	  GATA6	   against	   SSEA-­‐3,	   and	   found	   that	   cells	   exposed	   for	   two	  days	   to	   CT	   99021	   generated	   each	   of	   the	   four	   fractions	   originally	   identified	   in	  KO/SR	  and	  MEF	  culture	  (3+6-­‐,	  3+6L,	  3+6H	  &	  3-­‐6+),	  and	  efficiently	  induced	  the	  3+6H	  fraction	  (Fig.	  5.7A).	  We	  also	  confirmed	  that	  GATA6	  induction	  through	  CT	  99021	  was	  dose	  dependent,	  and	  that	   the	  optimum	  concentration	  was	  2	  μM	  as	  found	  within	  the	  initial	  screen	  (Fig.	  5.7B).	  PD	  0325901	  also	  induced	  GATA6	  as	  expected,	   but	   did	   not	   recapitulate	   feeder	   conditions.	   The	   addition	   of	   this	  inhibitor	  only	  induced	  the	  3+6L	  fraction	  but	  not	  the	  3+6H	  fraction,	  irrespective	  of	  the	  concentration	  used	  (Fig.	  5.7C).	  	  	  We	  then	  performed	  qPCR	  analysis	  to	  investigate	  the	  gene	  expression	  profiles	  of	  cells	   that	   had	   been	   treated	   with	   CT	   99021	   or	   PD	   0325901,	   and	   whether	   the	  expression	  profiles	  matched	  with	   the	   fractions	   from	  KO/SR	  &	  MEF	  conditions.	  Firstly,	   cells	   treated	   with	   CT	   99021	   showed	   a	   downregulation	   in	   stem	   cell	  associated	  genes	  which	  became	  more	  apparent	  with	   increasing	  concentrations	  
(Fig.	   5.8A.i).	    This	  was	   coupled	  with	   a	   strong	   upregulation	   in	   endoderm	   and	  primitive	  streak	  associated	  genes	  such	  as	  SOX17,	  GATA4,	  FOXA2,	  BRACHYURY	  &	  
MIXL1,	  as	  was	  seen	  in	  the	  fractions	  from	  KO/SR	  &	  MEF	  conditions	  (Fig.	  5.8A.ii	  
&	   Fig.	   5.8A.iii).	   This	   upregulation	  was	   apparent	   for	   all	   concentrations	   tested,	  however,	   we	   noticed	   that	   at	   higher	   concentrations	   of	   CT	   99021,	   SOX17	   and	  FOXA2	   were	   not	   expressed	   at	   levels	   higher	   than	   the	   control	   sample	   (Fig.	  
5.8A.ii).	   In	   concordance	   with	   the	   upregulation	   of	   genes	   associated	   with	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endoderm	   and	   the	   primitive	   streak,	   the	   expression	   of	   genes	   indicative	   of	  ectoderm,	   PAX6	   and	   SOX2	   were	   downregulated	   at	   all	   concentrations.	  Conversely,	  SOX1	  expression	  showed	  no	  change	  between	  CT	  99021	  treated	  and	  non-­‐treated	  cells	  (Fig.	   5.8A.iv).	  Thus,	  CT	  99021,	   in	  a	  dose	  dependent	  manner,	  induced	   GATA6	   expression	   and	   directed	   cells	   to	   an	   endodermal	   /	   primitive	  streak	  like	  fate.	  Furthermore,	  CT	  99021	  exposure	  induced	  the	  4	  fractions	  (3+6-­‐,	  3+6L,	  3+6H	  &	  3-­‐6+),	  which	  are	  ordinarily	   lost	   in	  defined	  conditions,	  similar	  to	  that	  of	  KO/SR	  &	  MEF	  culture.	  	  	  Cells	   that	   had	   been	   exposed	   to	   PD	   0325901	   showed	   a	   different	   lineage	   gene	  expression	  profile	   to	   that	  of	  CT	  99021.	  Similarly	   to	  CT	  99021	   treatment,	   stem	  cell	   associated	   genes	   were	   downregulated.	   The	   endoderm	   genes	   GATA6	   and	  
GATA4	  were	  upregulated	  but	  other,	  markers	  of	  endoderm	  (SOX17,	  FOXA2)	  and	  primitive	   streak	   (MIXL1)	  were	   not	   (Fig.	   5.8B.i).	  T	   expression	   did	   not	   show	   a	  change	  between	   treated	  and	  untreated	   cells	  (Fig.	   5.8B.ii	   &	   Fig.	   5.8B.iii).	   The	  definitive	   endoderm	  marker	  SOX17	  was	  undetected	   at	   all	   concentrations	   (Fig.	  
5.8B.ii),	   but	   the	  ectodermal	  marker	  PAX6	  was	   increased	   in	  all	   concentrations.	  This	  trend	  was	  not	  apparent	  for	  other	  ectodermal	  markers	  including	  SOX1	  and	  
SOX2	  (Fig.	   5.8B.iv).	   Thus,	  PD	  0325901	  appeared	   to	   induce	  differentiation	  but	  cells	   were	   directed	   to	   an	   alternative	   lineage	   when	   compared	   to	   CT	   99021	  treatment,	   which	   did	   not	   seem	   to	   correlate	   with	   endoderm	   differentiation.	  Furthermore,	  GATA6	   was	   not	   highly	   induced	   by	   PD	   0325901	   and	   did	   not	   re-­‐establish	  the	  four	  fractions	  in	  defined	  conditions.	  	  	  In	   conclusion,	  WNT	  activation	   through	   the	  GSK3β	   inhibitor	   efficiently	   induced	  
GATA6	   expression	   and	   generated	   the	   four	   cell	   fractions	   identified	   in	  KO/SR	  &	  MEF	   culture	   that	   were	   otherwise	   missing	   in	   defined	   culture.	   WNT	   signalling	  therefore	  appears	  to	  play,	  at	  least	  in	  part,	  a	  role	  in	  the	  generation	  of	  GATA6(+)	  cells	  in	  culture.	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5.2.6 Functional	  characterisation	  of	  CT	  99021	  induced	  GATA6(+)	  cells	  	  	  To	   examine	   whether	   CT	   99021	   induced	   GATA6(+)	   cells	   were	   functionally	  equivalent	  to	  GATA6(+)	  cells	  in	  KO/SR	  &	  MEF	  culture,	  we	  performed	  functional	  assays	  on	  cells	  pre-­‐treated	  with	  2	  μM	  of	  CT	  99021	  for	  two	  days.	  Consistent	  with	  previous	  findings,	  we	  were	  able	  to	  generate	  the	  four	  cell	  fractions	  similar	  to	  the	  KO/SR	  &	  MEF	  conditions	  (Fig.	  5.9A),	  which	  we	  went	  on	  to	  FACS	  sort.	  To	  assess	  the	  self-­‐renewing	  potential	  of	  each	  fraction,	  single	  cells	  were	  sorted	  and	  seeded	  at	   clonogenic	  density	   of	   500	   cells/cm2	   and	   colonies	  were	   left	   to	  develop	   for	  4	  days.	  Colonies	  were	  fixed	  and	  stained	  for	  OCT4	  or	  SOX2.	  	  	  Firstly,	  we	  found	  that	  each	  fraction	  (3+6-­‐,	  3+6L,	  3+6H	  &	  3-­‐6+)	  on	  vitronectin/E8	  treated	  with	  2	  μM	  CT	  99021	   for	  2	  days,	  similarly	   to	  KO/SR	  &	  MEF	  conditions,	  generated	  both	  OCT4	  and	  SOX2	  positive	  stem	  cell	  colonies	  (Fig.	   5.9B),	  but	  we	  found	   that	   the	   cloning	   efficiencies	   between	   fractions	   were	   different.	   Most	  notably,	  the	  3+6L	  fraction	  cloned	  at	  a	  significantly	  lower	  efficiency	  than	  the	  3+6-­‐	  fraction,	  which	  was	  not	  observed	  between	  the	  two	  fractions	  on	  KO/SR	  &	  MEFs	  
(Fig.	   5.9B).	  The	  3+6H	  fraction	  had	  a	  further	  reduction	  in	  cloning	  efficiency,	  as	  did	   the	   3-­‐6+	   fraction	   when	   compared	   to	   3+6-­‐	   (Fig.	   5.9B).	   Although	   the	  reduction	   in	   cloning	   efficiency	   of	   the	   3+6H	   and	   3-­‐6+	   fractions	  was	   consistent	  with	  what	  we	  observed	  on	  KO/SR	  &	  MEF	  conditions	  when	  compared	   to	  3+6-­‐,	  the	   reduced	   cloning	   efficiency	   in	   this	   case	   was	   more	   dramatic.	   Thus,	   when	  comparing	   the	   CT	   99021	   treated	   and	   KO/SR	   &	  MEF	   conditions,	   all	  GATA6(+)	  fractions	   had	   a	   reduction	   in	   cloning	   efficiency,	   implying	   a	   higher	   rate	   of	  differentiation	  and/or	  cell	  death	  from	  CT	  99021	  treatment.	  	  	  Upon	  analysis	  of	  each	  fraction	  with	  respect	  to	  single	  cell	  differentiation	  bias,	  we	  found	  that	  the	  3+6L	  fraction	  in	  the	  CT	  99021	  pre-­‐treated	  cells	  as	  opposed	  to	  the	  3+6H	   fraction	   in	   KO/SR	   &	   MEF	   conditions	   showed	   greatest	   endodermal	   bias	  
(Fig.	  5.9C).	  Additionally,	  we	  saw	  a	  relatively	  high	  percentage	  of	  colonies	  within	  the	  3+6-­‐	  fraction	  that	  were	  double	  positive	  for	  OCT4	  and	  SOX17,	  which	  was	  not	  observed	   in	   KO/SR	   &	   MEF	   conditions	   to	   the	   same	   extent.	   The	   majority	   of	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colonies	   from	   the	   3+6H	   fraction	   contained	   only	   SOX17+	   cells	   and	   likely	  represent	  endoderm	  commitment	  within	  this	  fraction.	  Curiously,	  the	  same	  was	  not	   true	  when	  using	  GATA4	   as	   the	  endodermal	  marker	  (Fig.	   5.9C.ii).	  With	  CT	  99021	   pre-­‐treatment,	   almost	   no	   colonies	   showed	   co-­‐staining	   of	   OCT4	   and	  
GATA4	  in	  any	  fraction,	  even	  though	  there	  were	  colonies	  containing	  GATA4	  only.	  	  Having	  identified	  and	  characterised	  the	  existence	  of	  a	  GATA6(+)	  substate	  within	  the	   stem	   cell	   compartment,	   that	   biases	   cells	   to	   the	   endoderm	   lineage	   in	   both	  KO/SR	  /	  MEF	  and	  in	  fully	  defined	  conditions,	  and	  with	  some	  knowledge	  of	  the	  mechanism	  through	  which	  these	  biased	  stem	  cells	  arise,	  we	  sought	   to	  develop	  culture	  conditions	  in	  which	  these	  cells	  could	  be	  stabilised	  and	  propagated.	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5.2.7 Development	  of	  media	  conditions	  to	  stabilise	  the	  GATA6(+),	  endodermally	  biased	  substate	  	  	   5.2.7.1 Prolonged	  CT	  99021	  exposure	  results	  in	  hESC	  differentiation	  	  	  	  As	  CT	  99021	  was	  effective	  at	   inducing	  GATA6	   expression,	  we	  wanted	  assess	   if	  the	   exposure	   of	   the	   inhibitor	   could	   propagate	  GATA6(+)	   stem	   cells	   long-­‐term.	  We	   therefore	   cultured	   cells	   in	   the	   presence	   1	   μM,	   2	   μM	   and	   5	   μM	   of	   the	  inhibitor.	  After	  five	  days	  exposure,	  cells	  under	  each	  concentration	  tested	  had	  a	  very	   different	   morphology	   to	   untreated	   cells.	   Cells	   had	   lost	   the	   compacted	  colony	  morphology	   and	   had	   proliferated	   to	   form	   larger	   and	   longer	   cells	   (Fig.	  
5.10A).	   FACS	  analysis	   showed	   that	   cells	   exposed	   to	  high	  concentrations	  of	  CT	  99021	  had	   almost	   completely	   lost	   the	   expression	   of	   SSEA-­‐3	   as	  well	   as	  GATA6	  
(Fig.	   5.10B).	  Cells	  at	  1	  μM	  had	  distinct	  differentiated	  SSEA-­‐3(-­‐)	  GATA6(+)	  but	  also	   had	   a	   population	   of	   SSEA-­‐3(+)	   GATA6(-­‐)	   cells,	   which	   had	   resisted	  differentiation	  even	  upon	  CT	  99021	  exposure	  (Fig.	  5.10B).	  Prolonged	  exposure	  to	  CT	  99021	  therefore	  appeared	  to	  induce	  complete	  differentiation	  at	  2	  μM	  and	  above	  and	  was	  unable	  to	  stabilise	  the	  3+6H	  fraction	  in	  the	  long-­‐term.	  At	  1	  μM,	  remaining	  stem	  cells	  were	  not	  GATA6(+).	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5.2.7.2 GATA6	  expressing	  hESCs	  are	  not	  stable	  in	  culture	  	  	  	  The	  inability	  for	  a	  single	  inhibitor	  of	  GSK3β	  to	  both	  induce	  GATA6	  and	  hold	  cells	  within	   the	   stem	   cell	   compartment	   then	   led	   to	   the	   idea	   that	   a	   combination	   of	  inhibitors	   may	   be	   required	   to	   block	   CT	   99021	   induced	   hESC	   differentiation.	  Upon	  cross	  comparison	  of	  the	  inhibitors	  identified	  within	  our	  screen	  to	  induce	  
GATA6,	   we	   found	   that	   both	   CT	   99021	   and	   PD	   0325901	   were	   integral	  components	  of	   all	  media	   conditions	   in	  which	   ‘naïve’	   hESCs	  had	  been	  derived.	  (Gafni	   et	   al.	   2013;	   Ware	   et	   al.	   2014;	   Valamehr	   et	   al.	   2014;	   Theunissen	   et	   al.	  2014).	  Strikingly,	  one	  particular	  set	  of	  conditions	  reported	  the	  derivation	  of	  pre-­‐implantation	  epiblast	  like	  hESCs	  that	  expressed	  GATA6	  (Chan	  et	  al.	  2013).	  This	  medium	   used	   mTeSR1	   as	   the	   base	   with	   the	   addition	   of	   BIO,	   PD	   0325901,	  Dorsomorphin	  and	  rhLIF,	  and	  was	  called	  3iL	  (3	  inhibitors	  +	  LIF).	  The	  targeted	  pathways	   in	   3iL	   were	   also	   the	   pathways	   that	   were	   found	   to	   induce	   GATA6	  expression	   in	   our	   initial	   inhibitor	   screen.	   We	   therefore	   exposed	   our	   GATA6	  reporter	   line	   to	   3iL	   to	   ascertain	   whether	   these	   conditions	   could	   stabilise	   the	  
GATA6(+)	   endodermally	   biased	   substate.	   Although	   the	   SSEA-­‐3(+)/GATA6(+)	  fraction	  was	  induced	  after	  one	  passage,	  cells	  began	  to	  lose	  SSEA-­‐3	  over	  the	  next	  three	   passages.	   GATA6	   expression	   did	   remain	   throughout,	   but	   after	   four	  passages,	   cells	   were	   difficult	   to	   maintain	   and	   had	   lost	   entirely	   their	   hESC	  morphology	  (Fig.	  5.11).	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5.2.7.3 Off-­‐target	  effect	  of	  chemical	  inhibitors	  results	  in	  hESC	  differentiation	  	  	  	  By	  cross-­‐referencing	  both	  BIO	  and	  Dorsomorphin	  with	  the	  MRC	  Kinase	  Screen	  database	  we	  found	  that	  both	  these	  inhibitors	  strongly	  inhibit	  kinases	  that	  were	  classed	  as	  off	  target	  effects.	  We	  hypothesised	  that	  the	  inability	  to	  stabilise	  stem	  cells	  in	  these	  conditions	  were	  due	  to	  the	  off-­‐target	  effects,	  therefore	  we	  titrated	  each	  inhibitor	  as	  well	  as	  LIF	  in	  an	  attempt	  to	  stabilise	  hESCs.	  	  Upon	   titrating	  BIO	  and	  Dorsomorphin	  as	  well	   as	   rhLIF	   (Fig.	   5.12A),	  we	  were	  still	  unable	  to	  maintain	  the	  SSEA-­‐3(+)/GATA6(+)	  cell	  phenotype	  for	  more	  than	  two	  passages.	   Cells	   rapidly	   lost	   the	   expression	  of	   SSEA3,	   and	  were	  difficult	   to	  maintain	  in	  culture	  due	  to	  differentiation	  (Fig.	  5.12B).	  We	  therefore	  used	  more	  specific	  inhibitors	  to	  GSK3β	  and	  inhibitors	  to	  BMP	  signalling	  that	  did	  not	  show	  the	  extensive	  off-­‐target	  effects	  of	  BIO	  and	  Dorsomorphin.	  We	  termed	  this	  new	  media	   formulation	   ‘3iL	   Sheffield’	   (2	   μM	   CT	   99021,	   1	   µM	   PD	   0325901,	   2	   µM	  DMH-­‐1	  &	  10	  ng/mL	  rhLIF).	  Under	  these	  conditions,	  we	  were	  able	  to	  successfully	  propagate	  hESCs	  that	  retained	  normal	  hESC	  morphology	  similar	  to	  the	  parental	  line	   (Fig.	   5.13A),	  which	   remained	  SSEA-­‐3(+)	  over	   a	  prolonged	  period	  of	   time	  
(Fig.	  5.13B).	  Cells	  under	  these	  modified	  3iL	  conditions	  were	  passaged	  up	  to	  10	  passages	  with	   no	   apparent	   loss	   of	   hESC	  morphology	   or	   the	   stem	   cell	  marker	  SSEA-­‐3	  (Fig.	   5.13B).	  All	  media	  conditions	   for	   the	  derivation	  of	  naive-­‐like	  cells	  thus	   far,	  with	   the	   exception	  of	   a	   report	   by	  Takashima	   et	   al	   require	   feeders	   in	  order	  to	  stabilise	  hESCs	  within	  the	  naïve	  state.	  Using	  our	  new	  3iL	  conditions	  we	  wanted	   to	   assess	  whether	  hESCs	   could	  be	   stabilised	   in	   feeder	   free	   conditions.	  Similarly	  to	  previous	  reports,	  however,	  we	  were	  not	  able	  to	  maintain	  SSEA-­‐3(+)	  hESCs	   in	   feeder	   free	   conditions	   in	   our	   improved	   3iL	   media.	   Morphologically,	  cells	  began	  differentiating	  after	  the	  first	  passage	  (Fig.	  5.13C)	  and	  FACS	  analysis	  demonstrated	  the	  loss	  of	  SSEA-­‐3	  (Fig.	  5.13D).	  	  	  We	  then	  assessed	  whether	  the	  3iL	  Sheffield	  conditions	  were	  inducing	  GATA6	  in	  hESCs.	   In	   contrast	   to	   the	   published	   3iL	   conditions,	   the	   optimised	   3iL	   Shef	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conditions	  did	  not	  lead	  to	  the	  upregulation	  in	  expression	  of	  GATA6	  at	  levels	  any	  higher	  than	  in	  KO/SR	  &	  MEF	  culture	  conditions	  (Fig.	  5.13B).	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5.2.7.4 Further	  optimisation	  could	  not	  yield	  GATA6	  expressing	  hESCs	  	  	  	  To	  investigate	  whether	  the	  induction	  of	  GATA6	  was	  due	  to	  an	  off-­‐target	  effect	  of	  inhibitors	   used	   in	   the	   original	   3iL	   formulation,	   we	   identified	   several	   key	  pathways	  involved	  in	  hESC	  specification	  and	  self-­‐renewal	  which	  were	  also	  being	  targeted	  by	  the	  action	  of	  BIO	  and	  Dorsomorphin,	  but	  not	  by	  CT	  99021	  or	  DMH-­‐1.	  Protein	  kinase	  C	  (PKC),	  FGF,	  VEGF,	  Src	  and	  PDK1	  were	  all	  strongly	  inhibited	  by	   BIO	   and/or	   Dorsomorphin	   and	   all	   have	   roles	   in	   hESC	   self-­‐renewal	   and	  specification	   (Fig.	   5.14A).	   Several	   pathways	   other	   than	   those	   listed	   are	   also	  involved	   in	  hESC	   self-­‐renewal	  or	   specification	  but	   specific	   inhibitors	  were	  not	  commercially	   available.	   Inhibitors	   to	   each	   pathway	   were	   then	   added	   to	   the	  optimised	   3iL	   Sheffield,	   generating	  what	   we	   called	   7iL	   (3iL	   +	   Go	   6893	   -­‐	   PKC	  inhibitor;	   Su	   5402	   -­‐	   FGF	   7	   VEGF	   inhibitor;	  WH-­‐4-­‐023	   -­‐	   Src	   inhibitor	   and	  GSK	  2334470	   -­‐	   PDK1	   inhibitor).	   Cells	   were	   exposed	   to	   the	   new	   7iL	   media	  formulation	  to	  assess	  hESC	  propagation	  and	  GATA6	  expression.	  Cells	  exposed	  to	  the	   new	   7iL	   conditions	   did	   propagate	   well	   initially,	   and	   did	   retain	   hESC	   like	  morphology	   (Fig.	   5.14B).	   Cells	  were	  maintained	  over	   four	  passages,	   but	   over	  time	  cells	  did	  begin	  to	  lose	  SSEA-­‐3	  expression	  (Fig.	  5.14C).	  Although	  cells	  in	  7iL	  could	   be	   maintained	   for	   up	   to	   four	   passages,	   the	   level	   of	   GATA6	   was	   not	  upregulated	  at	  any	  point	  under	   these	  conditions,	  and	   therefore	   these	   targeted	  pathways,	  at	  least	  in	  combination,	  did	  not	  promote	  GATA6	  expression.	  We	  were	  therefore	  unable	  to	  stabilise	  cells	  residing	  within	  the	  3+6H	  substate.	  	  In	  conclusion,	  we	  were	  able	  to	  demonstrate	  that	  high	  GATA6	  expression	  leads	  to	  endoderm	  biased	  stem	  cells,	  and	  that	  WNT	  signalling	   is	   likely	  to	  be,	  at	   least	   in	  part,	  responsible	  for	  the	  appearance	  of	  these	  cells	  in	  culture.	  We	  unfortunately	  were	  unable	  to	  stabilise	  GATA6	  expression	  hESCs.	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5.3 Discussion	  	  	  	  Following	   on	   from	   our	   data	   demonstrating	   the	   existence	   of	   stem	   cells	   that	  express	  the	  early	  endodermal	  marker	  GATA6,	  we	  wanted	  to	  investigate	  whether	  these	  cells	   showed	  directed	  differentiation	  bias.	  Firstly,	  we	   investigated	  at	   the	  population	   level	  whether	  GATA6	  conferred	  a	   lineage	  bias	  under	  differentiation	  conditions.	   Using	   a	   defined,	   neutral	   EB	   system,	   we	   demonstrated	   that	   cell	  fractions	  expressing	  GATA6	  at	  both	   low	  and	  high	   levels	  showed	  differentiation	  bias	  towards	  predominantly	  the	  endoderm,	  but	  also	  the	  mesoderm	  lineages	  at	  the	   expense	  of	   ectoderm	  when	   compared	   to	   the	  GATA6	   negative	   fraction.	  The	  morphology	  of	  EBs	  from	  the	  3+6H	  and	  3-­‐6+	  fractions	  resembled	  that	  of	  ‘cystic	  EBs’	  originally	  classified	   in	  EC	  cell	  derived	  EBs	  that	  contained	  a	  wide	  range	  of	  endodermal	   cell	   types	   (Itskovitz-­‐Eldor	   et	   al.	   2000).	   Consistent	   with	   previous	  reports	  that	  GATA6	  is	  a	  key	  regulator	  and	  is	  fundamental	  in	  the	  specification	  of	  endoderm	  lineages	  (Koutsourakis	  et	  al.	  1999;	  Fujikura	  et	  al.	  2002;	  Morrisey	  et	  al.	   1996;	   Morrisey	   et	   al.	   1998)	   we	   found	   within	   our	   assay	   that	   GATA6	   also	  appeared	  to	  be	  a	  positive	  and	  sensitive	  readout	  for	  lineage	  specification,	  as	  even	  at	   low	   expression	   levels,	   was	   able	   to	   identify	   cells	   with	   an	   endodermal	   fate.	  Although	   the	   strongest	   upregulation	   was	   in	   genes	   for	   the	   endodermal	   germ	  layer,	  we	  did	  find	  that	  mesoderm	  associated	  genes	  were	  also	  upregulated	  within	  EBs	  derived	  from	  the	  GATA6	  positive	  fractions.	  GATA6	  is	  implicated	  specifically	  in	  the	  endoderm	  lineage	  during	  the	  segregation	  of	  the	  ICM	  and	  extra-­‐embryonic	  lineages	   in	   the	  mouse	   blastocyst,	   but	   it	   is	   possible	   that	   a	   small	   proportion	   of	  SSEA-­‐3(+)	  GATA6(+)	  cells	  are	  representative	  of	  mesodermal	  lineages	  as	  GATA6	  is	   also	   expressed	   in	   cells	   of	   the	   lateral	   plate	   mesoderm	   which	   gives	   rise	   to	  structures	  such	  as	  the	  cardiac	  tract	  (Koutsourakis	  et	  al.	  1999).	  Additionally,	  as	  we	  have	  shown,	  inter-­‐converting,	  pluripotent	  stem	  cells	  do	  exist	  within	  all	  of	  the	  
GATA6(+)	   fractions	   (3+6-­‐,	   3+6L,	   3+6H,	   3-­‐6+)	   and	   these	   stem	   cells	   may	   be	  accountable	  for	  the	  appearance	  of	  the	  multi-­‐lineage	  differentiation	  in	  the	  3+6L	  and	   3+6H	   fraction.	   The	   random	   nature	   of	   EB	   differentiation	   would	   be	  permissive	  for	  the	  appearance	  of	  the	  three	  primary	  germ	  layers	  (Itskovitz-­‐Eldor	  et	  al.	  2000).	  The	  step-­‐wise	  decrease	  in	  ectoderm	  specification	  within	  the	  3+6H	  
	   168	  
and	   3-­‐6+	   fractions	  would	   also	   correlate	  with	   the	   reduction	   of	   the	   pluripotent	  stem	  cell	  pool	  capable	  of	  inter-­‐converting	  and	  specifying	  neural	  lineages,	  which	  are	   generally	   not	   associated	   with	   GATA6	   at	   this	   stage	   of	   development.	   The	  population	  differentiation,	  however,	  was	  not	   informative	  as	   to	  whether	  biased	  stem	   cells,	   or	   a	   population	   of	   differentiated	   cells	   was	   responsible	   for	   the	  observed	  bias.	  	  	  We	   therefore	   devised	   an	   assay	   in	   which	   the	   self-­‐renewal	   potential	   and	  differentiation	  bias	  could	  be	  assessed	  at	  single	  cell	  level.	  This	  assay	  allowed	  us	  to	   analyse	   OCT4	   positive	   stem	   cell	   colonies	   positive	   for	   the	   appearance	   of	  endoderm	   differentiation	   using	   SOX17	   and	   GATA4.	   We	   classified	   a	   colony	   as	  being	  OCT4	  and	  SOX17	  or	  GATA4	  positive	   if	   that	   colony	  had	  at	   least	  1	  OCT4+	  cell,	  and	  at	  least	  10%	  SOX17	  or	  GATA4	  positive	  cells.	  We	  chose	  10%	  for	  SOX17	  and	   GATA4	   as	   the	   culture	   conditions	   that	   cells	   were	   seeded	   into	   (KO/SR	   &	  MEFs)	  can	  be	  inductive	  for	  mesendoderm	  differentiation	  due	  to	  the	  secretion	  of	  WNT	   protein	   by	   MEFs	   (Hao	   et	   al.	   2006).	   We	   therefore	   wanted	   to	   try	   and	  eliminate	   colonies	   that	  were	   showing	   stochastic	   differentiation	   as	   opposed	   to	  actual	  stem	  cell	  bias.	   Increasing	   the	  percentage	  past	  10%	  resulted	   in	  very	   few	  colonies	   being	   double	   positive,	   which	   implies	   the	   effect	   of	   the	   differentiation	  bias	  observed	  within	  stem	  cells	  is	  subtle.	  	  By	  quantifying	  the	  percentage	  of	  these	  colonies	  within	  each	  of	  the	  cell	  fractions	  (3+6-­‐,	   3+6L,	   3+6H	   &	   3-­‐6+),	   we	   found	   that	   the	   3+6H	   fraction	   consisted	   of	  significantly	   more	   stem	   cell	   colonies	   with	   SOX17	   or	   GATA4	   positive	   cells,	  indicative	  of	  a	  higher	  percentage	  of	  stem	  cells	  possessing	  endoderm	  bias	  within	  this	  fraction.	  Although	  SOX17	  and	  GATA4	  have	  been	  implicated	  in	  lineages	  from	  an	  non-­‐endodermal	  origin	  at	   later	  stages	  of	  development,	   in	  particular	  cardiac	  cells	  (Masino	  et	  al.	  2004;	  Martin	  et	  al.	  2004),	  published	  reports	  strongly	  link	  the	  expression	  of	  SOX17	  and	  GATA4	  during	  the	  first	  differentiation	  events	  of	  hESCs	  into	  endodermal	  lineages	  (D'Amour	  et	  al.	  2005;	  Wang	  et	  al.	  2011;	  Fujikura	  et	  al.	  2002).	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Although	  the	  3+6L	  fraction	  at	  population	  level	  under	  differentiation	  conditions	  did	   show	   differentiation	   bias,	   under	   self-­‐renewing	   conditions,	   this	   bias	   was	  eradicated.	  Thus,	   there	  would	  appear	   to	  be	  discreet	  substates	  within	   the	  stem	  cell	   compartment	   that	   represent	   different	   functional	   behaviours	   in	   individual	  cells,	  which	  are	  context	  dependent	  and	  characterise	  different	  stages	  of	   lineage	  bias.	  Within	   the	  GATA6	   scenario,	   cells	   that	  express	  GATA6	   at	   low	   levels	  would	  represent	  a	  state	   in	  which	  cells	  become	  more	  sensitive	   to	  differentiation	  cues,	  when	  compared	  to	  GATA6	  negative	  cells.	  This	  functionally	  manifests	  as	  lineage	  biased	   differentiation	   within	   the	   EB	   context.	   In	   the	   presence	   of	   self-­‐renewal	  conditions	   and	   the	   absence	   of	   differentiation	   cues,	   however,	   this	   substate	  retains	   functional	   equivalence	   to	   GATA6	   negative	   cells	   with	   respect	   to	   self-­‐renewal	  potential.	  GATA6	  at	  high	   levels	  represents	  a	  second	  substate	   in	  which	  cells	  also	  show	  a	  heightened	  sensitivity	  to	  differentiate,	  but	  under	  self-­‐renewing	  conditions,	   retains	   differentiation	   bias,	   even	   within	   stem	   cell	   colonies.	   The	  observation	  of	  multiple	  stages	  of	  cell	  bias	  would	  confirm	  our	  previous	  data	  that	  differentiation	   commitment	   is	   not	   a	   deterministic,	   but	   is	   a	   probabilistic	   event	  that	  is	  context	  dependent.	  	  	  We	   have	   therefore	   shown	   that	   high	   GATA6	   expression	   shifts	   self-­‐renewal	   vs.	  differentiation	  probabilities	  in	  such	  a	  way	  as	  to	  favour	  not	  only	  differentiation,	  but	   also	   lineage	   specific	   as	   opposed	   to	   stochastic	   differentiation,	   in	   this	   case,	  towards	   endoderm.	  3+6-­‐,	   3+6L,	   3+6H	  and	  3-­‐6+	   therefore	   appear	   to	   represent	  incremental	   stages	   along	   the	   self-­‐renewal	   versus	   differentiation	   pathway,	  whereby	  endodermal	  differentiation	   is	   the	  most	  probable	  route.	  Although	  few,	  the	  appearance	  of	  colonies	  within	  all	  of	  the	  SSEA-­‐3(+)	  fractions	  containing	  cells	  that	   did	   not	   have	   either	   OCT4,	   SOX17	   or	   GATA4	   staining	   may	   represent	  differentiation	  to	  a	   lineage	  other	  than	  endoderm.	  This	  proves	  important	   in	  the	  context	  of	  lineage	  bias	  versus	  lineage	  priming.	  Lineage	  bias	  implies	  that	  cells	  are	  capable	  of	  choosing	  lineage	  fates	  other	  than	  endoderm,	  although	  the	  probability	  they	   do	   choose	   endoderm	   is	   highly	   favoured.	   Lineage	   priming	   would	   imply	  more	   that	   cells	   are	   moving	   solely	   towards	   an	   endodermal	   trajectory	   without	  necessarily	  committing	  at	  the	  expense	  of	  other	  lineages.	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To	  better	  understand	  the	  mechanism	  through	  which	  biased	  cells	  arise	  in	  KO/SR	  &	  MEF	  culture,	  we	  performed	  a	  screen	  in	  fully	  defined	  conditions	  on	  inhibitors	  to	   several	   pathways	   known	   to	   impinge	   on	   hESC	   behaviour	   (Chan	   et	   al.	   2013;	  Gafni	  et	  al.	  2013;	  Takashima	  et	  al.	  2013;	  Theunissen	  et	  al.	  2014).	  The	  action	  of	  CT	  99021,	  an	  inhibitor	  of	  GSK3β	  which	  activates	  canonical	  WNT	  signalling,	  was	  capable	  of	  activating	  the	  expression	  of	  GATA6	  and	  recapitulating	  the	  4	  fractions	  seen	   in	   KO/SR	   &	   MEF	   conditions.	   qPCR	   analysis	   demonstrated	   that	   the	  treatment	  of	  cells	  with	  CT	  99021	  pushed	  cells	  to	  a	  mesendodermal	  like	  cell	  type	  through	   upregulation	   of	   endoderm	   and	  mesoderm	   and	   the	   downregulation	   of	  ectoderm	   specific	   genes,	   consistent	   with	   the	   role	   of	   WNT	   signalling	   during	  development	   (Bakre	   et	   al.	   2007;	   Sumi	   et	   al.	   2008;	   Aubert	   et	   al.	   2002).	  Importantly,	  this	  lineage	  gene	  expression	  profile	  was	  similar	  to	  the	  fractions	  in	  KO/SR	  &	  MEF	  conditions.	  Although	  the	  exact	  role	  of	  WNT	  signalling	  in	  hESCs	  is	  still	  in	  dispute	  (Sato	  et	  al.	  2004;	  Davidson	  et	  al.	  2012)	  WNT	  signalling	  does	  have	  roles	   during	   gastrulation	   by	   setting	   up	   the	   primitive	   streak,	   directing	   axis	  formation	  and	  subsequently	  giving	  rise	  to	  migrating	  mesoderm	  and	  embryonic	  endoderm,	   both	   of	   which	   involve	   GATA6	   (Liu	   et	   al.	   1999;	   Tam	   &	   Behringer	  1997;	   Huggon	   et	   al.	   1997;	   Zhao	   et	   al.	   2005).	   It	   has	   been	   shown	   that	   mouse	  embryonic	   fibroblasts	   (MEFs)	  secrete	  detectable	   levels	  of	  many	  WNT	  proteins	  including	  WNT3a	   (Hao	   et	   al.	   2006),	   which	  may	   in	   part	   explain	   the	   origins	   of	  
GATA6(+)	  stem	  cells	  in	  KO/SR	  &	  MEF	  conditions.	  We	  did	  find	  that	  the	  functional	  behaviour	  of	  GATA6(+)	  cells	  from	  KO/SR	  &	  MEF	  compared	  to	  CT	  99021	  treated	  cells	  was	  different,	  in	  that	  GATA6(+)	  fractions	  from	  CT	  99021	  treated	  cells	  were	  less	   clonogenic	   than	   the	  equivalent	   fractions	   in	  KO/SR	  &	  MEF	  conditions.	  The	  substantial	   downregulation	   of	   stem	   cell	   associated	   genes	   after	   short-­‐term	   CT	  99021	  exposure,	  that	  is	  not	  apparent	  in	  KO/SR	  &	  MEF	  culture,	  would	  indicate	  a	  significantly	   higher	   level	   of	   WNT	   signalling	   by	   CT	   99021	   addition,	   impairing	  self-­‐renewal.	  This	  data	  also	   implies	  that	  the	   levels	  of	  GATA6	  expression	  do	  not	  necessarily	  correlate	  with	  differentiation,	  as	  similar	  levels	  of	  GATA6	  expression	  between	   CT	   99021	   treated	   and	   cells	   in	   KO/SR	   &	   MEF	   ultimately	   results	   in	  different	  functional	  outcomes.	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Having	  established	  that	  cells	  of	   the	  3+6H	  fraction	   in	  KO/SR	  &	  MEF	  conditions,	  and	  3+6-­‐/3+6L	  in	  CT	  99021	  treated	  cells	  show	  fate	  bias	  at	  the	  single	  cell	  level,	  it	  became	  apparent	  that	  if	  these	  cells	  could	  be	  stabilised	  and	  propagated	  as	  biased	  stem	   cells,	   it	   may	   provide	   a	   platform	   for	   better	   controlled,	   more	   uniform	  endodermal	  differentiation.	  To	  better	  understand	  the	  mechanism	  and	  signalling	  behind	  the	  GATA6	  biased	  substate	  we	  attempted	  to	  trap	  cells	  within	  the	  SSEA-­‐
3(+)	  /	  GATA6(+)	  fraction.	  Work	  by	  Ying	  et	  al	  demonstrated	  that	  the	  capacity	  for	  self-­‐renewal	  and	  the	  retention	  of	  pluripotency	  of	  ground	  state	  mESCs	   involves	  the	   prevention	   of	   cells	   leaving	   that	   state,	   rather	   than	   the	   active	   process	   of	  maintaining	  it	  (Ying	  et	  al.	  2008).	  We	  therefore	  postulated	  that	  GATA6(+)	  hESCs	  could	  be	  stabilised	  not	  simply	  through	  the	  active	  process	  of	  inducing	  GATA6,	  but	  by	   also	   blocking	   differentiation	   pathways.	   This	   idea	   became	   feasible	   after	   the	  publication	   of	   conditions	   known	   as	   3iL	   (3	   inhibitors	   +	   LIF),	   which	   also	  contained	   the	   WNT	   activator	   BIO	   and	   which	   gave	   rise	   to	   GATA6	   expressing	  hESCs	   (Chan	   et	   al.	   2013).	  We	  were	   unable,	   however,	   to	   repeat	   these	   findings	  with	  our	  reporter	   line	  as	  3iL	  conditions	  rapidly	  resulted	   in	  differentiation.	  We	  did	   find	   that	   through	   the	   formulation	   of	   an	   optimised	   medium	   using	   more	  specific	  inhibitors,	  we	  could	  stabilise	  hESCs.	  We	  found	  that	  the	  off-­‐target	  effects	  of	   inhibitors	   originally	   used	   by	   Chan	   et	   al	   were	   potentially	   responsible	   for	  differentiation	   as	   replacement	   of	   BIO	  with	   CT	   99021	   and	  Dorsomorphin	  with	  DMH-­‐1,	  which	  show	  much	  less	  off-­‐target	  effects,	  stabilised	  long-­‐term	  hESC	  self-­‐renewal.	   Off-­‐target	   pathways	   including	   IGF-­‐1R,	   FGF-­‐R1	   and	   PDK1	   (to	   a	   lesser	  extent)	  are	  know	  to	  be	  heavily	  involved	  in	  self-­‐renewal,	  thus	  the	  destabilisation	  of	   self-­‐renewal	   is	   not	   surprising	   upon	   their	   inhibition	   (Bendall	   et	   al.	   2007;	  Burdon	  et	  al.	  2002).	  	  	  Even	   though	   we	   were	   able	   to	   stabilise	   pluripotent	   stem	   cells	   using	   a	  combination	   of	   more	   specific	   inhibitors	   to	   the	   same	   pathways	   identified	   by	  Chan	  et	  al,	  we	  did	  not	  see	  the	  induction	  of	  GATA6	  expression	  within	  these	  cells,	  as	   we	   saw	   using	   the	   original	   3iL	   conditions.	   Again	   we	   hypothesised	   that	   off-­‐target	   effects	   of	   inhibitors	   used	   within	   the	   original	   3iL	   conditions	   were	  responsible	   for	   GATA6	   activation	   either	   directly	   or	   indirectly.	   Other	   existing	  media	  formulations	  that	  use	  CT	  99021	  for	  WNT	  activation	  in	  combination	  with	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other	   pathway	   inhibitors	   for	   the	   propagation	   of	   hESCs	   have	   not	   reported	   the	  elevated	  expression	  of	  GATA6.	  (Takashima	  et	  al.	  2014;	  Gafni	  et	  al.	  2013;	  Ware	  et	  al.	  2014).	  This	   indicates	   that	   the	  use	  of	  BIO	  as	  opposed	   to	  CT	  99021	   for	  WNT	  activation	  may	   play	   a	   part	   in	  GATA6	   induction,	   and	   that	   it	   is	   likely	   not	  WNT	  signalling	  alone,	  at	  least	  within	  this	  context,	  which	  is	  responsible.	  Further	  work	  is	  required	  to	  dissect	  specific	  pathways	  that	  relate	  to	  GATA6	  expression	  within	  the	  3iL	  context.	  	  In	  conclusion,	  we	  have	  shown	  that	  GATA6(+)	  cells	  in	  KO/SR	  &	  MEF	  culture	  show	  a	   heightened	   sensitivity	   to	   differentiate	   and	   exhibit	   endoderm	   bias	   at	   the	  population	  level	  under	  differentiation	  conditions.	  We	  found	  that	  it	  is	  specifically	  the	   high	   expression	   of	   GATA6	   in	   KO/SR	   &	   MEF	   conditions	   that	   results	   in	  endoderm	   biased	   stem	   cells	   under	   self-­‐renewing	   conditions.	   Care	   should	  therefore	  be	  taken	  when	  describing	  hESCs	  as	  being	  ‘primed’	  or	  ‘biased’	  as	  our	  data	  shows	  that	   lineage	  gene	  expression	   levels	  are	   important	   in	  the	   functional	  translation	  of	  a	  cell,	  whereby,	  at	  least	  in	  the	  case	  of	  GATA6	  within	  our	  cell	  line,	  low	   expression	   levels	   do	   not	   translate	   to	   behavioural	   alterations	   in	   self-­‐renewing	  conditions.	  	  Although	   we	   were	   not	   able	   to	   stabilise	   the	   3+6H	   state	   in	   culture,	   our	   work	  provides	  evidence	  that	  one	  or	  more	  off-­‐target	  effect	  of	  the	  GSK3β	  inhibitor	  BIO	  may	   result	   in	   GATA6	   expression.	   The	   ability	   to	   assign	   particular	   signalling	  pathways	  with	  a	  molecular	  phenotype	   in	  a	  particular	  context	   is	  currently	  very	  difficult	  due	  to	  the	  nature	  of	  off-­‐target	  effects	  of	  chemical	  inhibitors	  (Karaman	  et	  al.	  2008).	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6 Final	  Discussion	  	  	  6.1 Development	  of	  a	  defined,	  reproducible	  differentiation	  assay	  	  	  	  Our	   results	   demonstrate	   that	   by	   controlling	   the	   input	   cell	   number	   and	   the	  quality	  of	  the	  starting	  population	  of	  hESCs,	  highly	  reproducible	  differentiation	  of	  pooled	   EBs	   can	   be	   achieved.	   The	   use	   of	   EBs	   to	   better	   mimic	   embryonic	  development	  and	  for	  the	  generation	  of	  cell	   types	  of	   interest	  have	  been	  gaining	  substantial	   interest,	   and	   substantial	   progress	   has	   been	   made	   (Ungrin	   et	   al.	  2008;	   Ng	   2005).	   We	   wanted	   to	   build	   upon	   existing	   knowledge	   to	   develop	   a	  reproducible	   differentiation	   assay	   that	   could	   be	   efficiently	   manipulated	   and	  controlled	  through	  the	  use	  of	  exogenous	  cues.	  The	  reproducibility	  of	  this	  assay	  subsequently	   led	   to	   its	   use	   as	   a	  model	   for	   predictive	   reproductive	   toxicology.	  Although	  we	  only	  used	  a	  small	  panel	  of	  genes	  to	  assess	  drug	  induced	  differential	  gene	  expression,	  we	  demonstrated	  that	  the	  controlled	  differentiation	  of	  EBs	  did	  lead	   to	   a	   high	   success	   rate	   in	   the	   identification	   of	   known	   teratogens	   in	  concordance	   with	   existing	   data.	   The	   reproducibility	   and	   the	   high-­‐throughput	  format	   of	   this	   assay	   has	   the	   potential	   to	   accurately	   screen	   for	   the	   on-­‐going	  generation	   of	   thousands	   of	   new	   compounds	   by	   academia	   and	   industry.	   As	  therapeutics	   progress,	   however,	   it	   is	   emerging	   that	   personalised	   medicine	   is	  becoming	   a	   new	   requirement	   for	   healthcare,	   as	   it	   is	   very	  much	   apparent	   that	  individual	   patients	   respond	   differently	   to	   drugs.	   Within	   this	   assay,	   we	   use	   a	  single	  hESC	  line,	  H9,	  which	  almost	  certainly	  is	  not	  representative	  of	  the	  genetic	  make-­‐up	   of	   the	   general	   population.	   A	   more	   powerful	   approach	   to	   this	   assay	  would	  be	  to	  incorporate	  induced	  pluripotent	  stem	  cell	  (iPS)	  technology	  so	  that	  the	   genetic,	   and	   epigenetic	  make-­‐up	   of	   individual	   patients	   is	   reflected	   (Rubin	  2008;	   Davila	   et	   al.	   2004).	   The	   incorporation	   of	   iPS	   technology	   in	   predictive	  toxicology	  would	  also	  allow	  for	  a	  high-­‐throughput	  approach	  to	  fully	  understand	  the	   mechanisms	   behind	   drug	   induced	   toxicity,	   which	   could	   aid	   in	   the	  development	  of	  both	  general	  and	  personalised	  medicine.	  Furthermore,	   the	  use	  of	   iPS	   technology	   would	   allow	   for	   detailed	   modelling	   and	   subsequently,	   a	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thorough	   understanding	   of	   the	   mechanistic	   cause	   for	   disease	   (Allison	   et	   al.	  2015).	   A	   more	   systematic	   approach	   could	   then	   be	   applied	   to	   the	   drug	  development	  process.	  
	  
6.2 Differentiation	  of	  hESCs	  is	  heterogeneous	  	  	  	  During	   the	   development	   of	   the	   differentiation	   assay,	   we	   noticed	   that	   single	  embryoid	  bodies,	   even	  under	  uniform	  differentiation	  conditions,	  did	  not	   show	  exactly	   the	   same	   morphologies,	   and	   showed	   differential	   gene	   expression	  patterns.	  Even	  though	  this	  assay	  was	  designed	  to	  eliminate,	  as	  much	  as	  possible,	  random	   differentiation,	   it	   is	   possible	   that	   the	   discrepancy	   between	   EB	  differentiation	   was	   due	   to	   further	   uncontrolled	   parameters	   during	   the	  formation	  process,	  for	  example,	  the	  lack	  of	  spatial	  restriction,	  previously	  shown	  to	  be	  beneficial	  in	  differentiation	  reproducibility	  (Ungrin	  et	  al.	  2008).	  We	  found	  that	  the	  spatial	  organisation	  of	  EB	  formation,	  although	  important,	  was	  unlikely	  to	  be	  the	  only	  parameter	  in	  the	  hindrance	  of	  reproducibility	  as	  by	  purifying	  the	  quality	  of	  the	  starting	  population	  of	  hESCs	  using	  SSEA-­‐3,	  we	  were	  able	  to	  reduce	  gene	  expression	  variability,	   thereby	   improving	  reproducibility.	  This	   raised	   the	  possibility	   that	   the	   heterogeneity	   in	   differentiation	   of	   hESCs	   may	   be	   more	  inherent	   to	   the	   properties	   of	   individual	   stem	   cells,	   and	   the	   dynamics	   of	   the	  pluripotent	  stem	  cell	  compartment.	  Supportive	  of	  this	  theory	  is	  the	  finding	  that	  single	  cells	  of	   the	  embryonal	   carcinoma	  cell	   line	  NTERA2/D1	  appear	   to	    make	  lineage	   decisions	   before	   commitment	   (Tonge	   et	   al.	   2010).	   The	   uniform	  application	  of	  exogenous	  differentiation	  agents	  therefore	  may	  not	  be	  sufficient	  to	   override	   any	   intrinsic	   decisions	   that	   have	   been	   already	  made	   by	   the	   cells,	  thus	  resulting	  in	  heterogeneity	  in	  the	  resulting	  cell	  population.	  Heterogeneity	  of	  surface	  markers	  and	  gene	  expression	  patterns	  within	   the	  embryonic	   stem	  cell	  compartment	  have	  been	  documented	  and	  may	  be	   indicative	  of	  stem	  cells	  with	  these	   pre-­‐made	   commitment	   decisions	   (Graf	   &	   Stadtfeld	   2008).	   Furthermore,	  the	   observation	   that	   lineage	   associated	   genes	   can	   be	   highly	   expressed	   with	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pluripotency	  associated	  genes	   in	   single	  hESCs	   implies	   certain	   lineages	  may	  be	  favoured	  if	  a	  cell	  then	  commits	  to	  differentiate	  (Gokhale	  et	  al.	  2015).	  Thus,	  the	  heterogeneous	   differentiation	   of	   hESCs	   even	   when	   exposed	   to	   uniform	  differentiation	   conditions	   may	   be,	   in	   part,	   accounted	   for	   by	   the	   use	   of	   a	  heterogeneous	   starting	   population	   of	   stem	   cells.	   The	   mechanisms	   of	   lineage	  decisions	  thus	  appears	  more	  complex	  than	  the	  general	  activation	  or	   inhibition	  of	   signalling	  pathways	  and	   indicates	   that	  subtle	   forms	  of	  heterogeneity	  within	  the	  stem	  cell	  compartment	  can	  alter	  specification	  trajectories.	  
	  
6.3 Functionally	  discreet	  substates	  in	  the	  stem	  cell	  compartment	  	  	  	  Following	   on	   from	   our	   observations	   and	   existing	   reports	   that	   hESC	  differentiation	   is	   not	   a	   uniform	  process,	  we	  went	   back	   to	   the	   basic	   biology	   of	  fate	  decision	  mechanisms	  in	  hESCs.	  We	  were	  interested	  in	  the	  expression	  of	  the	  early	   endodermal	   marker	   GATA6	  due	   to	   the	   high	   level	   of	   co-­‐expression	   with	  genes	  associated	  with	  pluripotency	  (Gokhale	  et	  al.	  2015).	   In	  concordance	  with	  this	  report,	  we	  identified	  cells	  in	  culture	  that	  co-­‐expressed	  the	  stem	  cell	  marker	  SSEA-­‐3	   and	   GATA6,	   whereby	   a	   subset	   of	   these	   cells	   retained	   self-­‐renewal	  capacity	  over	  extended	  periods	  of	   time.	  The	   identification	  of	  a	  novel	  substates	  within	  the	  stem	  cell	  compartment,	  characterised	  by	  GATA6	  expression	  supports	  the	   concept	   that	  hierarchies	  of	   stem	  cells	   exist	   in	   culture	   (Laslett	   et	   al.	  2007).	  We	   have	   shown	   at	   the	   single	   cell	   level	   that	   the	   GATA6	   substate	   does	   confer	  functional	   alterations	   on	   the	   behaviour	   of	   cells,	   such	   that	   differentiation	   is	  biased	   towards	   the	   endoderm	   lineage.	   The	   finding	   that	   cells	   within	   the	  haematopoietic	   stem	   cell	   system	   transition	   through	   stages	   of	   priming	   before	  commitment	   to	   differentiate	   also	   translates	   to	   our	   findings	   within	   the	  pluripotent	   stem	   cell	   scenario	   (Chang	   et	   al.	   2006).	   Cells	   with	   low	   GATA6	  eaxpression	  under	  differentiation	  conditions	  show	  lineage	  bias,	  but	  under	  self-­‐renewal	   conditions	   do	   not,	  whereas	   cells	  with	   high	  GATA6	   expression	   exhibit	  differentiation	  bias	  in	  both	  conditions,	  indicative	  of	  incremental	  stages	  towards	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the	   committed	  phenotype.	  The	   concept	  of	   substates	  may	  also	  be	  applicable	   to	  adult	  systems,	  where	  evidence	  exists,	  for	  example	  in	  stem	  cells	  of	  the	  intestinal	  crypt,	   that	   the	   stem	   cell	   compartment	   shows	   degrees	   of	   heterogeneity	   in	  differentiation	  gene	  expression.	  Cells	  moving	  up	  the	  crypt	  progressively	  take	  on	  a	   more	   differentiated	   phenotype,	   which	   eventually	   becomes	   terminal.	   Some	  cells,	  however,	  can	  also	  move	  back	  down	  the	  crypt	  and	  still	  have	  the	  capacity	  for	  multi-­‐lineage	   differentiation	   and	   self-­‐renewal	   (Booth	   &	   Potten	   2000).	   The	  question	   as	   to	   why	   functional	   heterogeneity	   exists	   within	   the	   stem	   cell	  compartment	   remains	   an	   unanswered	   question,	   but	   hypotheses	   propose	   that	  heterogeneity	   allows	   the	   retention	   of	   self-­‐renewal	   capacity	   but	   provides	  windows	  of	  opportunity	  to	  respond	  to	  extrinsic	  environmental	  cues	  for	  specific	  differentiation	  (Graf	  &	  Stadtfeld	  2008).	  The	  extensive	  heterogeneity	  seen	  within	  hESCs	   may	   also	   be	   the	   reason	   for	   their	   pluripotency,	   and	   it	   is	   the	   gradual	  suppression	   of	   heterogeneity	   as	   cells	   transition	   through	   differentiation	   to	  multipotent	   cell	   types,	   which	   eventually	   results	   in	   a	   terminally	   differentiated	  specialised	  cell.	   In	  regards	  to	   the	  translation	  of	   in	  vitro	  heterogeneity	   to	   the	   in	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6.4 WNT	  signalling	  generates	  GATA6	  expressing	  hESCs	  	  	  	  The	   underlying	  mechanism	   of	  what	   drives	   the	   expression	   of	   lineage	   genes	   in	  hESCs,	   without	   necessarily	   resulting	   in	   their	   commitment	   to	   differentiate	   is	  unknown.	   With	   an	   understanding	   of	   how	   cells	   can	   balance	   two	   opposing	  lineages	  would	   not	   only	   provide	   information	   as	   to	   how	   the	   embryo	   regulates	  heterogeneity,	   but	   it	   would	   also	   offer	   potential	   strategies	   to	   develop	   more	  efficient	   and	   uniform	   differentiation	   in	   vitro.	   Our	   results	   indicate	   that	   the	  activation	  of	  WNT	  signalling,	  at	  least	  in	  part,	  is	  responsible	  for	  the	  generation	  of	  
GATA6	   expressing,	   endodermally	   biased	   stem	   cells	   in	   culture.	   A	   lack	   of	  mechanistic	   understanding	   of	   this	   substate	   meant,	   however,	   that	   we	   were	  unable	   to	   stabilise	   the	   GATA6	   substate	   within	   the	   stem	   cell	   compartment.	  Further	  work	  is	  required	  to	  find	  stable	  conditions	  for	  the	  propagation	  of	  these	  cells,	   for	   further	   analysis	   and	   for	   improved	   directed	   differentiation.	   The	  observation	   that	   the	   ground	   state	   in	   mESCs	   is	   actually	   maintained	   by	   the	  prevention	  of	  cells	  leaving	  the	  state	  through	  signalling	  inhibition	  as	  opposed	  to	  the	  active	  process	  of	  maintaining	  it	  may	  be	  relevant	  within	  this	  context	  (Ying	  et	  al.	   2008).	   The	   long-­‐term	   maintenance	   of	   GATA6	   expressing	   stem	   cells	   may	  require	   the	  blocking	  of	   signalling	  pathways	   inducing	   commitment,	  but	   further	  work	  is	  required	  to	  elucidate	  which	  pathways	  are	  important.	  Finally,	  we	  found	  that	  we	  could	   induce	  endoderm-­‐biased	  stem	  cells	   in	   feeder	   free	   conditions	  by	  inducing	  WNT	  signalling.	  The	  generation	  of	  these	  cells	  in	  feeder	  free	  conditions	  has	  provided	  a	  step	  forward	  to	  capturing	  these	  endoderm	  biased	  stem	  cells	  in	  a	  clinically	   relevant	   context.	   Although	   we	   were	   unable	   to	   stabilise	   GATA6	  expressing	  stem	  cells,	  the	  act	  of	  pre-­‐treatment	  with	  WNT	  agonists	  (specifically	  CT	  99021	  in	  this	  study)	  to	  induce	  biased	  cells,	  and	  to	  sensitise	  them	  to	  further	  differentiation	   may	   aid	   in	   homogenising	   differentiation	   whilst	   increasing	   the	  efficiency	  at	  which	  endoderm	  progenitors	  are	  generated.	  Pre-­‐treatment	  of	  cells	  using	   chemical	   inhibitors	   has	   been	   used	   to	   improve	   the	   efficiencies	   of	  differentiation,	   for	   example	   rapamycin	   and	   the	   specification	   of	   definitive	  endoderm	   (Tahamtani	   et	   al.	   2013),	   but	   the	   underlying	   mechanisms	   have	   not	  been	   studied.	   Our	   observation	   of	   discreet	   functional	   substates	   may	   well	   be	  
	   178	  
















	   179	  
7 Concluding	  remarks	  	  	  	  In	   this	   study,	  we	   sought	   to	   delineate	   lineage	   specific	   differentiation	   of	   hESCs,	  with	   a	   view	   to	   improving	   our	   understanding	   of	   human	   development.	   We	  developed	  a	  reproducible	  differentiation	  assay	  using	  embryoid	  bodies	  to	  better	  recapitulate	  embryonic	  development,	  which	  also	  proved	  useful	   as	   a	  model	   for	  predictive	  toxicology.	  Within	  this	  assay,	  it	  was	  apparent	  that	  the	  differentiation	  of	   stem	   cells	   proceeded	   in	   a	   non-­‐uniform	   and	   heterogeneous	   fashion.	   We	  therefore	   went	   back	   to	   interrogate	   the	   cause	   of	   this	   heterogeneity.	  Consequently,	  we	  found	  that	  discreet,	  yet	  functional	  substates	  existed	  within	  the	  stem	   cell	   compartment,	   and	   these	   states	   represented	   alterations	   in	   the	  probabilities	  of	  cell	  fate	  decisions.	  Using	  a	  GATA6	  reporter	  line,	  we	  were	  able	  to	  identify	  and	  characterise	  an	  endoderm	  biased	  state	  in	  uncommitted	  stem	  cells.	  Furthermore,	   we	   have	   shed	   light	   onto	   a	   potential	   mechanism	   through	   which	  these	   biased	   stem	   cells	   arise.	   With	   a	   deeper	   knowledge	   of	   the	   causes	   and	  consequences	   of	   heterogeneity	   within	   the	   stem	   cell	   compartment,	   we	   have	  developed	   a	   platform	   in	   which	   the	   differentiation	   of	   hESCs	   in	   vitro	   could	   be	  more	   homogeneous	   and	   thus	   more	   controllable.	   Finally,	   the	   assays	   we	   have	  developed	   could	   be	   applied	   in	   the	   search	   for	   other	   functionally	   discrete	  substates,	  not	  only	  within	  the	  pluripotent	  stem	  cell	  compartment,	  but	  also	  more	  committed	  cell	  types.	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